id	sid	tid	token	lemma	pos
bjp-823	1	1	introduction	introduction	NOUN
bjp-823	1	2	globally	globally	ADV
bjp-823	1	3	,	,	PUNCT
bjp-823	1	4	cardiovascular	cardiovascular	ADJ
bjp-823	1	5	disease	disease	NOUN
bjp-823	1	6	contributes	contribute	VERB
bjp-823	1	7	to	to	ADP
bjp-823	1	8	one	one	NUM
bjp-823	1	9	in	in	ADP
bjp-823	1	10	three	three	NUM
bjp-823	1	11	deaths	death	NOUN
bjp-823	1	12	(	(	PUNCT
bjp-823	1	13	eckardstien	eckardstien	ADJ
bjp-823	1	14	,	,	PUNCT
bjp-823	1	15	2005	2005	NUM
bjp-823	1	16	)	)	PUNCT
bjp-823	1	17	.	.	PUNCT
bjp-823	2	1	though	though	SCONJ
bjp-823	2	2	cardiovascular	cardiovascular	ADJ
bjp-823	2	3	disease	disease	NOUN
bjp-823	2	4	death	death	NOUN
bjp-823	2	5	rates	rate	NOUN
bjp-823	2	6	are	be	AUX
bjp-823	2	7	declining	decline	VERB
bjp-823	2	8	in	in	ADP
bjp-823	2	9	the	the	DET
bjp-823	2	10	developed	develop	VERB
bjp-823	2	11	countries	country	NOUN
bjp-823	2	12	(	(	PUNCT
bjp-823	2	13	chockalingam	chockalingam	PROPN
bjp-823	2	14	and	and	CCONJ
bjp-823	2	15	campbell	campbell	PROPN
bjp-823	2	16	,	,	PUNCT
bjp-823	2	17	2005	2005	NUM
bjp-823	2	18	)	)	PUNCT
bjp-823	2	19	it	it	PRON
bjp-823	2	20	becomes	become	VERB
bjp-823	2	21	a	a	DET
bjp-823	2	22	leading	lead	VERB
bjp-823	2	23	cause	cause	NOUN
bjp-823	2	24	of	of	ADP
bjp-823	2	25	morbidity	morbidity	NOUN
bjp-823	2	26	and	and	CCONJ
bjp-823	2	27	mortality	mortality	NOUN
bjp-823	2	28	in	in	ADP
bjp-823	2	29	the	the	DET
bjp-823	2	30	developing	develop	VERB
bjp-823	2	31	countries	country	NOUN
bjp-823	2	32	(	(	PUNCT
bjp-823	2	33	bovet	bovet	NOUN
bjp-823	2	34	et	et	PROPN
bjp-823	2	35	al	al	PROPN
bjp-823	2	36	.	.	PROPN
bjp-823	2	37	,	,	PUNCT
bjp-823	2	38	2006	2006	NUM
bjp-823	2	39	)	)	PUNCT
bjp-823	2	40	.	.	PUNCT
bjp-823	3	1	every	every	DET
bjp-823	3	2	year	year	NOUN
bjp-823	3	3	,	,	PUNCT
bjp-823	3	4	more	more	ADJ
bjp-823	3	5	than	than	ADP
bjp-823	3	6	15	15	NUM
bjp-823	3	7	million	million	NUM
bjp-823	3	8	deaths	death	NOUN
bjp-823	3	9	occur	occur	VERB
bjp-823	3	10	in	in	ADP
bjp-823	3	11	worldwide	worldwide	NOUN
bjp-823	3	12	due	due	ADP
bjp-823	3	13	to	to	ADP
bjp-823	3	14	cardiovascular	cardiovascular	ADJ
bjp-823	3	15	disease	disease	NOUN
bjp-823	3	16	.	.	PUNCT
bjp-823	4	1	of	of	ADP
bjp-823	4	2	them	they	PRON
bjp-823	4	3	9	9	NUM
bjp-823	4	4	million	million	NUM
bjp-823	4	5	deaths	death	NOUN
bjp-823	4	6	are	be	AUX
bjp-823	4	7	accounted	account	VERB
bjp-823	4	8	for	for	ADP
bjp-823	4	9	the	the	DET
bjp-823	4	10	developing	develop	VERB
bjp-823	4	11	countries	country	NOUN
bjp-823	4	12	(	(	PUNCT
bjp-823	4	13	chockalingam	chockalingam	PROPN
bjp-823	4	14	and	and	CCONJ
bjp-823	4	15	campbell	campbell	PROPN
bjp-823	4	16	,	,	PUNCT
bjp-823	4	17	2005	2005	NUM
bjp-823	4	18	)	)	PUNCT
bjp-823	4	19	.	.	PUNCT
bjp-823	5	1	the	the	DET
bjp-823	5	2	americans	americans	PROPN
bjp-823	5	3	and	and	CCONJ
bjp-823	5	4	the	the	DET
bjp-823	5	5	south	south	PROPN
bjp-823	5	6	asians	asians	PROPN
bjp-823	5	7	exhibit	exhibit	VERB
bjp-823	5	8	the	the	DET
bjp-823	5	9	highest	high	ADJ
bjp-823	5	10	prevalence	prevalence	NOUN
bjp-823	5	11	of	of	ADP
bjp-823	5	12	coronary	coronary	ADJ
bjp-823	5	13	artery	artery	NOUN
bjp-823	5	14	disease	disease	NOUN
bjp-823	5	15	and	and	CCONJ
bjp-823	5	16	coronary	coronary	ADJ
bjp-823	5	17	risk	risk	NOUN
bjp-823	5	18	factors	factor	NOUN
bjp-823	5	19	are	be	AUX
bjp-823	5	20	more	more	ADV
bjp-823	5	21	as	as	ADP
bjp-823	5	22	compared	compare	VERB
bjp-823	5	23	with	with	ADP
bjp-823	5	24	caucasians	caucasian	NOUN
bjp-823	5	25	(	(	PUNCT
bjp-823	5	26	deedwania	deedwania	PROPN
bjp-823	5	27	and	and	CCONJ
bjp-823	5	28	singh	singh	PROPN
bjp-823	5	29	,	,	PUNCT
bjp-823	5	30	2005	2005	NUM
bjp-823	5	31	)	)	PUNCT
bjp-823	5	32	.	.	PUNCT
bjp-823	6	1	the	the	DET
bjp-823	6	2	coronary	coronary	ADJ
bjp-823	6	3	artery	artery	NOUN
bjp-823	6	4	disease	disease	NOUN
bjp-823	6	5	rates	rate	NOUN
bjp-823	6	6	among	among	ADP
bjp-823	6	7	indians	indians	PROPN
bjp-823	6	8	were	be	AUX
bjp-823	6	9	6	6	NUM
bjp-823	6	10	times	time	NOUN
bjp-823	6	11	higher	high	ADJ
bjp-823	6	12	than	than	ADP
bjp-823	6	13	the	the	DET
bjp-823	6	14	chinese	chinese	PROPN
bjp-823	6	15	and	and	CCONJ
bjp-823	6	16	4	4	NUM
bjp-823	6	17	times	time	NOUN
bjp-823	6	18	higher	high	ADJ
bjp-823	6	19	than	than	ADP
bjp-823	6	20	the	the	DET
bjp-823	6	21	other	other	ADJ
bjp-823	6	22	asian	asian	ADJ
bjp-823	6	23	americans	americans	PROPN
bjp-823	6	24	(	(	PUNCT
bjp-823	6	25	mckeigue	mckeigue	NOUN
bjp-823	6	26	et	et	PROPN
bjp-823	6	27	al	al	PROPN
bjp-823	6	28	.	.	PROPN
bjp-823	6	29	,	,	PUNCT
bjp-823	6	30	1989	1989	NUM
bjp-823	6	31	)	)	PUNCT
bjp-823	6	32	.	.	PUNCT
bjp-823	7	1	in	in	ADP
bjp-823	7	2	bangladesh	bangladesh	NOUN
bjp-823	7	3	,	,	PUNCT
bjp-823	7	4	cardiovascular	cardiovascular	ADJ
bjp-823	7	5	diseases	disease	NOUN
bjp-823	7	6	are	be	AUX
bjp-823	7	7	becoming	become	VERB
bjp-823	7	8	a	a	DET
bjp-823	7	9	significant	significant	ADJ
bjp-823	7	10	burden	burden	NOUN
bjp-823	7	11	on	on	ADP
bjp-823	7	12	health	health	NOUN
bjp-823	7	13	care	care	NOUN
bjp-823	7	14	services	service	NOUN
bjp-823	7	15	(	(	PUNCT
bjp-823	7	16	sultana	sultana	NOUN
bjp-823	7	17	et	et	PROPN
bjp-823	7	18	al	al	PROPN
bjp-823	7	19	.	.	PROPN
bjp-823	7	20	,	,	PUNCT
bjp-823	7	21	2002	2002	NUM
bjp-823	7	22	)	)	PUNCT
bjp-823	7	23	.	.	PUNCT
bjp-823	8	1	dyslipidemia	dyslipidemia	NOUN
bjp-823	8	2	plays	play	VERB
bjp-823	8	3	an	an	DET
bjp-823	8	4	important	important	ADJ
bjp-823	8	5	role	role	NOUN
bjp-823	8	6	for	for	ADP
bjp-823	8	7	provocation	provocation	NOUN
bjp-823	8	8	of	of	ADP
bjp-823	8	9	cardiovascular	cardiovascular	ADJ
bjp-823	8	10	disease	disease	NOUN
bjp-823	8	11	(	(	PUNCT
bjp-823	8	12	miller	miller	PROPN
bjp-823	8	13	,	,	PUNCT
bjp-823	8	14	2003	2003	NUM
bjp-823	8	15	)	)	PUNCT
bjp-823	8	16	.	.	PUNCT
bjp-823	9	1	the	the	DET
bjp-823	9	2	major	major	ADJ
bjp-823	9	3	detrimental	detrimental	ADJ
bjp-823	9	4	components	component	NOUN
bjp-823	9	5	of	of	ADP
bjp-823	9	6	dyslipidemia	dyslipidemia	NOUN
bjp-823	9	7	are	be	AUX
bjp-823	9	8	low	low	ADJ
bjp-823	9	9	high	high	ADJ
bjp-823	9	10	density	density	NOUN
bjp-823	9	11	lipoprotein	lipoprotein	ADJ
bjp-823	9	12	cholesterol	cholesterol	NOUN
bjp-823	9	13	(	(	PUNCT
bjp-823	9	14	hdl	hdl	NOUN
bjp-823	9	15	-	-	PUNCT
bjp-823	9	16	c	c	NOUN
bjp-823	9	17	)	)	PUNCT
bjp-823	9	18	,	,	PUNCT
bjp-823	9	19	high	high	ADJ
bjp-823	9	20	triglyceride	triglyceride	ADV
bjp-823	9	21	and	and	CCONJ
bjp-823	9	22	elevated	elevated	ADJ
bjp-823	9	23	low	low	ADJ
bjp-823	9	24	density	density	NOUN
bjp-823	9	25	lipoprotein	lipoprotein	ADJ
bjp-823	9	26	cholesterol	cholesterol	NOUN
bjp-823	9	27	(	(	PUNCT
bjp-823	9	28	ldl	ldl	NOUN
bjp-823	9	29	-	-	PUNCT
bjp-823	9	30	c	c	NOUN
bjp-823	9	31	)	)	PUNCT
bjp-823	9	32	.	.	PUNCT
bjp-823	10	1	recent	recent	ADJ
bjp-823	10	2	publications	publication	NOUN
bjp-823	10	3	and	and	CCONJ
bjp-823	10	4	guidelines	guideline	NOUN
bjp-823	10	5	have	have	AUX
bjp-823	10	6	raised	raise	VERB
bjp-823	10	7	awareness	awareness	NOUN
bjp-823	10	8	of	of	ADP
bjp-823	10	9	the	the	DET
bjp-823	10	10	need	need	NOUN
bjp-823	10	11	to	to	PART
bjp-823	10	12	prompt	prompt	VERB
bjp-823	10	13	treatment	treatment	NOUN
bjp-823	10	14	of	of	ADP
bjp-823	10	15	dyslipidemia	dyslipidemia	NOUN
bjp-823	10	16	to	to	PART
bjp-823	10	17	reduce	reduce	VERB
bjp-823	10	18	cardiovascular	cardiovascular	ADJ
bjp-823	10	19	risks	risk	NOUN
bjp-823	10	20	in	in	ADP
bjp-823	10	21	patients	patient	NOUN
bjp-823	10	22	with	with	ADP
bjp-823	10	23	diabetes	diabetes	NOUN
bjp-823	10	24	or	or	CCONJ
bjp-823	10	25	metabolic	metabolic	NOUN
bjp-823	10	26	syndrome	syndrome	NOUN
bjp-823	10	27	(	(	PUNCT
bjp-823	10	28	davidson	davidson	NOUN
bjp-823	10	29	,	,	PUNCT
bjp-823	10	30	2003	2003	NUM
bjp-823	10	31	)	)	PUNCT
bjp-823	10	32	.	.	PUNCT
bjp-823	11	1	a	a	DET
bjp-823	11	2	journal	journal	NOUN
bjp-823	11	3	of	of	ADP
bjp-823	11	4	the	the	DET
bjp-823	11	5	bangladesh	bangladesh	NOUN
bjp-823	11	6	pharmacological	pharmacological	ADJ
bjp-823	11	7	society	society	NOUN
bjp-823	11	8	(	(	PUNCT
bjp-823	11	9	bdps	bdps	NOUN
bjp-823	11	10	)	)	PUNCT
bjp-823	11	11	bangladesh	bangladesh	PROPN
bjp-823	11	12	j	j	PROPN
bjp-823	11	13	pharmacol	pharmacol	PROPN
bjp-823	11	14	2008	2008	NUM
bjp-823	11	15	;	;	PUNCT
bjp-823	11	16	3	3	NUM
bjp-823	11	17	:	:	SYM
bjp-823	11	18	8	8	NUM
bjp-823	11	19	-	-	SYM
bjp-823	11	20	16	16	NUM
bjp-823	11	21	journal	journal	NOUN
bjp-823	11	22	homepage	homepage	NOUN
bjp-823	11	23	:	:	PUNCT
bjp-823	11	24	www.banglajol.info	www.banglajol.info	PROPN
bjp-823	11	25	abstracted	abstract	VERB
bjp-823	11	26	/	/	SYM
bjp-823	11	27	indexed	index	VERB
bjp-823	11	28	in	in	ADP
bjp-823	11	29	academic	academic	ADJ
bjp-823	11	30	search	search	NOUN
bjp-823	11	31	complete	complete	ADJ
bjp-823	11	32	,	,	PUNCT
bjp-823	11	33	asia	asia	PROPN
bjp-823	11	34	journals	journal	NOUN
bjp-823	11	35	online	online	ADV
bjp-823	11	36	,	,	PUNCT
bjp-823	11	37	bangladesh	bangladesh	NOUN
bjp-823	11	38	journals	journal	NOUN
bjp-823	11	39	online	online	ADV
bjp-823	11	40	,	,	PUNCT
bjp-823	11	41	biological	biological	ADJ
bjp-823	11	42	abstracts	abstract	NOUN
bjp-823	11	43	,	,	PUNCT
bjp-823	11	44	biosis	biosis	NOUN
bjp-823	11	45	previews	preview	NOUN
bjp-823	11	46	,	,	PUNCT
bjp-823	11	47	cab	cab	NOUN
bjp-823	11	48	abstracts	abstract	NOUN
bjp-823	11	49	,	,	PUNCT
bjp-823	11	50	current	current	ADJ
bjp-823	11	51	abstracts	abstract	NOUN
bjp-823	11	52	,	,	PUNCT
bjp-823	11	53	directory	directory	NOUN
bjp-823	11	54	of	of	ADP
bjp-823	11	55	open	open	ADJ
bjp-823	11	56	access	access	NOUN
bjp-823	11	57	journals	journal	NOUN
bjp-823	11	58	,	,	PUNCT
bjp-823	11	59	embase	embase	NOUN
bjp-823	11	60	/	/	SYM
bjp-823	11	61	excerpta	excerpta	NOUN
bjp-823	11	62	medica	medica	NOUN
bjp-823	11	63	,	,	PUNCT
bjp-823	11	64	google	google	PROPN
bjp-823	11	65	scholar	scholar	NOUN
bjp-823	11	66	,	,	PUNCT
bjp-823	11	67	hinari	hinari	X
bjp-823	11	68	(	(	PUNCT
bjp-823	11	69	who	who	PRON
bjp-823	11	70	)	)	PUNCT
bjp-823	11	71	,	,	PUNCT
bjp-823	11	72	international	international	ADJ
bjp-823	11	73	pharmaceutical	pharmaceutical	ADJ
bjp-823	11	74	abstracts	abstract	NOUN
bjp-823	11	75	,	,	PUNCT
bjp-823	11	76	open	open	ADJ
bjp-823	11	77	j	j	PROPN
bjp-823	11	78	-	-	PUNCT
bjp-823	11	79	gate	gate	NOUN
bjp-823	11	80	,	,	PUNCT
bjp-823	11	81	science	science	NOUN
bjp-823	11	82	citation	citation	NOUN
bjp-823	11	83	index	index	NOUN
bjp-823	11	84	expanded	expand	VERB
bjp-823	11	85	,	,	PUNCT
bjp-823	11	86	scopus	scopus	NOUN
bjp-823	11	87	and	and	CCONJ
bjp-823	11	88	social	social	ADJ
bjp-823	11	89	sciences	sciences	PROPN
bjp-823	11	90	citation	citation	NOUN
bjp-823	11	91	index	index	NOUN
bjp-823	11	92	;	;	PUNCT
bjp-823	11	93	issn	issn	PROPN
bjp-823	11	94	:	:	PUNCT
bjp-823	11	95	1991	1991	NUM
bjp-823	11	96	-	-	SYM
bjp-823	11	97	0088	0088	NUM
bjp-823	11	98	abstract	abstract	NOUN
bjp-823	11	99	the	the	DET
bjp-823	11	100	study	study	NOUN
bjp-823	11	101	was	be	AUX
bjp-823	11	102	designed	design	VERB
bjp-823	11	103	to	to	PART
bjp-823	11	104	evaluate	evaluate	VERB
bjp-823	11	105	and	and	CCONJ
bjp-823	11	106	compare	compare	VERB
bjp-823	11	107	the	the	DET
bjp-823	11	108	effects	effect	NOUN
bjp-823	11	109	of	of	ADP
bjp-823	11	110	coadministration	coadministration	NOUN
bjp-823	11	111	of	of	ADP
bjp-823	11	112	atorvastatin	atorvastatin	NOUN
bjp-823	11	113	(	(	PUNCT
bjp-823	11	114	10	10	NUM
bjp-823	11	115	mg	mg	NOUN
bjp-823	11	116	)	)	PUNCT
bjp-823	11	117	either	either	CCONJ
bjp-823	11	118	with	with	ADP
bjp-823	11	119	niacin	niacin	NOUN
bjp-823	11	120	(	(	PUNCT
bjp-823	11	121	1	1	NUM
bjp-823	11	122	g	g	NOUN
bjp-823	11	123	)	)	PUNCT
bjp-823	11	124	or	or	CCONJ
bjp-823	11	125	fenofibrate	fenofibrate	NOUN
bjp-823	11	126	(	(	PUNCT
bjp-823	11	127	200	200	NUM
bjp-823	11	128	mg	mg	NOUN
bjp-823	11	129	)	)	PUNCT
bjp-823	11	130	daily	daily	ADV
bjp-823	11	131	for	for	ADP
bjp-823	11	132	12	12	NUM
bjp-823	11	133	weeks	week	NOUN
bjp-823	11	134	in	in	ADP
bjp-823	11	135	67	67	NUM
bjp-823	11	136	coronary	coronary	ADJ
bjp-823	11	137	heart	heart	NOUN
bjp-823	11	138	disease	disease	NOUN
bjp-823	11	139	patients	patient	NOUN
bjp-823	11	140	with	with	ADP
bjp-823	11	141	dyslipidemia	dyslipidemia	NOUN
bjp-823	11	142	.	.	PUNCT
bjp-823	12	1	there	there	PRON
bjp-823	12	2	were	be	VERB
bjp-823	12	3	no	no	DET
bjp-823	12	4	significant	significant	ADJ
bjp-823	12	5	differences	difference	NOUN
bjp-823	12	6	among	among	ADP
bjp-823	12	7	the	the	DET
bjp-823	12	8	two	two	NUM
bjp-823	12	9	groups	group	NOUN
bjp-823	12	10	(	(	PUNCT
bjp-823	12	11	35	35	NUM
bjp-823	12	12	patients	patient	NOUN
bjp-823	12	13	in	in	ADP
bjp-823	12	14	group	group	NOUN
bjp-823	12	15	i	i	PROPN
bjp-823	12	16	and	and	CCONJ
bjp-823	12	17	32	32	NUM
bjp-823	12	18	patients	patient	NOUN
bjp-823	12	19	in	in	ADP
bjp-823	12	20	group	group	PROPN
bjp-823	12	21	ii	ii	PROPN
bjp-823	12	22	)	)	PUNCT
bjp-823	12	23	in	in	ADP
bjp-823	12	24	serum	serum	NOUN
bjp-823	12	25	lipid	lipid	NOUN
bjp-823	12	26	profile	profile	NOUN
bjp-823	12	27	except	except	SCONJ
bjp-823	12	28	in	in	ADP
bjp-823	12	29	level	level	NOUN
bjp-823	12	30	of	of	ADP
bjp-823	12	31	triglyceride	triglyceride	ADJ
bjp-823	12	32	reduction	reduction	NOUN
bjp-823	12	33	where	where	SCONJ
bjp-823	12	34	fenofibrate	fenofibrate	NOUN
bjp-823	12	35	-	-	PUNCT
bjp-823	12	36	atorvastatin	atorvastatin	PROPN
bjp-823	12	37	combination	combination	NOUN
bjp-823	12	38	yielded	yield	VERB
bjp-823	12	39	significant	significant	ADJ
bjp-823	12	40	(	(	PUNCT
bjp-823	12	41	p<0.001	p<0.001	ADJ
bjp-823	12	42	)	)	PUNCT
bjp-823	12	43	results	result	NOUN
bjp-823	12	44	.	.	PUNCT
bjp-823	13	1	sgpt	sgpt	NOUN
bjp-823	13	2	level	level	NOUN
bjp-823	13	3	significantly	significantly	ADV
bjp-823	13	4	raised	raise	VERB
bjp-823	13	5	and	and	CCONJ
bjp-823	13	6	fasting	fast	VERB
bjp-823	13	7	blood	blood	NOUN
bjp-823	13	8	glucose	glucose	NOUN
bjp-823	13	9	level	level	NOUN
bjp-823	13	10	decreased	decrease	VERB
bjp-823	13	11	in	in	ADP
bjp-823	13	12	fenofibrate	fenofibrate	NOUN
bjp-823	13	13	-	-	PUNCT
bjp-823	13	14	atorvastatin	atorvastatin	PROPN
bjp-823	13	15	treated	treat	VERB
bjp-823	13	16	group	group	NOUN
bjp-823	13	17	than	than	ADP
bjp-823	13	18	niacin	niacin	NOUN
bjp-823	13	19	-	-	PUNCT
bjp-823	13	20	atorvastatin	atorvastatin	NOUN
bjp-823	13	21	combination	combination	NOUN
bjp-823	13	22	.	.	PUNCT
bjp-823	14	1	serum	serum	NOUN
bjp-823	14	2	creatinine	creatinine	NOUN
bjp-823	14	3	level	level	NOUN
bjp-823	14	4	decreased	decrease	VERB
bjp-823	14	5	in	in	ADP
bjp-823	14	6	niacin	niacin	NOUN
bjp-823	14	7	-	-	PUNCT
bjp-823	14	8	atorvastatin	atorvastatin	PROPN
bjp-823	14	9	treated	treat	VERB
bjp-823	14	10	group	group	NOUN
bjp-823	14	11	compared	compare	VERB
bjp-823	14	12	to	to	ADP
bjp-823	14	13	fenofibrate	fenofibrate	NOUN
bjp-823	14	14	-	-	PUNCT
bjp-823	14	15	atorvastatin	atorvastatin	NOUN
bjp-823	14	16	,	,	PUNCT
bjp-823	14	17	but	but	CCONJ
bjp-823	14	18	the	the	DET
bjp-823	14	19	changes	change	NOUN
bjp-823	14	20	was	be	AUX
bjp-823	14	21	within	within	ADP
bjp-823	14	22	normal	normal	ADJ
bjp-823	14	23	limit	limit	NOUN
bjp-823	14	24	.	.	PUNCT
bjp-823	15	1	this	this	DET
bjp-823	15	2	study	study	NOUN
bjp-823	15	3	shows	show	VERB
bjp-823	15	4	that	that	SCONJ
bjp-823	15	5	both	both	DET
bjp-823	15	6	combinations	combination	NOUN
bjp-823	15	7	are	be	AUX
bjp-823	15	8	equally	equally	ADV
bjp-823	15	9	effective	effective	ADJ
bjp-823	15	10	in	in	ADP
bjp-823	15	11	dyslipidemia	dyslipidemia	NOUN
bjp-823	15	12	.	.	PUNCT
bjp-823	16	1	although	although	SCONJ
bjp-823	16	2	,	,	PUNCT
bjp-823	16	3	fenofibrate	fenofibrate	NOUN
bjp-823	16	4	-	-	PUNCT
bjp-823	16	5	atorvastatin	atorvastatin	PROPN
bjp-823	16	6	combination	combination	NOUN
bjp-823	16	7	decreased	decrease	VERB
bjp-823	16	8	more	more	ADV
bjp-823	16	9	triglyceride	triglyceride	ADJ
bjp-823	16	10	and	and	CCONJ
bjp-823	16	11	niacin	niacin	NOUN
bjp-823	16	12	-	-	PUNCT
bjp-823	16	13	atorvastatin	atorvastatin	NOUN
bjp-823	16	14	combination	combination	NOUN
bjp-823	16	15	appeared	appear	VERB
bjp-823	16	16	safer	safe	ADJ
bjp-823	16	17	considering	consider	VERB
bjp-823	16	18	some	some	DET
bjp-823	16	19	adverse	adverse	ADJ
bjp-823	16	20	effects	effect	NOUN
bjp-823	16	21	.	.	PUNCT
bjp-823	17	1	article	article	NOUN
bjp-823	17	2	info	info	NOUN
bjp-823	17	3	received	receive	VERB
bjp-823	17	4	:	:	PUNCT
bjp-823	17	5	28	28	NUM
bjp-823	17	6	january	january	PROPN
bjp-823	17	7	2008	2008	NUM
bjp-823	17	8	accepted	accept	VERB
bjp-823	17	9	:	:	PUNCT
bjp-823	17	10	8	8	NUM
bjp-823	17	11	april	april	PROPN
bjp-823	17	12	2008	2008	NUM
bjp-823	17	13	available	available	ADJ
bjp-823	17	14	online	online	NOUN
bjp-823	17	15	:	:	PUNCT
bjp-823	17	16	19	19	NUM
bjp-823	17	17	april	april	PROPN
bjp-823	17	18	2008	2008	NUM
bjp-823	17	19	doi	doi	NOUN
bjp-823	17	20	:	:	PUNCT
bjp-823	17	21	10.3329	10.3329	NUM
bjp-823	17	22	/	/	SYM
bjp-823	17	23	bjp.v3i1.823	bjp.v3i1.823	NOUN
bjp-823	17	24	cite	cite	VERB
bjp-823	17	25	this	this	DET
bjp-823	17	26	article	article	NOUN
bjp-823	17	27	:	:	PUNCT
bjp-823	17	28	ahmed	ahmed	PROPN
bjp-823	17	29	s	s	PROPN
bjp-823	17	30	,	,	PUNCT
bjp-823	17	31	hossain	hossain	PROPN
bjp-823	17	32	akmm	akmm	PROPN
bjp-823	17	33	,	,	PUNCT
bjp-823	17	34	dey	dey	PROPN
bjp-823	17	35	sr	sr	PROPN
bjp-823	17	36	,	,	PUNCT
bjp-823	17	37	akhtaruzzaman	akhtaruzzaman	PROPN
bjp-823	17	38	akm	akm	PROPN
bjp-823	17	39	,	,	PUNCT
bjp-823	17	40	siddika	siddika	PROPN
bjp-823	17	41	mm	mm	PROPN
bjp-823	17	42	.	.	PUNCT
bjp-823	18	1	a	a	DET
bjp-823	18	2	comparative	comparative	ADJ
bjp-823	18	3	study	study	NOUN
bjp-823	18	4	on	on	ADP
bjp-823	18	5	the	the	DET
bjp-823	18	6	effects	effect	NOUN
bjp-823	18	7	of	of	ADP
bjp-823	18	8	niacin	niacin	NOUN
bjp-823	18	9	plus	plus	CCONJ
bjp-823	18	10	atorvastatin	atorvastatin	NOUN
bjp-823	18	11	with	with	ADP
bjp-823	18	12	that	that	PRON
bjp-823	18	13	of	of	ADP
bjp-823	18	14	fenofibrate	fenofibrate	NOUN
bjp-823	18	15	plus	plus	CCONJ
bjp-823	18	16	atorvastatin	atorvastatin	NOUN
bjp-823	18	17	in	in	ADP
bjp-823	18	18	dyslipidemia	dyslipidemia	NOUN
bjp-823	18	19	patients	patient	NOUN
bjp-823	18	20	.	.	PUNCT
bjp-823	19	1	bangladesh	bangladesh	PROPN
bjp-823	19	2	j	j	PROPN
bjp-823	19	3	pharmacol	pharmacol	PROPN
bjp-823	19	4	.	.	PROPN
bjp-823	19	5	2008	2008	NUM
bjp-823	19	6	;	;	PUNCT
bjp-823	19	7	3	3	NUM
bjp-823	19	8	:	:	SYM
bjp-823	19	9	8	8	NUM
bjp-823	19	10	-	-	SYM
bjp-823	19	11	16	16	NUM
bjp-823	19	12	.	.	PUNCT
bjp-823	20	1	a	a	DET
bjp-823	20	2	comparative	comparative	ADJ
bjp-823	20	3	study	study	NOUN
bjp-823	20	4	on	on	ADP
bjp-823	20	5	the	the	DET
bjp-823	20	6	effects	effect	NOUN
bjp-823	20	7	of	of	ADP
bjp-823	20	8	niacin	niacin	NOUN
bjp-823	20	9	plus	plus	CCONJ
bjp-823	20	10	atorvastatin	atorvastatin	NOUN
bjp-823	20	11	with	with	ADP
bjp-823	20	12	that	that	PRON
bjp-823	20	13	of	of	ADP
bjp-823	20	14	fenofibrate	fenofibrate	NOUN
bjp-823	20	15	plus	plus	CCONJ
bjp-823	20	16	atorvastatin	atorvastatin	NOUN
bjp-823	20	17	in	in	ADP
bjp-823	20	18	dyslipidemia	dyslipidemia	NOUN
bjp-823	20	19	patients	patient	NOUN
bjp-823	20	20	salim	salim	PROPN
bjp-823	20	21	ahmed1	ahmed1	PROPN
bjp-823	20	22	,	,	PUNCT
bjp-823	20	23	a.	a.	PROPN
bjp-823	20	24	k.	k.	PROPN
bjp-823	20	25	m.	m.	PROPN
bjp-823	20	26	mosharrof	mosharrof	PROPN
bjp-823	20	27	hossain1	hossain1	PROPN
bjp-823	20	28	,	,	PUNCT
bjp-823	20	29	sudhangshu	sudhangshu	NOUN
bjp-823	20	30	ranjan	ranjan	PROPN
bjp-823	20	31	dey2	dey2	PROPN
bjp-823	20	32	,	,	PUNCT
bjp-823	20	33	a.	a.	PROPN
bjp-823	20	34	k.	k.	PROPN
bjp-823	20	35	m.	m.	PROPN
bjp-823	21	1	akhtaruzzaman2	akhtaruzzaman2	PROPN
bjp-823	21	2	,	,	PUNCT
bjp-823	21	3	and	and	CCONJ
bjp-823	21	4	musammath	musammath	NOUN
bjp-823	21	5	moriom	moriom	PROPN
bjp-823	21	6	siddika3	siddika3	PROPN
bjp-823	21	7	department	department	PROPN
bjp-823	21	8	of	of	ADP
bjp-823	21	9	1pharmacology	1pharmacology	NUM
bjp-823	21	10	,	,	PUNCT
bjp-823	21	11	2cardiology	2cardiology	PROPN
bjp-823	21	12	and	and	CCONJ
bjp-823	21	13	3pediatrics	3pediatrics	NUM
bjp-823	21	14	,	,	PUNCT
bjp-823	21	15	sylhet	sylhet	NOUN
bjp-823	21	16	m.	m.	NOUN
bjp-823	21	17	a.	a.	PROPN
bjp-823	21	18	g.	g.	PROPN
bjp-823	21	19	osmani	osmani	PROPN
bjp-823	22	1	medical	medical	PROPN
bjp-823	22	2	college	college	PROPN
bjp-823	22	3	,	,	PUNCT
bjp-823	22	4	sylhet	sylhet	NOUN
bjp-823	22	5	3100	3100	NUM
bjp-823	22	6	,	,	PUNCT
bjp-823	22	7	bangladesh	bangladesh	NOUN
bjp-823	22	8	.	.	PUNCT
bjp-823	23	1	this	this	DET
bjp-823	23	2	work	work	NOUN
bjp-823	23	3	is	be	AUX
bjp-823	23	4	licensed	license	VERB
bjp-823	23	5	under	under	ADP
bjp-823	23	6	a	a	DET
bjp-823	23	7	creative	creative	ADJ
bjp-823	23	8	commons	common	NOUN
bjp-823	23	9	attribution	attribution	NOUN
bjp-823	23	10	4.0	4.0	NUM
bjp-823	23	11	license	license	NOUN
bjp-823	23	12	.	.	PUNCT
bjp-823	24	1	you	you	PRON
bjp-823	24	2	are	be	AUX
bjp-823	24	3	free	free	ADJ
bjp-823	24	4	to	to	PART
bjp-823	24	5	copy	copy	VERB
bjp-823	24	6	,	,	PUNCT
bjp-823	24	7	distribute	distribute	VERB
bjp-823	24	8	and	and	CCONJ
bjp-823	24	9	perform	perform	VERB
bjp-823	24	10	the	the	DET
bjp-823	24	11	work	work	NOUN
bjp-823	24	12	.	.	PUNCT
bjp-823	25	1	you	you	PRON
bjp-823	25	2	must	must	AUX
bjp-823	25	3	attribute	attribute	VERB
bjp-823	25	4	the	the	DET
bjp-823	25	5	work	work	NOUN
bjp-823	25	6	in	in	ADP
bjp-823	25	7	the	the	DET
bjp-823	25	8	manner	manner	NOUN
bjp-823	25	9	specified	specify	VERB
bjp-823	25	10	by	by	ADP
bjp-823	25	11	the	the	DET
bjp-823	25	12	author	author	NOUN
bjp-823	25	13	or	or	CCONJ
bjp-823	25	14	licensor	licensor	NOUN
bjp-823	25	15	.	.	PUNCT
bjp-823	26	1	low	low	PROPN
bjp-823	26	2	hdl	hdl	PROPN
bjp-823	26	3	-	-	PUNCT
bjp-823	26	4	c	c	PROPN
bjp-823	26	5	is	be	AUX
bjp-823	26	6	an	an	DET
bjp-823	26	7	independent	independent	ADJ
bjp-823	26	8	risk	risk	NOUN
bjp-823	26	9	factor	factor	NOUN
bjp-823	26	10	for	for	ADP
bjp-823	26	11	coronary	coronary	ADJ
bjp-823	26	12	artery	artery	NOUN
bjp-823	26	13	disease	disease	NOUN
bjp-823	26	14	and	and	CCONJ
bjp-823	26	15	its	its	PRON
bjp-823	26	16	prevalence	prevalence	NOUN
bjp-823	26	17	is	be	AUX
bjp-823	26	18	high	high	ADJ
bjp-823	26	19	and	and	CCONJ
bjp-823	26	20	increasing	increase	VERB
bjp-823	26	21	(	(	PUNCT
bjp-823	26	22	gordon	gordon	PROPN
bjp-823	26	23	et	et	PROPN
bjp-823	26	24	al	al	PROPN
bjp-823	26	25	.	.	PROPN
bjp-823	26	26	,	,	PUNCT
bjp-823	26	27	1977	1977	NUM
bjp-823	26	28	)	)	PUNCT
bjp-823	26	29	.	.	PUNCT
bjp-823	27	1	the	the	DET
bjp-823	27	2	prevalence	prevalence	NOUN
bjp-823	27	3	of	of	ADP
bjp-823	27	4	low	low	ADJ
bjp-823	27	5	hdl	hdl	PROPN
bjp-823	27	6	-	-	PUNCT
bjp-823	27	7	c	c	PROPN
bjp-823	27	8	appears	appear	VERB
bjp-823	27	9	to	to	PART
bjp-823	27	10	be	be	AUX
bjp-823	27	11	high	high	ADJ
bjp-823	27	12	in	in	ADP
bjp-823	27	13	latin	latin	ADJ
bjp-823	27	14	american	american	ADJ
bjp-823	27	15	subjects	subject	NOUN
bjp-823	27	16	,	,	PUNCT
bjp-823	27	17	as	as	SCONJ
bjp-823	27	18	shown	show	VERB
bjp-823	27	19	by	by	ADP
bjp-823	27	20	surveys	survey	NOUN
bjp-823	27	21	carried	carry	VERB
bjp-823	27	22	out	out	ADP
bjp-823	27	23	in	in	ADP
bjp-823	27	24	mexico	mexico	PROPN
bjp-823	27	25	(	(	PUNCT
bjp-823	27	26	92.1	92.1	NUM
bjp-823	27	27	%	%	NOUN
bjp-823	27	28	in	in	ADP
bjp-823	27	29	men	man	NOUN
bjp-823	27	30	,	,	PUNCT
bjp-823	27	31	96.6	96.6	NUM
bjp-823	27	32	%	%	NOUN
bjp-823	27	33	in	in	ADP
bjp-823	27	34	women	woman	NOUN
bjp-823	27	35	)	)	PUNCT
bjp-823	27	36	and	and	CCONJ
bjp-823	27	37	brazil	brazil	PROPN
bjp-823	27	38	(	(	PUNCT
bjp-823	27	39	50	50	NUM
bjp-823	27	40	%	%	NOUN
bjp-823	27	41	both	both	CCONJ
bjp-823	27	42	men	man	NOUN
bjp-823	27	43	and	and	CCONJ
bjp-823	27	44	women	woman	NOUN
bjp-823	27	45	)	)	PUNCT
bjp-823	27	46	.	.	PUNCT
bjp-823	28	1	in	in	ADP
bjp-823	28	2	mexico	mexico	PROPN
bjp-823	28	3	,	,	PUNCT
bjp-823	28	4	the	the	DET
bjp-823	28	5	prevalence	prevalence	NOUN
bjp-823	28	6	of	of	ADP
bjp-823	28	7	low	low	ADJ
bjp-823	28	8	hdl	hdl	PROPN
bjp-823	28	9	-	-	PUNCT
bjp-823	28	10	c	c	PROPN
bjp-823	28	11	increased	increase	VERB
bjp-823	28	12	by	by	ADP
bjp-823	28	13	23	23	NUM
bjp-823	28	14	%	%	NOUN
bjp-823	28	15	within	within	ADP
bjp-823	28	16	a	a	DET
bjp-823	28	17	period	period	NOUN
bjp-823	28	18	of	of	ADP
bjp-823	28	19	only	only	ADV
bjp-823	28	20	7	7	NUM
bjp-823	28	21	years	year	NOUN
bjp-823	28	22	(	(	PUNCT
bjp-823	28	23	bruckert	bruckert	NOUN
bjp-823	28	24	,	,	PUNCT
bjp-823	28	25	2006	2006	NUM
bjp-823	28	26	)	)	PUNCT
bjp-823	28	27	.	.	PUNCT
bjp-823	29	1	the	the	DET
bjp-823	29	2	prevalence	prevalence	NOUN
bjp-823	29	3	in	in	ADP
bjp-823	29	4	uk	uk	PROPN
bjp-823	29	5	showed	show	VERB
bjp-823	29	6	that	that	SCONJ
bjp-823	29	7	approximately	approximately	ADV
bjp-823	29	8	one	one	NUM
bjp-823	29	9	man	man	NOUN
bjp-823	29	10	in	in	ADP
bjp-823	29	11	four	four	NUM
bjp-823	29	12	and	and	CCONJ
bjp-823	29	13	about	about	ADV
bjp-823	29	14	one	one	NUM
bjp-823	29	15	woman	woman	NOUN
bjp-823	29	16	in	in	ADP
bjp-823	29	17	twelve	twelve	NUM
bjp-823	29	18	had	have	VERB
bjp-823	29	19	low	low	ADJ
bjp-823	29	20	hdlc	hdlc	NOUN
bjp-823	29	21	(	(	PUNCT
bjp-823	29	22	patel	patel	PROPN
bjp-823	29	23	et	et	PROPN
bjp-823	29	24	al	al	PROPN
bjp-823	29	25	.	.	PROPN
bjp-823	29	26	,	,	PUNCT
bjp-823	29	27	2004	2004	NUM
bjp-823	29	28	)	)	PUNCT
bjp-823	29	29	.	.	PUNCT
bjp-823	30	1	the	the	DET
bjp-823	30	2	overall	overall	ADJ
bjp-823	30	3	prevalence	prevalence	NOUN
bjp-823	30	4	of	of	ADP
bjp-823	30	5	low	low	ADJ
bjp-823	30	6	hdl	hdl	PROPN
bjp-823	30	7	-c	-c	PUNCT
bjp-823	30	8	was	be	AUX
bjp-823	30	9	33	33	NUM
bjp-823	30	10	%	%	NOUN
bjp-823	30	11	in	in	ADP
bjp-823	30	12	men	man	NOUN
bjp-823	30	13	and	and	CCONJ
bjp-823	30	14	40	40	NUM
bjp-823	30	15	%	%	NOUN
bjp-823	30	16	in	in	ADP
bjp-823	30	17	women	woman	NOUN
bjp-823	30	18	.	.	PUNCT
bjp-823	31	1	an	an	DET
bjp-823	31	2	elevated	elevated	ADJ
bjp-823	31	3	triglyceride	triglyceride	ADV
bjp-823	31	4	often	often	ADV
bjp-823	31	5	accompanies	accompany	VERB
bjp-823	31	6	low	low	ADJ
bjp-823	31	7	hdl	hdl	PROPN
bjp-823	31	8	-	-	PUNCT
bjp-823	31	9	c	c	PROPN
bjp-823	31	10	,	,	PUNCT
bjp-823	31	11	found	find	VERB
bjp-823	31	12	in	in	ADP
bjp-823	31	13	47	47	NUM
bjp-823	31	14	-57	-57	NUM
bjp-823	31	15	%	%	NOUN
bjp-823	31	16	of	of	ADP
bjp-823	31	17	men	man	NOUN
bjp-823	31	18	and	and	CCONJ
bjp-823	31	19	44	44	NUM
bjp-823	31	20	-	-	SYM
bjp-823	31	21	48	48	NUM
bjp-823	31	22	%	%	NOUN
bjp-823	31	23	of	of	ADP
bjp-823	31	24	women	woman	NOUN
bjp-823	31	25	.	.	PUNCT
bjp-823	32	1	combined	combine	VERB
bjp-823	32	2	lipid	lipid	NOUN
bjp-823	32	3	abnormalities	abnormality	NOUN
bjp-823	32	4	occurred	occur	VERB
bjp-823	32	5	together	together	ADV
bjp-823	32	6	in	in	ADP
bjp-823	32	7	21	21	NUM
bjp-823	32	8	-	-	SYM
bjp-823	32	9	26	26	NUM
bjp-823	32	10	%	%	NOUN
bjp-823	32	11	of	of	ADP
bjp-823	32	12	men	man	NOUN
bjp-823	32	13	and	and	CCONJ
bjp-823	32	14	25	25	NUM
bjp-823	32	15	-	-	SYM
bjp-823	32	16	27	27	NUM
bjp-823	32	17	%	%	NOUN
bjp-823	32	18	of	of	ADP
bjp-823	32	19	women	woman	NOUN
bjp-823	32	20	(	(	PUNCT
bjp-823	32	21	bruckert	bruckert	NOUN
bjp-823	32	22	,	,	PUNCT
bjp-823	32	23	2006	2006	NUM
bjp-823	32	24	)	)	PUNCT
bjp-823	32	25	.	.	PUNCT
bjp-823	33	1	according	accord	VERB
bjp-823	33	2	to	to	ADP
bjp-823	33	3	framingham	framingham	PROPN
bjp-823	33	4	study	study	PROPN
bjp-823	33	5	,	,	PUNCT
bjp-823	33	6	in	in	ADP
bjp-823	33	7	older	old	ADJ
bjp-823	33	8	men	man	NOUN
bjp-823	33	9	and	and	CCONJ
bjp-823	33	10	women	woman	NOUN
bjp-823	33	11	from	from	ADP
bjp-823	33	12	age	age	NOUN
bjp-823	33	13	49	49	NUM
bjp-823	33	14	to	to	PART
bjp-823	33	15	82	82	NUM
bjp-823	33	16	years	year	NOUN
bjp-823	33	17	,	,	PUNCT
bjp-823	33	18	the	the	DET
bjp-823	33	19	most	most	ADV
bjp-823	33	20	potent	potent	ADJ
bjp-823	33	21	risk	risk	NOUN
bjp-823	33	22	factor	factor	NOUN
bjp-823	33	23	for	for	ADP
bjp-823	33	24	coronary	coronary	ADJ
bjp-823	33	25	artery	artery	NOUN
bjp-823	33	26	disease	disease	NOUN
bjp-823	33	27	was	be	AUX
bjp-823	33	28	low	low	ADJ
bjp-823	33	29	hdl	hdl	PROPN
bjp-823	33	30	-	-	PUNCT
bjp-823	33	31	c.	c.	PROPN
bjp-823	33	32	low	low	PROPN
bjp-823	33	33	hdl	hdl	PROPN
bjp-823	33	34	-	-	PUNCT
bjp-823	33	35	c	c	PROPN
bjp-823	33	36	had	have	VERB
bjp-823	33	37	an	an	DET
bjp-823	33	38	inverse	inverse	NOUN
bjp-823	33	39	association	association	NOUN
bjp-823	33	40	with	with	ADP
bjp-823	33	41	coronary	coronary	ADJ
bjp-823	33	42	artery	artery	NOUN
bjp-823	33	43	disease	disease	NOUN
bjp-823	33	44	in	in	ADP
bjp-823	33	45	men	man	NOUN
bjp-823	33	46	and	and	CCONJ
bjp-823	33	47	women	woman	NOUN
bjp-823	33	48	.	.	PUNCT
bjp-823	34	1	the	the	DET
bjp-823	34	2	association	association	NOUN
bjp-823	34	3	between	between	ADP
bjp-823	34	4	ldl	ldl	PROPN
bjp-823	34	5	-	-	PUNCT
bjp-823	34	6	c	c	PROPN
bjp-823	34	7	was	be	AUX
bjp-823	34	8	weaker	weak	ADJ
bjp-823	34	9	than	than	ADP
bjp-823	34	10	hdl	hdl	NOUN
bjp-823	34	11	-	-	PUNCT
bjp-823	34	12	c	c	PROPN
bjp-823	34	13	(	(	PUNCT
bjp-823	34	14	gorden	gorden	PROPN
bjp-823	34	15	et	et	PROPN
bjp-823	34	16	al	al	PROPN
bjp-823	34	17	.	.	PROPN
bjp-823	34	18	,	,	PUNCT
bjp-823	34	19	1977	1977	NUM
bjp-823	34	20	)	)	PUNCT
bjp-823	34	21	.	.	PUNCT
bjp-823	35	1	low	low	PROPN
bjp-823	35	2	hdl	hdl	PROPN
bjp-823	35	3	-	-	PUNCT
bjp-823	35	4	c	c	PROPN
bjp-823	35	5	together	together	ADV
bjp-823	35	6	with	with	ADP
bjp-823	35	7	elevated	elevate	VERB
bjp-823	35	8	triglyceride	triglyceride	ADV
bjp-823	35	9	is	be	AUX
bjp-823	35	10	common	common	ADJ
bjp-823	35	11	dyslipidemia	dyslipidemia	NOUN
bjp-823	35	12	feature	feature	NOUN
bjp-823	35	13	found	find	VERB
bjp-823	35	14	in	in	ADP
bjp-823	35	15	patients	patient	NOUN
bjp-823	35	16	with	with	ADP
bjp-823	35	17	coronary	coronary	ADJ
bjp-823	35	18	heart	heart	NOUN
bjp-823	35	19	disease	disease	NOUN
bjp-823	35	20	.	.	PUNCT
bjp-823	36	1	in	in	ADP
bjp-823	36	2	veterans	veterans	PROPN
bjp-823	36	3	affairs	affairs	PROPN
bjp-823	36	4	hdl	hdl	PROPN
bjp-823	36	5	intervention	intervention	PROPN
bjp-823	36	6	trial	trial	NOUN
bjp-823	36	7	(	(	PUNCT
bjp-823	36	8	va	va	NOUN
bjp-823	36	9	-	-	PUNCT
bjp-823	36	10	hit	hit	NOUN
bjp-823	36	11	)	)	PUNCT
bjp-823	36	12	on	on	ADP
bjp-823	36	13	8,500	8,500	NUM
bjp-823	36	14	coronary	coronary	ADJ
bjp-823	36	15	heart	heart	NOUN
bjp-823	36	16	disease	disease	NOUN
bjp-823	36	17	patients	patient	NOUN
bjp-823	36	18	,	,	PUNCT
bjp-823	36	19	87	87	NUM
bjp-823	36	20	%	%	NOUN
bjp-823	36	21	had	have	VERB
bjp-823	36	22	elevated	elevate	VERB
bjp-823	36	23	ldl	ldl	NOUN
bjp-823	36	24	-	-	PUNCT
bjp-823	36	25	c	c	NOUN
bjp-823	36	26	levels	level	NOUN
bjp-823	36	27	,	,	PUNCT
bjp-823	36	28	64	64	NUM
bjp-823	36	29	%	%	NOUN
bjp-823	36	30	also	also	ADV
bjp-823	36	31	had	have	VERB
bjp-823	36	32	low	low	ADJ
bjp-823	36	33	hdl	hdl	PROPN
bjp-823	36	34	-	-	PUNCT
bjp-823	36	35	c	c	NOUN
bjp-823	36	36	levels	level	NOUN
bjp-823	36	37	and	and	CCONJ
bjp-823	36	38	33	33	NUM
bjp-823	36	39	%	%	NOUN
bjp-823	36	40	had	have	AUX
bjp-823	36	41	elevated	elevate	VERB
bjp-823	36	42	triglyceride	triglyceride	ADJ
bjp-823	36	43	level	level	NOUN
bjp-823	36	44	(	(	PUNCT
bjp-823	36	45	rubins	rubin	NOUN
bjp-823	36	46	et	et	NOUN
bjp-823	36	47	al	al	PROPN
bjp-823	36	48	.	.	PROPN
bjp-823	36	49	,	,	PUNCT
bjp-823	36	50	1995	1995	NUM
bjp-823	36	51	)	)	PUNCT
bjp-823	36	52	.	.	PUNCT
bjp-823	37	1	optimal	optimal	ADJ
bjp-823	37	2	dyslipidemia	dyslipidemia	NOUN
bjp-823	37	3	management	management	NOUN
bjp-823	37	4	,	,	PUNCT
bjp-823	37	5	including	include	VERB
bjp-823	37	6	therapeutic	therapeutic	ADJ
bjp-823	37	7	life	life	NOUN
bjp-823	37	8	style	style	NOUN
bjp-823	37	9	changes	change	NOUN
bjp-823	37	10	(	(	PUNCT
bjp-823	37	11	tlc	tlc	NOUN
bjp-823	37	12	)	)	PUNCT
bjp-823	37	13	,	,	PUNCT
bjp-823	37	14	is	be	AUX
bjp-823	37	15	recommended	recommend	VERB
bjp-823	37	16	for	for	ADP
bjp-823	37	17	all	all	DET
bjp-823	37	18	patients	patient	NOUN
bjp-823	37	19	at	at	ADP
bjp-823	37	20	risk	risk	NOUN
bjp-823	37	21	of	of	ADP
bjp-823	37	22	coronary	coronary	ADJ
bjp-823	37	23	artery	artery	NOUN
bjp-823	37	24	disease	disease	NOUN
bjp-823	37	25	.	.	PUNCT
bjp-823	38	1	however	however	ADV
bjp-823	38	2	,	,	PUNCT
bjp-823	38	3	tlc	tlc	NOUN
bjp-823	38	4	has	have	VERB
bjp-823	38	5	limited	limit	VERB
bjp-823	38	6	effects	effect	NOUN
bjp-823	38	7	on	on	ADP
bjp-823	38	8	low	low	ADJ
bjp-823	38	9	hdl	hdl	PROPN
bjp-823	38	10	-	-	PUNCT
bjp-823	38	11	c	c	PROPN
bjp-823	38	12	and	and	CCONJ
bjp-823	38	13	therefore	therefore	ADV
bjp-823	38	14	drugs	drug	NOUN
bjp-823	38	15	are	be	AUX
bjp-823	38	16	needed	need	VERB
bjp-823	38	17	to	to	PART
bjp-823	38	18	help	help	VERB
bjp-823	38	19	dyslipidemic	dyslipidemic	ADJ
bjp-823	38	20	patients	patient	NOUN
bjp-823	38	21	to	to	PART
bjp-823	38	22	achieve	achieve	VERB
bjp-823	38	23	lipid	lipid	NOUN
bjp-823	38	24	profile	profile	NOUN
bjp-823	38	25	goals	goal	NOUN
bjp-823	38	26	(	(	PUNCT
bjp-823	38	27	fodor	fodor	PROPN
bjp-823	38	28	et	et	PROPN
bjp-823	38	29	al	al	PROPN
bjp-823	38	30	.	.	PROPN
bjp-823	38	31	,	,	PUNCT
bjp-823	38	32	2000	2000	NUM
bjp-823	38	33	)	)	PUNCT
bjp-823	38	34	.	.	PUNCT
bjp-823	39	1	at	at	ADP
bjp-823	39	2	present	present	ADJ
bjp-823	39	3	available	available	ADJ
bjp-823	39	4	drug	drug	NOUN
bjp-823	39	5	classes	class	NOUN
bjp-823	39	6	that	that	PRON
bjp-823	39	7	modify	modify	VERB
bjp-823	39	8	lipid	lipid	NOUN
bjp-823	39	9	and	and	CCONJ
bjp-823	39	10	lipoprotein	lipoprotein	ADJ
bjp-823	39	11	metabolism	metabolism	NOUN
bjp-823	39	12	are	be	AUX
bjp-823	39	13	:	:	PUNCT
bjp-823	39	14	statin	statin	ADJ
bjp-823	39	15	,	,	PUNCT
bjp-823	39	16	bile	bile	NOUN
bjp-823	39	17	acid	acid	NOUN
bjp-823	39	18	sequestrants	sequestrant	NOUN
bjp-823	39	19	,	,	PUNCT
bjp-823	39	20	fibrate	fibrate	VERB
bjp-823	39	21	derivatives	derivative	NOUN
bjp-823	39	22	,	,	PUNCT
bjp-823	39	23	nicotinic	nicotinic	ADJ
bjp-823	39	24	acid	acid	NOUN
bjp-823	39	25	and	and	CCONJ
bjp-823	39	26	ezetimibe	ezetimibe	NOUN
bjp-823	39	27	.	.	PUNCT
bjp-823	40	1	the	the	DET
bjp-823	40	2	mechanism	mechanism	NOUN
bjp-823	40	3	of	of	ADP
bjp-823	40	4	action	action	NOUN
bjp-823	40	5	of	of	ADP
bjp-823	40	6	statins	statin	NOUN
bjp-823	40	7	,	,	PUNCT
bjp-823	40	8	fibrates	fibrate	NOUN
bjp-823	40	9	and	and	CCONJ
bjp-823	40	10	nicotinic	nicotinic	ADJ
bjp-823	40	11	acid	acid	NOUN
bjp-823	40	12	are	be	AUX
bjp-823	40	13	distinct	distinct	ADJ
bjp-823	40	14	.	.	PUNCT
bjp-823	41	1	the	the	DET
bjp-823	41	2	statin	statin	PROPN
bjp-823	41	3	blocks	block	VERB
bjp-823	41	4	the	the	DET
bjp-823	41	5	rate	rate	NOUN
bjp-823	41	6	limiting	limit	VERB
bjp-823	41	7	step	step	NOUN
bjp-823	41	8	in	in	ADP
bjp-823	41	9	cholesterol	cholesterol	NOUN
bjp-823	41	10	biosynthesis	biosynthesis	NOUN
bjp-823	41	11	(	(	PUNCT
bjp-823	41	12	weirzbicki	weirzbicki	NOUN
bjp-823	41	13	et	et	PROPN
bjp-823	41	14	al	al	PROPN
bjp-823	41	15	.	.	PROPN
bjp-823	41	16	,	,	PUNCT
bjp-823	41	17	2003	2003	NUM
bjp-823	41	18	)	)	PUNCT
bjp-823	41	19	and	and	CCONJ
bjp-823	41	20	has	have	VERB
bjp-823	41	21	the	the	DET
bjp-823	41	22	most	most	ADV
bjp-823	41	23	powerful	powerful	ADJ
bjp-823	41	24	ldl	ldl	NOUN
bjp-823	41	25	-	-	PUNCT
bjp-823	41	26	c	c	NOUN
bjp-823	41	27	lowering	lower	VERB
bjp-823	41	28	effects	effect	NOUN
bjp-823	41	29	out	out	ADP
bjp-823	41	30	of	of	ADP
bjp-823	41	31	all	all	DET
bjp-823	41	32	lipid	lipid	NOUN
bjp-823	41	33	modifying	modify	VERB
bjp-823	41	34	agents	agent	NOUN
bjp-823	41	35	(	(	PUNCT
bjp-823	41	36	deedwania	deedwania	PROPN
bjp-823	41	37	and	and	CCONJ
bjp-823	41	38	singh	singh	PROPN
bjp-823	41	39	,	,	PUNCT
bjp-823	41	40	2005	2005	NUM
bjp-823	41	41	)	)	PUNCT
bjp-823	41	42	.	.	PUNCT
bjp-823	42	1	niacin	niacin	PROPN
bjp-823	42	2	inhibits	inhibit	VERB
bjp-823	42	3	the	the	DET
bjp-823	42	4	release	release	NOUN
bjp-823	42	5	of	of	ADP
bjp-823	42	6	free	free	ADJ
bjp-823	42	7	fatty	fatty	NOUN
bjp-823	42	8	acids	acid	NOUN
bjp-823	42	9	from	from	ADP
bjp-823	42	10	adipose	adipose	ADJ
bjp-823	42	11	tissue	tissue	NOUN
bjp-823	42	12	,	,	PUNCT
bjp-823	42	13	increases	increase	VERB
bjp-823	42	14	lipoprotein	lipoprotein	ADJ
bjp-823	42	15	lipase	lipase	NOUN
bjp-823	42	16	activity	activity	NOUN
bjp-823	42	17	and	and	CCONJ
bjp-823	42	18	decreases	decrease	VERB
bjp-823	42	19	the	the	DET
bjp-823	42	20	hepatic	hepatic	ADJ
bjp-823	42	21	production	production	NOUN
bjp-823	42	22	of	of	ADP
bjp-823	42	23	vldlc	vldlc	NOUN
bjp-823	42	24	and	and	CCONJ
bjp-823	42	25	ldl	ldl	NOUN
bjp-823	42	26	-	-	PUNCT
bjp-823	42	27	c	c	NOUN
bjp-823	42	28	production	production	NOUN
bjp-823	42	29	.	.	PUNCT
bjp-823	43	1	fibrates	fibrate	NOUN
bjp-823	43	2	belong	belong	VERB
bjp-823	43	3	to	to	ADP
bjp-823	43	4	the	the	DET
bjp-823	43	5	drug	drug	NOUN
bjp-823	43	6	classes	class	NOUN
bjp-823	43	7	that	that	PRON
bjp-823	43	8	exert	exert	VERB
bjp-823	43	9	their	their	PRON
bjp-823	43	10	effect	effect	NOUN
bjp-823	43	11	by	by	ADP
bjp-823	43	12	activating	activate	VERB
bjp-823	43	13	ppar	ppar	NOUN
bjp-823	43	14	-	-	PUNCT
bjp-823	43	15	α	α	NOUN
bjp-823	43	16	(	(	PUNCT
bjp-823	43	17	barter	barter	NOUN
bjp-823	43	18	and	and	CCONJ
bjp-823	43	19	rye	rye	NOUN
bjp-823	43	20	,	,	PUNCT
bjp-823	43	21	2006	2006	NUM
bjp-823	43	22	)	)	PUNCT
bjp-823	43	23	.	.	PUNCT
bjp-823	44	1	individually	individually	ADV
bjp-823	44	2	nicotinic	nicotinic	ADJ
bjp-823	44	3	acid	acid	NOUN
bjp-823	44	4	and	and	CCONJ
bjp-823	44	5	fibrates	fibrate	NOUN
bjp-823	44	6	are	be	AUX
bjp-823	44	7	the	the	DET
bjp-823	44	8	most	most	ADV
bjp-823	44	9	effective	effective	ADJ
bjp-823	44	10	pharmacological	pharmacological	ADJ
bjp-823	44	11	agents	agent	NOUN
bjp-823	44	12	for	for	ADP
bjp-823	44	13	dyslipidemia	dyslipidemia	NOUN
bjp-823	44	14	by	by	ADP
bjp-823	44	15	raising	raise	VERB
bjp-823	44	16	hdl	hdl	PROPN
bjp-823	44	17	-	-	PUNCT
bjp-823	44	18	c	c	PROPN
bjp-823	44	19	and	and	CCONJ
bjp-823	44	20	reducing	reduce	VERB
bjp-823	44	21	triglyceride	triglyceride	INTJ
bjp-823	44	22	(	(	PUNCT
bjp-823	44	23	grundy	grundy	PROPN
bjp-823	44	24	et	et	PROPN
bjp-823	44	25	al	al	PROPN
bjp-823	44	26	.	.	PROPN
bjp-823	44	27	,	,	PUNCT
bjp-823	44	28	2004	2004	NUM
bjp-823	44	29	)	)	PUNCT
bjp-823	44	30	.	.	PUNCT
bjp-823	45	1	results	result	NOUN
bjp-823	45	2	of	of	ADP
bjp-823	45	3	clinical	clinical	ADJ
bjp-823	45	4	trials	trial	NOUN
bjp-823	45	5	with	with	ADP
bjp-823	45	6	fibrates	fibrate	NOUN
bjp-823	45	7	or	or	CCONJ
bjp-823	45	8	nicotinic	nicotinic	ADJ
bjp-823	45	9	acid	acid	NOUN
bjp-823	45	10	showed	show	VERB
bjp-823	45	11	improve	improve	VERB
bjp-823	45	12	total	total	ADJ
bjp-823	45	13	lipid	lipid	NOUN
bjp-823	45	14	profile	profile	NOUN
bjp-823	45	15	;	;	PUNCT
bjp-823	45	16	strongly	strongly	ADV
bjp-823	45	17	suggested	suggest	VERB
bjp-823	45	18	a	a	DET
bjp-823	45	19	benefit	benefit	NOUN
bjp-823	45	20	(	(	PUNCT
bjp-823	45	21	barter	barter	NOUN
bjp-823	45	22	and	and	CCONJ
bjp-823	45	23	rye	rye	NOUN
bjp-823	45	24	,	,	PUNCT
bjp-823	45	25	2006	2006	NUM
bjp-823	45	26	)	)	PUNCT
bjp-823	45	27	.	.	PUNCT
bjp-823	46	1	the	the	DET
bjp-823	46	2	rationale	rationale	NOUN
bjp-823	46	3	for	for	ADP
bjp-823	46	4	combination	combination	NOUN
bjp-823	46	5	therapy	therapy	NOUN
bjp-823	46	6	is	be	AUX
bjp-823	46	7	that	that	SCONJ
bjp-823	46	8	drugs	drug	NOUN
bjp-823	46	9	with	with	ADP
bjp-823	46	10	complementary	complementary	ADJ
bjp-823	46	11	mechanism	mechanism	NOUN
bjp-823	46	12	of	of	ADP
bjp-823	46	13	action	action	NOUN
bjp-823	46	14	can	can	AUX
bjp-823	46	15	provide	provide	VERB
bjp-823	46	16	complementary	complementary	ADJ
bjp-823	46	17	effects	effect	NOUN
bjp-823	46	18	on	on	ADP
bjp-823	46	19	the	the	DET
bjp-823	46	20	lipid	lipid	NOUN
bjp-823	46	21	profile	profile	NOUN
bjp-823	46	22	(	(	PUNCT
bjp-823	46	23	venkataraman	venkataraman	NOUN
bjp-823	46	24	et	et	PROPN
bjp-823	46	25	al	al	PROPN
bjp-823	46	26	.	.	PROPN
bjp-823	46	27	,	,	PUNCT
bjp-823	46	28	2004	2004	NUM
bjp-823	46	29	)	)	PUNCT
bjp-823	46	30	.	.	PUNCT
bjp-823	47	1	the	the	DET
bjp-823	47	2	hdl	hdl	PROPN
bjp-823	47	3	atherosclerosis	atherosclerosis	NOUN
bjp-823	47	4	treatment	treatment	NOUN
bjp-823	47	5	study	study	NOUN
bjp-823	47	6	(	(	PUNCT
bjp-823	47	7	hats	hat	NOUN
bjp-823	47	8	)	)	PUNCT
bjp-823	47	9	showed	show	VERB
bjp-823	47	10	that	that	SCONJ
bjp-823	47	11	combined	combined	ADJ
bjp-823	47	12	effect	effect	NOUN
bjp-823	47	13	of	of	ADP
bjp-823	47	14	niacin	niacin	NOUN
bjp-823	47	15	or	or	CCONJ
bjp-823	47	16	a	a	DET
bjp-823	47	17	fibrate	fibrate	NOUN
bjp-823	47	18	with	with	ADP
bjp-823	47	19	a	a	DET
bjp-823	47	20	statin	statin	PROPN
bjp-823	47	21	improved	improve	VERB
bjp-823	47	22	hdl	hdl	PROPN
bjp-823	47	23	-	-	PUNCT
bjp-823	47	24	c	c	PROPN
bjp-823	47	25	and	and	CCONJ
bjp-823	47	26	ldl	ldl	NOUN
bjp-823	47	27	-	-	PUNCT
bjp-823	47	28	c	c	PROPN
bjp-823	47	29	which	which	PRON
bjp-823	47	30	inhibited	inhibit	VERB
bjp-823	47	31	the	the	DET
bjp-823	47	32	progression	progression	NOUN
bjp-823	47	33	of	of	ADP
bjp-823	47	34	atherosclerosis	atherosclerosis	NOUN
bjp-823	47	35	and	and	CCONJ
bjp-823	47	36	reduced	reduce	VERB
bjp-823	47	37	cardiovascular	cardiovascular	ADJ
bjp-823	47	38	events	event	NOUN
bjp-823	47	39	in	in	ADP
bjp-823	47	40	a	a	DET
bjp-823	47	41	high	high	ADJ
bjp-823	47	42	risk	risk	NOUN
bjp-823	47	43	population	population	NOUN
bjp-823	47	44	with	with	ADP
bjp-823	47	45	established	establish	VERB
bjp-823	47	46	coronary	coronary	ADJ
bjp-823	47	47	heart	heart	NOUN
bjp-823	47	48	disease	disease	NOUN
bjp-823	47	49	(	(	PUNCT
bjp-823	47	50	taylor	taylor	PROPN
bjp-823	47	51	,	,	PUNCT
bjp-823	47	52	2006	2006	NUM
bjp-823	47	53	)	)	PUNCT
bjp-823	47	54	.	.	PUNCT
bjp-823	48	1	combination	combination	NOUN
bjp-823	48	2	of	of	ADP
bjp-823	48	3	statin	statin	ADJ
bjp-823	48	4	-	-	PUNCT
bjp-823	48	5	niacin	niacin	NOUN
bjp-823	48	6	therapy	therapy	NOUN
bjp-823	48	7	is	be	AUX
bjp-823	48	8	associated	associate	VERB
bjp-823	48	9	with	with	ADP
bjp-823	48	10	flushing	flush	VERB
bjp-823	48	11	and	and	CCONJ
bjp-823	48	12	is	be	AUX
bjp-823	48	13	usually	usually	ADV
bjp-823	48	14	transient	transient	ADJ
bjp-823	48	15	but	but	CCONJ
bjp-823	48	16	hepatic	hepatic	ADJ
bjp-823	48	17	effects	effect	NOUN
bjp-823	48	18	and	and	CCONJ
bjp-823	48	19	myopathy	myopathy	ADJ
bjp-823	48	20	are	be	AUX
bjp-823	48	21	uncommon	uncommon	ADJ
bjp-823	48	22	.	.	PUNCT
bjp-823	49	1	the	the	DET
bjp-823	49	2	common	common	ADJ
bjp-823	49	3	adverse	adverse	ADJ
bjp-823	49	4	effects	effect	NOUN
bjp-823	49	5	of	of	ADP
bjp-823	49	6	statin	statin	ADJ
bjp-823	49	7	-	-	PUNCT
bjp-823	49	8	fibrate	fibrate	NOUN
bjp-823	49	9	therapy	therapy	NOUN
bjp-823	49	10	are	be	AUX
bjp-823	49	11	myopathy	myopathy	ADJ
bjp-823	49	12	,	,	PUNCT
bjp-823	49	13	elevated	elevated	ADJ
bjp-823	49	14	hepatic	hepatic	ADJ
bjp-823	49	15	enzyme	enzyme	NOUN
bjp-823	49	16	and	and	CCONJ
bjp-823	49	17	gastrointestinal	gastrointestinal	ADJ
bjp-823	49	18	upset	upset	ADJ
bjp-823	49	19	(	(	PUNCT
bjp-823	49	20	koh	koh	PROPN
bjp-823	49	21	et	et	PROPN
bjp-823	49	22	al	al	PROPN
bjp-823	49	23	.	.	PROPN
bjp-823	49	24	,	,	PUNCT
bjp-823	49	25	2005	2005	NUM
bjp-823	49	26	)	)	PUNCT
bjp-823	49	27	.	.	PUNCT
bjp-823	50	1	previous	previous	ADJ
bjp-823	50	2	studies	study	NOUN
bjp-823	50	3	established	establish	VERB
bjp-823	50	4	that	that	SCONJ
bjp-823	50	5	statin	statin	NOUN
bjp-823	50	6	in	in	ADP
bjp-823	50	7	combination	combination	NOUN
bjp-823	50	8	with	with	ADP
bjp-823	50	9	fenofibrate	fenofibrate	NOUN
bjp-823	50	10	significantly	significantly	ADV
bjp-823	50	11	improved	improve	VERB
bjp-823	50	12	lipid	lipid	NOUN
bjp-823	50	13	profile	profile	NOUN
bjp-823	50	14	than	than	ADP
bjp-823	50	15	monotherapy	monotherapy	NOUN
bjp-823	50	16	in	in	ADP
bjp-823	50	17	people	people	NOUN
bjp-823	50	18	with	with	ADP
bjp-823	50	19	type	type	NOUN
bjp-823	50	20	2	2	NUM
bjp-823	50	21	diabetes	diabetes	NOUN
bjp-823	50	22	,	,	PUNCT
bjp-823	50	23	dyslipidemia	dyslipidemia	NOUN
bjp-823	50	24	,	,	PUNCT
bjp-823	50	25	and	and	CCONJ
bjp-823	50	26	history	history	NOUN
bjp-823	50	27	of	of	ADP
bjp-823	50	28	coronary	coronary	ADJ
bjp-823	50	29	artery	artery	NOUN
bjp-823	50	30	disease	disease	NOUN
bjp-823	50	31	(	(	PUNCT
bjp-823	50	32	derosa	derosa	PROPN
bjp-823	50	33	et	et	PROPN
bjp-823	50	34	al	al	PROPN
bjp-823	50	35	.	.	PROPN
bjp-823	50	36	,	,	PUNCT
bjp-823	50	37	2004	2004	NUM
bjp-823	50	38	)	)	PUNCT
bjp-823	50	39	.	.	PUNCT
bjp-823	51	1	another	another	DET
bjp-823	51	2	combination	combination	NOUN
bjp-823	51	3	therapy	therapy	NOUN
bjp-823	51	4	of	of	ADP
bjp-823	51	5	statin	statin	PROPN
bjp-823	51	6	-	-	PUNCT
bjp-823	51	7	niacin	niacin	NOUN
bjp-823	51	8	,	,	PUNCT
bjp-823	51	9	reduced	reduce	VERB
bjp-823	51	10	ldl	ldl	NOUN
bjp-823	51	11	-	-	PUNCT
bjp-823	51	12	c	c	NOUN
bjp-823	51	13	significantly	significantly	ADV
bjp-823	51	14	more	more	ADV
bjp-823	51	15	than	than	ADP
bjp-823	51	16	niacin	niacin	NOUN
bjp-823	51	17	alone	alone	ADJ
bjp-823	51	18	and	and	CCONJ
bjp-823	51	19	hdl	hdl	PROPN
bjp-823	51	20	-	-	PUNCT
bjp-823	51	21	c	c	NOUN
bjp-823	51	22	level	level	NOUN
bjp-823	51	23	significantly	significantly	ADV
bjp-823	51	24	raised	raise	VERB
bjp-823	51	25	more	more	ADJ
bjp-823	51	26	than	than	ADP
bjp-823	51	27	statin	statin	PROPN
bjp-823	51	28	administration	administration	NOUN
bjp-823	51	29	alone	alone	ADV
bjp-823	51	30	.	.	PUNCT
bjp-823	52	1	it	it	PRON
bjp-823	52	2	was	be	AUX
bjp-823	52	3	also	also	ADV
bjp-823	52	4	more	more	ADV
bjp-823	52	5	effective	effective	ADJ
bjp-823	52	6	in	in	ADP
bjp-823	52	7	reducing	reduce	VERB
bjp-823	52	8	triglyceride	triglyceride	ADJ
bjp-823	52	9	levels	level	NOUN
bjp-823	52	10	than	than	ADP
bjp-823	52	11	either	either	CCONJ
bjp-823	52	12	monotherapy	monotherapy	NOUN
bjp-823	52	13	(	(	PUNCT
bjp-823	52	14	misra	misra	PROPN
bjp-823	52	15	et	et	PROPN
bjp-823	52	16	al	al	PROPN
bjp-823	52	17	.	.	PROPN
bjp-823	52	18	,	,	PUNCT
bjp-823	52	19	2004	2004	NUM
bjp-823	52	20	)	)	PUNCT
bjp-823	52	21	.	.	PUNCT
bjp-823	53	1	there	there	PRON
bjp-823	53	2	is	be	VERB
bjp-823	53	3	no	no	DET
bjp-823	53	4	significant	significant	ADJ
bjp-823	53	5	interaction	interaction	NOUN
bjp-823	53	6	between	between	ADP
bjp-823	53	7	statin	statin	PROPN
bjp-823	53	8	administered	administer	VERB
bjp-823	53	9	in	in	ADP
bjp-823	53	10	combination	combination	NOUN
bjp-823	53	11	either	either	CCONJ
bjp-823	53	12	with	with	ADP
bjp-823	53	13	niacin	niacin	NOUN
bjp-823	53	14	or	or	CCONJ
bjp-823	53	15	fibrate	fibrate	NOUN
bjp-823	53	16	.	.	PUNCT
bjp-823	54	1	therefore	therefore	ADV
bjp-823	54	2	,	,	PUNCT
bjp-823	54	3	the	the	DET
bjp-823	54	4	present	present	ADJ
bjp-823	54	5	study	study	NOUN
bjp-823	54	6	was	be	AUX
bjp-823	54	7	designed	design	VERB
bjp-823	54	8	to	to	PART
bjp-823	54	9	evaluate	evaluate	VERB
bjp-823	54	10	and	and	CCONJ
bjp-823	54	11	compare	compare	VERB
bjp-823	54	12	the	the	DET
bjp-823	54	13	effects	effect	NOUN
bjp-823	54	14	and	and	CCONJ
bjp-823	54	15	safety	safety	NOUN
bjp-823	54	16	of	of	ADP
bjp-823	54	17	combination	combination	NOUN
bjp-823	54	18	therapy	therapy	NOUN
bjp-823	54	19	of	of	ADP
bjp-823	54	20	statin	statin	PROPN
bjp-823	54	21	-	-	PUNCT
bjp-823	54	22	niacin	niacin	PROPN
bjp-823	54	23	and	and	CCONJ
bjp-823	54	24	statin	statin	PROPN
bjp-823	54	25	-	-	PUNCT
bjp-823	54	26	fenofibrate	fenofibrate	NOUN
bjp-823	54	27	on	on	ADP
bjp-823	54	28	dyslipidemic	dyslipidemic	ADJ
bjp-823	54	29	patients	patient	NOUN
bjp-823	54	30	of	of	ADP
bjp-823	54	31	high	high	ADJ
bjp-823	54	32	-	-	PUNCT
bjp-823	54	33	risk	risk	NOUN
bjp-823	54	34	group	group	NOUN
bjp-823	54	35	.	.	PUNCT
bjp-823	55	1	the	the	DET
bjp-823	55	2	result	result	NOUN
bjp-823	55	3	of	of	ADP
bjp-823	55	4	study	study	NOUN
bjp-823	55	5	would	would	AUX
bjp-823	55	6	suggest	suggest	VERB
bjp-823	55	7	for	for	ADP
bjp-823	55	8	rational	rational	ADJ
bjp-823	55	9	use	use	NOUN
bjp-823	55	10	of	of	ADP
bjp-823	55	11	lipid	lipid	NOUN
bjp-823	55	12	lowering	lower	VERB
bjp-823	55	13	agents	agent	NOUN
bjp-823	55	14	and	and	CCONJ
bjp-823	55	15	thereby	thereby	ADV
bjp-823	55	16	reduce	reduce	VERB
bjp-823	55	17	morbidity	morbidity	NOUN
bjp-823	55	18	and	and	CCONJ
bjp-823	55	19	mortality	mortality	NOUN
bjp-823	55	20	of	of	ADP
bjp-823	55	21	cardiovascular	cardiovascular	ADJ
bjp-823	55	22	disease	disease	NOUN
bjp-823	55	23	.	.	PUNCT
bjp-823	56	1	materials	material	NOUN
bjp-823	56	2	and	and	CCONJ
bjp-823	56	3	methods	method	NOUN
bjp-823	56	4	this	this	DET
bjp-823	56	5	prospective	prospective	ADJ
bjp-823	56	6	interventional	interventional	ADJ
bjp-823	56	7	study	study	NOUN
bjp-823	56	8	was	be	AUX
bjp-823	56	9	carried	carry	VERB
bjp-823	56	10	out	out	ADP
bjp-823	56	11	during	during	ADP
bjp-823	56	12	the	the	DET
bjp-823	56	13	period	period	NOUN
bjp-823	56	14	of	of	ADP
bjp-823	56	15	july	july	PROPN
bjp-823	56	16	2006	2006	NUM
bjp-823	56	17	to	to	ADP
bjp-823	56	18	june	june	PROPN
bjp-823	56	19	2007	2007	NUM
bjp-823	56	20	.	.	PUNCT
bjp-823	57	1	the	the	DET
bjp-823	57	2	patients	patient	NOUN
bjp-823	57	3	admitted	admit	VERB
bjp-823	57	4	in	in	ADP
bjp-823	57	5	coronary	coronary	ADJ
bjp-823	57	6	care	care	NOUN
bjp-823	57	7	unit	unit	NOUN
bjp-823	57	8	with	with	ADP
bjp-823	57	9	diagnosis	diagnosis	NOUN
bjp-823	57	10	of	of	ADP
bjp-823	57	11	a	a	DET
bjp-823	57	12	coronary	coronary	ADJ
bjp-823	57	13	heart	heart	NOUN
bjp-823	57	14	disease	disease	NOUN
bjp-823	57	15	and	and	CCONJ
bjp-823	57	16	dyslipidemia	dyslipidemia	NOUN
bjp-823	57	17	were	be	AUX
bjp-823	57	18	taken	take	VERB
bjp-823	57	19	as	as	ADP
bjp-823	57	20	study	study	NOUN
bjp-823	57	21	population	population	NOUN
bjp-823	57	22	.	.	PUNCT
bjp-823	58	1	adult	adult	NOUN
bjp-823	58	2	male	male	ADJ
bjp-823	58	3	and	and	CCONJ
bjp-823	58	4	female	female	ADJ
bjp-823	58	5	patients	patient	NOUN
bjp-823	58	6	of	of	ADP
bjp-823	58	7	3065	3065	NUM
bjp-823	58	8	years	year	NOUN
bjp-823	58	9	of	of	ADP
bjp-823	58	10	age	age	NOUN
bjp-823	58	11	having	have	VERB
bjp-823	58	12	coronary	coronary	ADJ
bjp-823	58	13	heart	heart	NOUN
bjp-823	58	14	disease	disease	NOUN
bjp-823	58	15	with	with	ADP
bjp-823	58	16	dyslipidemia	dyslipidemia	NOUN
bjp-823	58	17	(	(	PUNCT
bjp-823	58	18	ldl	ldl	NOUN
bjp-823	58	19	-	-	PUNCT
bjp-823	58	20	c	c	NOUN
bjp-823	58	21	level	level	NOUN
bjp-823	58	22	was	be	AUX
bjp-823	58	23	detected	detect	VERB
bjp-823	58	24	more	more	ADJ
bjp-823	58	25	than	than	ADP
bjp-823	58	26	100	100	NUM
bjp-823	58	27	mg	mg	PROPN
bjp-823	58	28	/	/	SYM
bjp-823	58	29	dl	dl	PROPN
bjp-823	58	30	,	,	PUNCT
bjp-823	58	31	triglyceride	triglyceride	ADP
bjp-823	58	32	more	more	ADJ
bjp-823	58	33	than	than	ADP
bjp-823	58	34	200	200	NUM
bjp-823	58	35	mg	mg	PROPN
bjp-823	58	36	/	/	SYM
bjp-823	58	37	dl	dl	PROPN
bjp-823	58	38	,	,	PUNCT
bjp-823	58	39	total	total	ADJ
bjp-823	58	40	bangladesh	bangladesh	PROPN
bjp-823	58	41	j	j	PROPN
bjp-823	58	42	pharmacol	pharmacol	PROPN
bjp-823	58	43	2008	2008	NUM
bjp-823	58	44	;	;	PUNCT
bjp-823	58	45	3	3	NUM
bjp-823	58	46	:	:	SYM
bjp-823	58	47	8	8	NUM
bjp-823	58	48	-	-	SYM
bjp-823	58	49	16	16	NUM
bjp-823	58	50	9	9	NUM
bjp-823	58	51	cholesterol	cholesterol	NOUN
bjp-823	58	52	more	more	ADJ
bjp-823	58	53	than	than	ADP
bjp-823	58	54	200	200	NUM
bjp-823	58	55	mg	mg	PROPN
bjp-823	58	56	/	/	SYM
bjp-823	58	57	dl	dl	PROPN
bjp-823	58	58	and	and	CCONJ
bjp-823	58	59	hdl	hdl	PROPN
bjp-823	58	60	-	-	PUNCT
bjp-823	58	61	c	c	NOUN
bjp-823	58	62	level	level	NOUN
bjp-823	58	63	less	less	ADJ
bjp-823	58	64	than	than	ADP
bjp-823	58	65	40	40	NUM
bjp-823	58	66	mg	mg	PROPN
bjp-823	58	67	/	/	SYM
bjp-823	58	68	dl	dl	PROPN
bjp-823	58	69	in	in	ADP
bjp-823	58	70	male	male	NOUN
bjp-823	58	71	,	,	PUNCT
bjp-823	58	72	50	50	NUM
bjp-823	58	73	mg	mg	PROPN
bjp-823	58	74	/	/	SYM
bjp-823	58	75	dl	dl	PROPN
bjp-823	58	76	in	in	ADP
bjp-823	58	77	female	female	NOUN
bjp-823	58	78	)	)	PUNCT
bjp-823	58	79	,	,	PUNCT
bjp-823	58	80	defined	define	VERB
bjp-823	58	81	as	as	ADP
bjp-823	58	82	high	high	ADJ
bjp-823	58	83	-	-	PUNCT
bjp-823	58	84	risk	risk	NOUN
bjp-823	58	85	category	category	NOUN
bjp-823	58	86	by	by	ADP
bjp-823	58	87	updated	update	VERB
bjp-823	58	88	ncep	ncep	PROPN
bjp-823	58	89	atp	atp	PROPN
bjp-823	58	90	-	-	PUNCT
bjp-823	58	91	iii	iii	NUM
bjp-823	58	92	guidelines	guideline	NOUN
bjp-823	58	93	2004	2004	NUM
bjp-823	58	94	were	be	AUX
bjp-823	58	95	included	include	VERB
bjp-823	58	96	in	in	ADP
bjp-823	58	97	this	this	DET
bjp-823	58	98	study	study	NOUN
bjp-823	58	99	(	(	PUNCT
bjp-823	58	100	grundy	grundy	PROPN
bjp-823	58	101	et	et	PROPN
bjp-823	58	102	al	al	PROPN
bjp-823	58	103	.	.	PROPN
bjp-823	58	104	,	,	PUNCT
bjp-823	58	105	2004	2004	NUM
bjp-823	58	106	)	)	PUNCT
bjp-823	58	107	.	.	PUNCT
bjp-823	59	1	exclusion	exclusion	NOUN
bjp-823	59	2	criteria	criterion	NOUN
bjp-823	59	3	were	be	AUX
bjp-823	59	4	chronic	chronic	ADJ
bjp-823	59	5	hepatic	hepatic	ADJ
bjp-823	59	6	disorder	disorder	NOUN
bjp-823	59	7	,	,	PUNCT
bjp-823	59	8	renal	renal	ADJ
bjp-823	59	9	impairment	impairment	NOUN
bjp-823	59	10	,	,	PUNCT
bjp-823	59	11	pregnant	pregnant	ADJ
bjp-823	59	12	and	and	CCONJ
bjp-823	59	13	lactating	lactate	VERB
bjp-823	59	14	mothers	mother	NOUN
bjp-823	59	15	,	,	PUNCT
bjp-823	59	16	on	on	ADP
bjp-823	59	17	going	go	VERB
bjp-823	59	18	treatment	treatment	NOUN
bjp-823	59	19	with	with	ADP
bjp-823	59	20	other	other	ADJ
bjp-823	59	21	drugs	drug	NOUN
bjp-823	59	22	that	that	PRON
bjp-823	59	23	affect	affect	VERB
bjp-823	59	24	lipids	lipid	NOUN
bjp-823	59	25	(	(	PUNCT
bjp-823	59	26	ßblocker	ßblocker	NOUN
bjp-823	59	27	,	,	PUNCT
bjp-823	59	28	steroid	steroid	NOUN
bjp-823	59	29	therapy	therapy	NOUN
bjp-823	59	30	,	,	PUNCT
bjp-823	59	31	etc	etc	X
bjp-823	59	32	.	.	X
bjp-823	59	33	)	)	PUNCT
bjp-823	59	34	,	,	PUNCT
bjp-823	59	35	extreme	extreme	ADJ
bjp-823	59	36	level	level	NOUN
bjp-823	59	37	of	of	ADP
bjp-823	59	38	triglyceride	triglyceride	ADJ
bjp-823	59	39	(	(	PUNCT
bjp-823	59	40	>	>	NOUN
bjp-823	59	41	400	400	NUM
bjp-823	59	42	mg	mg	PROPN
bjp-823	59	43	/	/	SYM
bjp-823	59	44	dl	dl	PROPN
bjp-823	59	45	)	)	PUNCT
bjp-823	59	46	,	,	PUNCT
bjp-823	59	47	hypersensitivity	hypersensitivity	NOUN
bjp-823	59	48	to	to	ADP
bjp-823	59	49	any	any	DET
bjp-823	59	50	component	component	NOUN
bjp-823	59	51	of	of	ADP
bjp-823	59	52	this	this	DET
bjp-823	59	53	medication	medication	NOUN
bjp-823	59	54	,	,	PUNCT
bjp-823	59	55	those	those	PRON
bjp-823	59	56	who	who	PRON
bjp-823	59	57	did	do	AUX
bjp-823	59	58	not	not	PART
bjp-823	59	59	give	give	VERB
bjp-823	59	60	informed	informed	ADJ
bjp-823	59	61	consent	consent	NOUN
bjp-823	59	62	and	and	CCONJ
bjp-823	59	63	on	on	ADP
bjp-823	59	64	going	go	VERB
bjp-823	59	65	treatment	treatment	NOUN
bjp-823	59	66	with	with	ADP
bjp-823	59	67	lipid	lipid	NOUN
bjp-823	59	68	lowering	lower	VERB
bjp-823	59	69	agents	agent	NOUN
bjp-823	59	70	.	.	PUNCT
bjp-823	60	1	after	after	ADP
bjp-823	60	2	selection	selection	NOUN
bjp-823	60	3	of	of	ADP
bjp-823	60	4	the	the	DET
bjp-823	60	5	participants	participant	NOUN
bjp-823	60	6	,	,	PUNCT
bjp-823	60	7	written	write	VERB
bjp-823	60	8	consent	consent	NOUN
bjp-823	60	9	was	be	AUX
bjp-823	60	10	obtained	obtain	VERB
bjp-823	60	11	after	after	ADP
bjp-823	60	12	explanation	explanation	NOUN
bjp-823	60	13	of	of	ADP
bjp-823	60	14	the	the	DET
bjp-823	60	15	objectives	objective	NOUN
bjp-823	60	16	,	,	PUNCT
bjp-823	60	17	nature	nature	NOUN
bjp-823	60	18	,	,	PUNCT
bjp-823	60	19	purpose	purpose	NOUN
bjp-823	60	20	and	and	CCONJ
bjp-823	60	21	potential	potential	ADJ
bjp-823	60	22	risk	risk	NOUN
bjp-823	60	23	of	of	ADP
bjp-823	60	24	all	all	DET
bjp-823	60	25	procedures	procedure	NOUN
bjp-823	60	26	used	use	VERB
bjp-823	60	27	for	for	ADP
bjp-823	60	28	the	the	DET
bjp-823	60	29	study	study	NOUN
bjp-823	60	30	to	to	ADP
bjp-823	60	31	the	the	DET
bjp-823	60	32	patient	patient	ADJ
bjp-823	60	33	and	and	CCONJ
bjp-823	60	34	accompanying	accompanying	ADJ
bjp-823	60	35	persons	person	NOUN
bjp-823	60	36	.	.	PUNCT
bjp-823	61	1	detail	detail	NOUN
bjp-823	61	2	history	history	NOUN
bjp-823	61	3	(	(	PUNCT
bjp-823	61	4	particulars	particular	NOUN
bjp-823	61	5	of	of	ADP
bjp-823	61	6	the	the	DET
bjp-823	61	7	patient	patient	NOUN
bjp-823	61	8	,	,	PUNCT
bjp-823	61	9	personal	personal	ADJ
bjp-823	61	10	history	history	NOUN
bjp-823	61	11	,	,	PUNCT
bjp-823	61	12	family	family	NOUN
bjp-823	61	13	history	history	NOUN
bjp-823	61	14	of	of	ADP
bjp-823	61	15	coronary	coronary	ADJ
bjp-823	61	16	heart	heart	NOUN
bjp-823	61	17	disease	disease	NOUN
bjp-823	61	18	and	and	CCONJ
bjp-823	61	19	associated	associated	ADJ
bjp-823	61	20	disease	disease	NOUN
bjp-823	61	21	like	like	ADP
bjp-823	61	22	hypertension	hypertension	NOUN
bjp-823	61	23	,	,	PUNCT
bjp-823	61	24	diabetes	diabetes	NOUN
bjp-823	61	25	)	)	PUNCT
bjp-823	61	26	and	and	CCONJ
bjp-823	61	27	clinical	clinical	ADJ
bjp-823	61	28	examination	examination	NOUN
bjp-823	61	29	(	(	PUNCT
bjp-823	61	30	pulse	pulse	NOUN
bjp-823	61	31	,	,	PUNCT
bjp-823	61	32	blood	blood	NOUN
bjp-823	61	33	pressure	pressure	NOUN
bjp-823	61	34	,	,	PUNCT
bjp-823	61	35	jaundice	jaundice	NOUN
bjp-823	61	36	,	,	PUNCT
bjp-823	61	37	height	height	NOUN
bjp-823	61	38	and	and	CCONJ
bjp-823	61	39	weight	weight	NOUN
bjp-823	61	40	,	,	PUNCT
bjp-823	61	41	etc	etc	X
bjp-823	61	42	.	.	X
bjp-823	61	43	)	)	PUNCT
bjp-823	61	44	were	be	AUX
bjp-823	61	45	taken	take	VERB
bjp-823	61	46	in	in	ADP
bjp-823	61	47	a	a	DET
bjp-823	61	48	prescribed	prescribed	ADJ
bjp-823	61	49	data	data	NOUN
bjp-823	61	50	collection	collection	NOUN
bjp-823	61	51	form	form	NOUN
bjp-823	61	52	.	.	PUNCT
bjp-823	62	1	blood	blood	NOUN
bjp-823	62	2	samples	sample	NOUN
bjp-823	62	3	were	be	AUX
bjp-823	62	4	collected	collect	VERB
bjp-823	62	5	from	from	ADP
bjp-823	62	6	the	the	DET
bjp-823	62	7	study	study	NOUN
bjp-823	62	8	subjects	subject	NOUN
bjp-823	62	9	after	after	ADP
bjp-823	62	10	12	12	NUM
bjp-823	62	11	hours	hour	NOUN
bjp-823	62	12	overnight	overnight	ADV
bjp-823	62	13	fasting	fast	VERB
bjp-823	62	14	for	for	ADP
bjp-823	62	15	estimation	estimation	NOUN
bjp-823	62	16	of	of	ADP
bjp-823	62	17	serum	serum	NOUN
bjp-823	62	18	level	level	NOUN
bjp-823	62	19	of	of	ADP
bjp-823	62	20	glucose	glucose	NOUN
bjp-823	62	21	,	,	PUNCT
bjp-823	62	22	triglyceride	triglyceride	ADJ
bjp-823	62	23	,	,	PUNCT
bjp-823	62	24	total	total	ADJ
bjp-823	62	25	cholesterol	cholesterol	NOUN
bjp-823	62	26	,	,	PUNCT
bjp-823	62	27	hdl	hdl	PROPN
bjp-823	62	28	-	-	PUNCT
bjp-823	62	29	c	c	PROPN
bjp-823	62	30	,	,	PUNCT
bjp-823	62	31	ldl	ldl	NOUN
bjp-823	62	32	-	-	PUNCT
bjp-823	62	33	c	c	NOUN
bjp-823	62	34	,	,	PUNCT
bjp-823	62	35	sgpt	sgpt	NOUN
bjp-823	62	36	and	and	CCONJ
bjp-823	62	37	serum	serum	NOUN
bjp-823	62	38	creatinine	creatinine	NOUN
bjp-823	62	39	.	.	PUNCT
bjp-823	63	1	initially	initially	ADV
bjp-823	63	2	there	there	PRON
bjp-823	63	3	were	be	VERB
bjp-823	63	4	132	132	NUM
bjp-823	63	5	study	study	NOUN
bjp-823	63	6	populations	population	NOUN
bjp-823	63	7	,	,	PUNCT
bjp-823	63	8	among	among	ADP
bjp-823	63	9	them	they	PRON
bjp-823	63	10	24	24	NUM
bjp-823	63	11	were	be	AUX
bjp-823	63	12	excluded	exclude	VERB
bjp-823	63	13	.	.	PUNCT
bjp-823	64	1	108	108	NUM
bjp-823	64	2	patients	patient	NOUN
bjp-823	64	3	satisfied	satisfy	VERB
bjp-823	64	4	the	the	DET
bjp-823	64	5	inclusion	inclusion	NOUN
bjp-823	64	6	,	,	PUNCT
bjp-823	64	7	exclusion	exclusion	NOUN
bjp-823	64	8	criteria	criterion	NOUN
bjp-823	64	9	and	and	CCONJ
bjp-823	64	10	they	they	PRON
bjp-823	64	11	were	be	AUX
bjp-823	64	12	allocated	allocate	VERB
bjp-823	64	13	to	to	ADP
bjp-823	64	14	group	group	NOUN
bjp-823	64	15	i	i	PRON
bjp-823	64	16	(	(	PUNCT
bjp-823	64	17	64	64	NUM
bjp-823	64	18	patients	patient	NOUN
bjp-823	64	19	)	)	PUNCT
bjp-823	64	20	and	and	CCONJ
bjp-823	64	21	group	group	NOUN
bjp-823	64	22	iі	iі	INTJ
bjp-823	64	23	(	(	PUNCT
bjp-823	64	24	44	44	NUM
bjp-823	64	25	patients	patient	NOUN
bjp-823	64	26	)	)	PUNCT
bjp-823	64	27	.	.	PUNCT
bjp-823	65	1	group	group	NOUN
bjp-823	66	1	i	i	PRON
bjp-823	66	2	was	be	AUX
bjp-823	66	3	treated	treat	VERB
bjp-823	66	4	with	with	ADP
bjp-823	66	5	niacin	niacin	NOUN
bjp-823	66	6	1	1	NUM
bjp-823	66	7	g	g	NOUN
bjp-823	66	8	(	(	PUNCT
bjp-823	66	9	500	500	NUM
bjp-823	66	10	mg	mg	NOUN
bjp-823	66	11	twice	twice	ADV
bjp-823	66	12	daily	daily	ADV
bjp-823	66	13	)	)	PUNCT
bjp-823	66	14	plus	plus	CCONJ
bjp-823	66	15	atorvastatin	atorvastatin	PROPN
bjp-823	66	16	10	10	NUM
bjp-823	66	17	mg	mg	NOUN
bjp-823	66	18	daily	daily	ADV
bjp-823	66	19	for	for	ADP
bjp-823	66	20	12	12	NUM
bjp-823	66	21	weeks	week	NOUN
bjp-823	66	22	and	and	CCONJ
bjp-823	66	23	group	group	PROPN
bjp-823	66	24	ii	ii	PROPN
bjp-823	66	25	was	be	AUX
bjp-823	66	26	treated	treat	VERB
bjp-823	66	27	with	with	ADP
bjp-823	66	28	fenofibrate	fenofibrate	NOUN
bjp-823	66	29	200	200	NUM
bjp-823	66	30	mg	mg	PROPN
bjp-823	66	31	plus	plus	CCONJ
bjp-823	66	32	atorvastatin	atorvastatin	PROPN
bjp-823	66	33	10	10	NUM
bjp-823	66	34	mg	mg	NOUN
bjp-823	66	35	daily	daily	ADV
bjp-823	66	36	for	for	ADP
bjp-823	66	37	12	12	NUM
bjp-823	66	38	weeks	week	NOUN
bjp-823	66	39	.	.	PUNCT
bjp-823	67	1	among	among	ADP
bjp-823	67	2	group	group	NOUN
bjp-823	67	3	i	i	PRON
bjp-823	67	4	,	,	PUNCT
bjp-823	67	5	26	26	NUM
bjp-823	67	6	patients	patient	NOUN
bjp-823	67	7	did	do	AUX
bjp-823	67	8	not	not	PART
bjp-823	67	9	turn	turn	VERB
bjp-823	67	10	to	to	PART
bjp-823	67	11	follow	follow	VERB
bjp-823	67	12	-	-	PUNCT
bjp-823	67	13	up	up	NOUN
bjp-823	67	14	(	(	PUNCT
bjp-823	67	15	dropped	drop	VERB
bjp-823	67	16	out	out	ADP
bjp-823	67	17	)	)	PUNCT
bjp-823	67	18	,	,	PUNCT
bjp-823	67	19	3	3	NUM
bjp-823	67	20	died	die	VERB
bjp-823	67	21	while	while	SCONJ
bjp-823	67	22	35	35	NUM
bjp-823	67	23	patients	patient	NOUN
bjp-823	67	24	completed	complete	VERB
bjp-823	67	25	the	the	DET
bjp-823	67	26	study	study	NOUN
bjp-823	67	27	.	.	PUNCT
bjp-823	68	1	of	of	ADP
bjp-823	68	2	them	they	PRON
bjp-823	68	3	28	28	NUM
bjp-823	68	4	were	be	AUX
bjp-823	68	5	males	male	NOUN
bjp-823	68	6	and	and	CCONJ
bjp-823	68	7	7	7	NUM
bjp-823	68	8	were	be	AUX
bjp-823	68	9	females	female	NOUN
bjp-823	68	10	.	.	PUNCT
bjp-823	69	1	in	in	ADP
bjp-823	69	2	group	group	NOUN
bjp-823	69	3	iі	iі	NOUN
bjp-823	69	4	,	,	PUNCT
bjp-823	69	5	11	11	NUM
bjp-823	69	6	patients	patient	NOUN
bjp-823	69	7	did	do	AUX
bjp-823	69	8	not	not	PART
bjp-823	69	9	turn	turn	VERB
bjp-823	69	10	to	to	PART
bjp-823	69	11	follow	follow	VERB
bjp-823	69	12	-	-	PUNCT
bjp-823	69	13	up	up	NOUN
bjp-823	69	14	,	,	PUNCT
bjp-823	69	15	1	1	NUM
bjp-823	69	16	died	die	VERB
bjp-823	69	17	and	and	CCONJ
bjp-823	69	18	32	32	NUM
bjp-823	69	19	patients	patient	NOUN
bjp-823	69	20	completed	complete	VERB
bjp-823	69	21	the	the	DET
bjp-823	69	22	study	study	NOUN
bjp-823	69	23	.	.	PUNCT
bjp-823	70	1	of	of	ADP
bjp-823	70	2	them	they	PRON
bjp-823	70	3	30	30	NUM
bjp-823	70	4	were	be	AUX
bjp-823	70	5	males	male	NOUN
bjp-823	70	6	and	and	CCONJ
bjp-823	70	7	2	2	NUM
bjp-823	70	8	were	be	AUX
bjp-823	70	9	females	female	NOUN
bjp-823	70	10	.	.	PUNCT
bjp-823	71	1	a	a	DET
bjp-823	71	2	total	total	ADJ
bjp-823	71	3	number	number	NOUN
bjp-823	71	4	of	of	ADP
bjp-823	71	5	67	67	NUM
bjp-823	71	6	patients	patient	NOUN
bjp-823	71	7	completed	complete	VERB
bjp-823	71	8	the	the	DET
bjp-823	71	9	study	study	NOUN
bjp-823	71	10	.	.	PUNCT
bjp-823	72	1	average	average	ADJ
bjp-823	72	2	duration	duration	NOUN
bjp-823	72	3	of	of	ADP
bjp-823	72	4	hospital	hospital	NOUN
bjp-823	72	5	stay	stay	NOUN
bjp-823	72	6	of	of	ADP
bjp-823	72	7	the	the	DET
bjp-823	72	8	patients	patient	NOUN
bjp-823	72	9	was	be	AUX
bjp-823	72	10	5	5	NUM
bjp-823	72	11	to	to	PART
bjp-823	72	12	7	7	NUM
bjp-823	72	13	days	day	NOUN
bjp-823	72	14	.	.	PUNCT
bjp-823	73	1	all	all	DET
bjp-823	73	2	patients	patient	NOUN
bjp-823	73	3	of	of	ADP
bjp-823	73	4	both	both	DET
bjp-823	73	5	groups	group	NOUN
bjp-823	73	6	were	be	AUX
bjp-823	73	7	instructed	instruct	VERB
bjp-823	73	8	to	to	PART
bjp-823	73	9	maintain	maintain	VERB
bjp-823	73	10	tlc	tlc	NOUN
bjp-823	73	11	such	such	ADJ
bjp-823	73	12	as	as	ADP
bjp-823	73	13	low	low	ADJ
bjp-823	73	14	fat	fat	ADJ
bjp-823	73	15	diet	diet	NOUN
bjp-823	73	16	during	during	ADP
bjp-823	73	17	the	the	DET
bjp-823	73	18	trial	trial	NOUN
bjp-823	73	19	period	period	NOUN
bjp-823	73	20	.	.	PUNCT
bjp-823	74	1	during	during	ADP
bjp-823	74	2	discharge	discharge	NOUN
bjp-823	74	3	from	from	ADP
bjp-823	74	4	hospital	hospital	NOUN
bjp-823	74	5	all	all	DET
bjp-823	74	6	the	the	DET
bjp-823	74	7	study	study	NOUN
bjp-823	74	8	participants	participant	NOUN
bjp-823	74	9	were	be	AUX
bjp-823	74	10	instructed	instruct	VERB
bjp-823	74	11	about	about	ADP
bjp-823	74	12	possible	possible	ADJ
bjp-823	74	13	adverse	adverse	ADJ
bjp-823	74	14	effects	effect	NOUN
bjp-823	74	15	and	and	CCONJ
bjp-823	74	16	to	to	PART
bjp-823	74	17	report	report	VERB
bjp-823	74	18	to	to	ADP
bjp-823	74	19	the	the	DET
bjp-823	74	20	principal	principal	ADJ
bjp-823	74	21	investigator	investigator	NOUN
bjp-823	74	22	if	if	SCONJ
bjp-823	74	23	they	they	PRON
bjp-823	74	24	experience	experience	VERB
bjp-823	74	25	any	any	DET
bjp-823	74	26	sort	sort	NOUN
bjp-823	74	27	of	of	ADP
bjp-823	74	28	drug	drug	NOUN
bjp-823	74	29	related	relate	VERB
bjp-823	74	30	adverse	adverse	ADJ
bjp-823	74	31	events	event	NOUN
bjp-823	74	32	such	such	ADJ
bjp-823	74	33	as	as	ADP
bjp-823	74	34	warming	warming	NOUN
bjp-823	74	35	of	of	ADP
bjp-823	74	36	the	the	DET
bjp-823	74	37	face	face	NOUN
bjp-823	74	38	,	,	PUNCT
bjp-823	74	39	neck	neck	NOUN
bjp-823	74	40	and	and	CCONJ
bjp-823	74	41	shoulder	shoulder	NOUN
bjp-823	74	42	;	;	PUNCT
bjp-823	74	43	intense	intense	ADJ
bjp-823	74	44	muscle	muscle	NOUN
bjp-823	74	45	pain	pain	NOUN
bjp-823	74	46	,	,	PUNCT
bjp-823	74	47	headache	headache	NOUN
bjp-823	74	48	,	,	PUNCT
bjp-823	74	49	yellow	yellow	ADJ
bjp-823	74	50	coloration	coloration	NOUN
bjp-823	74	51	of	of	ADP
bjp-823	74	52	skin	skin	NOUN
bjp-823	74	53	and	and	CCONJ
bjp-823	74	54	eye	eye	NOUN
bjp-823	74	55	,	,	PUNCT
bjp-823	74	56	etc	etc	X
bjp-823	74	57	.	.	X
bjp-823	75	1	within	within	ADP
bjp-823	75	2	this	this	DET
bjp-823	75	3	period	period	NOUN
bjp-823	75	4	either	either	CCONJ
bjp-823	75	5	over	over	ADP
bjp-823	75	6	telephone	telephone	NOUN
bjp-823	75	7	or	or	CCONJ
bjp-823	75	8	physically	physically	ADV
bjp-823	75	9	.	.	PUNCT
bjp-823	76	1	all	all	DET
bjp-823	76	2	the	the	DET
bjp-823	76	3	participants	participant	NOUN
bjp-823	76	4	were	be	AUX
bjp-823	76	5	advised	advise	VERB
bjp-823	76	6	to	to	PART
bjp-823	76	7	report	report	VERB
bjp-823	76	8	to	to	ADP
bjp-823	76	9	the	the	DET
bjp-823	76	10	cardiology	cardiology	NOUN
bjp-823	76	11	outpatient	outpatient	NOUN
bjp-823	76	12	department	department	NOUN
bjp-823	76	13	following	follow	VERB
bjp-823	76	14	overnight	overnight	ADJ
bjp-823	76	15	fasting	fasting	NOUN
bjp-823	76	16	,	,	PUNCT
bjp-823	76	17	12	12	NUM
bjp-823	76	18	weeks	week	NOUN
bjp-823	76	19	after	after	ADP
bjp-823	76	20	initiation	initiation	NOUN
bjp-823	76	21	of	of	ADP
bjp-823	76	22	lipid	lipid	NOUN
bjp-823	76	23	lowering	lower	VERB
bjp-823	76	24	drug	drug	NOUN
bjp-823	76	25	.	.	PUNCT
bjp-823	77	1	on	on	ADP
bjp-823	77	2	that	that	DET
bjp-823	77	3	day	day	NOUN
bjp-823	77	4	along	along	ADP
bjp-823	77	5	with	with	ADP
bjp-823	77	6	clinical	clinical	ADJ
bjp-823	77	7	examination	examination	NOUN
bjp-823	77	8	blood	blood	NOUN
bjp-823	77	9	samples	sample	NOUN
bjp-823	77	10	were	be	AUX
bjp-823	77	11	collected	collect	VERB
bjp-823	77	12	and	and	CCONJ
bjp-823	77	13	relevant	relevant	ADJ
bjp-823	77	14	test	test	NOUN
bjp-823	77	15	was	be	AUX
bjp-823	77	16	done	do	VERB
bjp-823	77	17	and	and	CCONJ
bjp-823	77	18	test	test	NOUN
bjp-823	77	19	results	result	NOUN
bjp-823	77	20	were	be	AUX
bjp-823	77	21	also	also	ADV
bjp-823	77	22	recorded	record	VERB
bjp-823	77	23	.	.	PUNCT
bjp-823	78	1	from	from	ADP
bjp-823	78	2	each	each	DET
bjp-823	78	3	study	study	NOUN
bjp-823	78	4	subject	subject	NOUN
bjp-823	78	5	5	5	NUM
bjp-823	78	6	ml	ml	ADP
bjp-823	78	7	fasting	fast	VERB
bjp-823	78	8	venous	venous	ADJ
bjp-823	78	9	blood	blood	NOUN
bjp-823	78	10	sample	sample	NOUN
bjp-823	78	11	was	be	AUX
bjp-823	78	12	collected	collect	VERB
bjp-823	78	13	by	by	ADP
bjp-823	78	14	disposable	disposable	ADJ
bjp-823	78	15	plastic	plastic	NOUN
bjp-823	78	16	syringe	syringe	NOUN
bjp-823	78	17	with	with	ADP
bjp-823	78	18	all	all	DET
bjp-823	78	19	aseptic	aseptic	ADJ
bjp-823	78	20	precautions	precaution	NOUN
bjp-823	78	21	.	.	PUNCT
bjp-823	79	1	the	the	DET
bjp-823	79	2	needle	needle	NOUN
bjp-823	79	3	was	be	AUX
bjp-823	79	4	detached	detach	VERB
bjp-823	79	5	from	from	ADP
bjp-823	79	6	the	the	DET
bjp-823	79	7	nozzle	nozzle	NOUN
bjp-823	79	8	and	and	CCONJ
bjp-823	79	9	blood	blood	NOUN
bjp-823	79	10	was	be	AUX
bjp-823	79	11	transferred	transfer	VERB
bjp-823	79	12	immediately	immediately	ADV
bjp-823	79	13	into	into	ADP
bjp-823	79	14	a	a	DET
bjp-823	79	15	dry	dry	ADJ
bjp-823	79	16	,	,	PUNCT
bjp-823	79	17	clean	clean	ADJ
bjp-823	79	18	and	and	CCONJ
bjp-823	79	19	plain	plain	ADJ
bjp-823	79	20	plastic	plastic	NOUN
bjp-823	79	21	test	test	NOUN
bjp-823	79	22	tube	tube	NOUN
bjp-823	79	23	without	without	ADP
bjp-823	79	24	any	any	DET
bjp-823	79	25	anticoagulant	anticoagulant	NOUN
bjp-823	79	26	with	with	ADP
bjp-823	79	27	a	a	DET
bjp-823	79	28	gentle	gentle	ADJ
bjp-823	79	29	push	push	NOUN
bjp-823	79	30	to	to	PART
bjp-823	79	31	avoid	avoid	VERB
bjp-823	79	32	hemolysis	hemolysis	NOUN
bjp-823	79	33	.	.	PUNCT
bjp-823	80	1	serum	serum	NOUN
bjp-823	80	2	was	be	AUX
bjp-823	80	3	separated	separate	VERB
bjp-823	80	4	by	by	ADP
bjp-823	80	5	centrifugation	centrifugation	NOUN
bjp-823	80	6	at	at	ADP
bjp-823	80	7	the	the	DET
bjp-823	80	8	rate	rate	NOUN
bjp-823	80	9	of	of	ADP
bjp-823	80	10	3,000	3,000	NUM
bjp-823	80	11	rpm	rpm	NOUN
bjp-823	80	12	for	for	ADP
bjp-823	80	13	15	15	NUM
bjp-823	80	14	min	min	NOUN
bjp-823	80	15	.	.	NOUN
bjp-823	80	16	estimations	estimation	NOUN
bjp-823	80	17	were	be	AUX
bjp-823	80	18	carried	carry	VERB
bjp-823	80	19	out	out	ADP
bjp-823	80	20	as	as	ADV
bjp-823	80	21	early	early	ADV
bjp-823	80	22	as	as	ADP
bjp-823	80	23	possible	possible	ADJ
bjp-823	80	24	.	.	PUNCT
bjp-823	81	1	whenever	whenever	SCONJ
bjp-823	81	2	there	there	PRON
bjp-823	81	3	was	be	VERB
bjp-823	81	4	delay	delay	NOUN
bjp-823	81	5	,	,	PUNCT
bjp-823	81	6	sample	sample	NOUN
bjp-823	81	7	was	be	AUX
bjp-823	81	8	stored	store	VERB
bjp-823	81	9	at	at	ADP
bjp-823	81	10	-20	-20	NUM
bjp-823	81	11	°	°	NOUN
bjp-823	81	12	c	c	NOUN
bjp-823	81	13	.	.	PUNCT
bjp-823	82	1	data	datum	NOUN
bjp-823	82	2	were	be	AUX
bjp-823	82	3	collected	collect	VERB
bjp-823	82	4	through	through	ADP
bjp-823	82	5	preformed	preformed	ADJ
bjp-823	82	6	data	datum	NOUN
bjp-823	82	7	collection	collection	NOUN
bjp-823	82	8	sheet	sheet	NOUN
bjp-823	82	9	by	by	ADP
bjp-823	82	10	pre	pre	ADJ
bjp-823	82	11	-	-	ADJ
bjp-823	82	12	tested	test	VERB
bjp-823	82	13	questionnaire	questionnaire	NOUN
bjp-823	82	14	,	,	PUNCT
bjp-823	82	15	clinical	clinical	ADJ
bjp-823	82	16	examination	examination	NOUN
bjp-823	82	17	,	,	PUNCT
bjp-823	82	18	ecg	ecg	PROPN
bjp-823	82	19	and	and	CCONJ
bjp-823	82	20	biochemical	biochemical	ADJ
bjp-823	82	21	examinations	examination	NOUN
bjp-823	82	22	.	.	PUNCT
bjp-823	83	1	after	after	ADP
bjp-823	83	2	an	an	DET
bjp-823	83	3	overnight	overnight	ADJ
bjp-823	83	4	fasting	fasting	NOUN
bjp-823	83	5	,	,	PUNCT
bjp-823	83	6	total	total	ADJ
bjp-823	83	7	cholesterol	cholesterol	NOUN
bjp-823	83	8	and	and	CCONJ
bjp-823	83	9	hdl	hdl	PROPN
bjp-823	83	10	-	-	PUNCT
bjp-823	83	11	c	c	PROPN
bjp-823	83	12	were	be	AUX
bjp-823	83	13	measured	measure	VERB
bjp-823	83	14	by	by	ADP
bjp-823	83	15	chod	chod	PROPN
bjp-823	83	16	-	-	PUNCT
bjp-823	83	17	pap	pap	NOUN
bjp-823	83	18	method	method	NOUN
bjp-823	83	19	using	use	VERB
bjp-823	83	20	reagents	reagent	NOUN
bjp-823	83	21	of	of	ADP
bjp-823	83	22	biocon	biocon	NOUN
bjp-823	83	23	®	®	NOUN
bjp-823	83	24	germany	germany	PROPN
bjp-823	83	25	by	by	ADP
bjp-823	83	26	spectrophotometer	spectrophotometer	PROPN
bjp-823	83	27	.	.	PUNCT
bjp-823	84	1	triglycerides	triglyceride	NOUN
bjp-823	84	2	were	be	AUX
bjp-823	84	3	also	also	ADV
bjp-823	84	4	measured	measure	VERB
bjp-823	84	5	by	by	ADP
bjp-823	84	6	gpo	gpo	NOUN
bjp-823	84	7	-	-	PUNCT
bjp-823	84	8	pap	pap	NOUN
bjp-823	84	9	method	method	NOUN
bjp-823	84	10	using	use	VERB
bjp-823	84	11	reagents	reagent	NOUN
bjp-823	84	12	of	of	ADP
bjp-823	84	13	biocon	biocon	NOUN
bjp-823	84	14	®	®	NOUN
bjp-823	84	15	germany	germany	PROPN
bjp-823	84	16	by	by	ADP
bjp-823	84	17	spectrophotometer	spectrophotometer	NOUN
bjp-823	84	18	(	(	PUNCT
bjp-823	84	19	gowland	gowland	NOUN
bjp-823	84	20	,	,	PUNCT
bjp-823	84	21	1998	1998	NUM
bjp-823	84	22	)	)	PUNCT
bjp-823	84	23	.	.	PUNCT
bjp-823	85	1	ldl	ldl	NOUN
bjp-823	85	2	cholesterol	cholesterol	NOUN
bjp-823	85	3	was	be	AUX
bjp-823	85	4	calculated	calculate	VERB
bjp-823	85	5	by	by	ADP
bjp-823	85	6	friedewald	friedewald	ADJ
bjp-823	85	7	formula	formula	NOUN
bjp-823	85	8	(	(	PUNCT
bjp-823	85	9	in	in	ADP
bjp-823	85	10	mg	mg	PROPN
bjp-823	85	11	/	/	SYM
bjp-823	85	12	dl	dl	NOUN
bjp-823	85	13	)	)	PUNCT
bjp-823	86	1	[	[	X
bjp-823	86	2	ldl	ldl	NOUN
bjp-823	86	3	-	-	PUNCT
bjp-823	86	4	c	c	NOUN
bjp-823	86	5	=	=	PUNCT
bjp-823	86	6	tc(tg/5	tc(tg/5	PROPN
bjp-823	87	1	+	+	CCONJ
bjp-823	87	2	hdl	hdl	NOUN
bjp-823	87	3	-	-	PUNCT
bjp-823	87	4	c	c	NOUN
bjp-823	87	5	)	)	PUNCT
bjp-823	87	6	]	]	PUNCT
bjp-823	87	7	.	.	PUNCT
bjp-823	88	1	estimation	estimation	NOUN
bjp-823	88	2	of	of	ADP
bjp-823	88	3	serum	serum	NOUN
bjp-823	88	4	glucose	glucose	NOUN
bjp-823	88	5	was	be	AUX
bjp-823	88	6	done	do	VERB
bjp-823	88	7	by	by	ADP
bjp-823	88	8	god	god	PROPN
bjp-823	88	9	-	-	PUNCT
bjp-823	88	10	pap	pap	NOUN
bjp-823	88	11	method	method	NOUN
bjp-823	88	12	(	(	PUNCT
bjp-823	88	13	mclauchlan	mclauchlan	NOUN
bjp-823	88	14	,	,	PUNCT
bjp-823	88	15	1998	1998	NUM
bjp-823	88	16	)	)	PUNCT
bjp-823	88	17	.	.	PUNCT
bjp-823	89	1	estimation	estimation	NOUN
bjp-823	89	2	of	of	ADP
bjp-823	89	3	sgpt	sgpt	NOUN
bjp-823	89	4	was	be	AUX
bjp-823	89	5	performed	perform	VERB
bjp-823	89	6	by	by	ADP
bjp-823	89	7	colorimetric	colorimetric	ADJ
bjp-823	89	8	method	method	NOUN
bjp-823	89	9	(	(	PUNCT
bjp-823	89	10	handerson	handerson	NOUN
bjp-823	89	11	and	and	CCONJ
bjp-823	89	12	donald	donald	PROPN
bjp-823	89	13	,	,	PUNCT
bjp-823	89	14	2001	2001	NUM
bjp-823	89	15	)	)	PUNCT
bjp-823	89	16	.	.	PUNCT
bjp-823	90	1	for	for	ADP
bjp-823	90	2	estimation	estimation	NOUN
bjp-823	90	3	of	of	ADP
bjp-823	90	4	serum	serum	NOUN
bjp-823	90	5	creatinine	creatinine	NOUN
bjp-823	90	6	kinetic	kinetic	NOUN
bjp-823	90	7	method	method	NOUN
bjp-823	90	8	was	be	AUX
bjp-823	90	9	used	use	VERB
bjp-823	90	10	(	(	PUNCT
bjp-823	90	11	david	david	PROPN
bjp-823	90	12	and	and	CCONJ
bjp-823	90	13	chistopher	chistopher	VERB
bjp-823	90	14	,	,	PUNCT
bjp-823	90	15	2001	2001	NUM
bjp-823	90	16	)	)	PUNCT
bjp-823	90	17	.	.	PUNCT
bjp-823	91	1	all	all	DET
bjp-823	91	2	statistical	statistical	ADJ
bjp-823	91	3	analyses	analysis	NOUN
bjp-823	91	4	were	be	AUX
bjp-823	91	5	done	do	VERB
bjp-823	91	6	by	by	ADP
bjp-823	91	7	spss	spss	PROPN
bjp-823	91	8	software	software	NOUN
bjp-823	91	9	package	package	NOUN
bjp-823	91	10	,	,	PUNCT
bjp-823	91	11	12.0	12.0	NUM
bjp-823	91	12	for	for	ADP
bjp-823	91	13	windows	window	NOUN
bjp-823	91	14	.	.	PUNCT
bjp-823	92	1	values	value	NOUN
bjp-823	92	2	were	be	AUX
bjp-823	92	3	presented	present	VERB
bjp-823	92	4	as	as	ADP
bjp-823	92	5	mean	mean	NOUN
bjp-823	92	6	±	±	NUM
bjp-823	92	7	sd	sd	NOUN
bjp-823	92	8	.	.	PUNCT
bjp-823	93	1	95	95	NUM
bjp-823	93	2	%	%	NOUN
bjp-823	93	3	significance	significance	NOUN
bjp-823	93	4	level	level	NOUN
bjp-823	93	5	(	(	PUNCT
bjp-823	93	6	p<0.05	p<0.05	NOUN
bjp-823	93	7	)	)	PUNCT
bjp-823	93	8	was	be	AUX
bjp-823	93	9	considered	consider	VERB
bjp-823	93	10	statistically	statistically	ADV
bjp-823	93	11	significant	significant	ADJ
bjp-823	93	12	.	.	PUNCT
bjp-823	94	1	paired	pair	VERB
bjp-823	94	2	t	t	PROPN
bjp-823	94	3	-	-	PUNCT
bjp-823	94	4	test	test	NOUN
bjp-823	94	5	was	be	AUX
bjp-823	94	6	done	do	VERB
bjp-823	94	7	to	to	PART
bjp-823	94	8	compare	compare	VERB
bjp-823	94	9	between	between	ADP
bjp-823	94	10	means	mean	NOUN
bjp-823	94	11	within	within	ADP
bjp-823	94	12	groups	group	NOUN
bjp-823	94	13	and	and	CCONJ
bjp-823	94	14	‘	'	PUNCT
bjp-823	94	15	z	z	NOUN
bjp-823	94	16	’	'	PUNCT
bjp-823	94	17	proportion	proportion	NOUN
bjp-823	94	18	test	test	NOUN
bjp-823	94	19	was	be	AUX
bjp-823	94	20	done	do	VERB
bjp-823	94	21	to	to	PART
bjp-823	94	22	see	see	VERB
bjp-823	94	23	any	any	DET
bjp-823	94	24	significant	significant	ADJ
bjp-823	94	25	difference	difference	NOUN
bjp-823	94	26	between	between	ADP
bjp-823	94	27	the	the	DET
bjp-823	94	28	study	study	NOUN
bjp-823	94	29	parameters	parameter	NOUN
bjp-823	94	30	.	.	PUNCT
bjp-823	95	1	the	the	DET
bjp-823	95	2	study	study	NOUN
bjp-823	95	3	was	be	AUX
bjp-823	95	4	approved	approve	VERB
bjp-823	95	5	by	by	ADP
bjp-823	95	6	ethics	ethic	NOUN
bjp-823	95	7	review	review	PROPN
bjp-823	95	8	committee	committee	PROPN
bjp-823	95	9	of	of	ADP
bjp-823	95	10	sylhet	sylhet	PROPN
bjp-823	95	11	m.a.g	m.a.g	PROPN
bjp-823	95	12	.	.	PUNCT
bjp-823	95	13	osmani	osmani	PROPN
bjp-823	95	14	medical	medical	PROPN
bjp-823	95	15	college	college	PROPN
bjp-823	95	16	.	.	PUNCT
bjp-823	96	1	informed	inform	VERB
bjp-823	96	2	written	write	VERB
bjp-823	96	3	consent	consent	NOUN
bjp-823	96	4	was	be	AUX
bjp-823	96	5	taken	take	VERB
bjp-823	96	6	from	from	ADP
bjp-823	96	7	all	all	DET
bjp-823	96	8	participants	participant	NOUN
bjp-823	96	9	prior	prior	ADV
bjp-823	96	10	to	to	AUX
bjp-823	96	11	study	study	VERB
bjp-823	96	12	.	.	PUNCT
bjp-823	97	1	results	result	NOUN
bjp-823	97	2	mean	mean	VERB
bjp-823	97	3	ages	age	NOUN
bjp-823	97	4	for	for	ADP
bjp-823	97	5	group	group	NOUN
bjp-823	97	6	i	i	PROPN
bjp-823	97	7	and	and	CCONJ
bjp-823	97	8	іі	іі	PROPN
bjp-823	97	9	were	be	AUX
bjp-823	97	10	50.7	50.7	NUM
bjp-823	97	11	±	±	NUM
bjp-823	97	12	10.0	10.0	NUM
bjp-823	97	13	years	year	NOUN
bjp-823	97	14	and	and	CCONJ
bjp-823	97	15	10	10	NUM
bjp-823	97	16	bangladesh	bangladesh	PROPN
bjp-823	97	17	j	j	PROPN
bjp-823	97	18	pharmacol	pharmacol	PROPN
bjp-823	97	19	2008	2008	NUM
bjp-823	97	20	;	;	PUNCT
bjp-823	97	21	3	3	NUM
bjp-823	97	22	:	:	SYM
bjp-823	97	23	8	8	NUM
bjp-823	97	24	-	-	SYM
bjp-823	97	25	16	16	NUM
bjp-823	97	26	47.6	47.6	NUM
bjp-823	97	27	±	±	NUM
bjp-823	97	28	8.3	8.3	NUM
bjp-823	97	29	years	year	NOUN
bjp-823	97	30	respectively	respectively	ADV
bjp-823	97	31	.	.	PUNCT
bjp-823	98	1	there	there	PRON
bjp-823	98	2	was	be	VERB
bjp-823	98	3	no	no	DET
bjp-823	98	4	significant	significant	ADJ
bjp-823	98	5	difference	difference	NOUN
bjp-823	98	6	between	between	ADP
bjp-823	98	7	group	group	NOUN
bjp-823	98	8	i	i	PROPN
bjp-823	98	9	and	and	CCONJ
bjp-823	98	10	іі	іі	PROPN
bjp-823	98	11	in	in	ADP
bjp-823	98	12	their	their	PRON
bjp-823	98	13	age	age	NOUN
bjp-823	98	14	distribution	distribution	NOUN
bjp-823	98	15	.	.	PUNCT
bjp-823	99	1	of	of	ADP
bjp-823	99	2	the	the	DET
bjp-823	99	3	study	study	NOUN
bjp-823	99	4	subjects	subject	NOUN
bjp-823	99	5	25	25	NUM
bjp-823	99	6	(	(	PUNCT
bjp-823	99	7	71.4	71.4	NUM
bjp-823	99	8	%	%	NOUN
bjp-823	99	9	)	)	PUNCT
bjp-823	99	10	of	of	ADP
bjp-823	99	11	group	group	NOUN
bjp-823	99	12	i	i	PROPN
bjp-823	99	13	and	and	CCONJ
bjp-823	99	14	27	27	NUM
bjp-823	99	15	(	(	PUNCT
bjp-823	99	16	84.4	84.4	NUM
bjp-823	99	17	%	%	NOUN
bjp-823	99	18	)	)	PUNCT
bjp-823	99	19	of	of	ADP
bjp-823	99	20	group	group	PROPN
bjp-823	99	21	ii	ii	PROPN
bjp-823	99	22	were	be	AUX
bjp-823	99	23	smokers	smoker	NOUN
bjp-823	99	24	.	.	PUNCT
bjp-823	100	1	family	family	NOUN
bjp-823	100	2	history	history	NOUN
bjp-823	100	3	of	of	ADP
bjp-823	100	4	coronary	coronary	ADJ
bjp-823	100	5	heart	heart	NOUN
bjp-823	100	6	disease	disease	NOUN
bjp-823	100	7	were	be	AUX
bjp-823	100	8	found	find	VERB
bjp-823	100	9	in	in	ADP
bjp-823	100	10	23	23	NUM
bjp-823	100	11	(	(	PUNCT
bjp-823	100	12	65.7	65.7	NUM
bjp-823	100	13	%	%	NOUN
bjp-823	100	14	)	)	PUNCT
bjp-823	100	15	and	and	CCONJ
bjp-823	100	16	20	20	NUM
bjp-823	100	17	(	(	PUNCT
bjp-823	100	18	62.5	62.5	NUM
bjp-823	100	19	%	%	NOUN
bjp-823	100	20	)	)	PUNCT
bjp-823	100	21	patients	patient	NOUN
bjp-823	100	22	of	of	ADP
bjp-823	100	23	group	group	NOUN
bjp-823	100	24	i	i	PROPN
bjp-823	100	25	and	and	CCONJ
bjp-823	100	26	ii	ii	PROPN
bjp-823	100	27	respectively	respectively	ADV
bjp-823	100	28	.	.	PUNCT
bjp-823	101	1	obesity	obesity	NOUN
bjp-823	101	2	(	(	PUNCT
bjp-823	101	3	bmi>25	bmi>25	PROPN
bjp-823	101	4	kg	kg	PROPN
bjp-823	101	5	/	/	SYM
bjp-823	101	6	m2	m2	PROPN
bjp-823	101	7	)	)	PUNCT
bjp-823	101	8	was	be	AUX
bjp-823	101	9	detected	detect	VERB
bjp-823	101	10	12	12	NUM
bjp-823	101	11	(	(	PUNCT
bjp-823	101	12	34.3	34.3	NUM
bjp-823	101	13	%	%	NOUN
bjp-823	101	14	)	)	PUNCT
bjp-823	101	15	in	in	ADP
bjp-823	101	16	group	group	NOUN
bjp-823	101	17	і	і	PROPN
bjp-823	101	18	and	and	CCONJ
bjp-823	101	19	group	group	NOUN
bjp-823	101	20	11	11	NUM
bjp-823	101	21	(	(	PUNCT
bjp-823	101	22	34.4	34.4	NUM
bjp-823	101	23	%	%	NOUN
bjp-823	101	24	)	)	PUNCT
bjp-823	101	25	in	in	ADP
bjp-823	101	26	ii	ii	PROPN
bjp-823	101	27	.	.	PUNCT
bjp-823	102	1	history	history	NOUN
bjp-823	102	2	of	of	ADP
bjp-823	102	3	sedentary	sedentary	ADJ
bjp-823	102	4	life	life	NOUN
bjp-823	102	5	style	style	NOUN
bjp-823	102	6	was	be	AUX
bjp-823	102	7	10	10	NUM
bjp-823	102	8	(	(	PUNCT
bjp-823	102	9	28.6	28.6	NUM
bjp-823	102	10	%	%	NOUN
bjp-823	102	11	)	)	PUNCT
bjp-823	102	12	in	in	ADP
bjp-823	102	13	group	group	NOUN
bjp-823	102	14	i	i	PROPN
bjp-823	102	15	and	and	CCONJ
bjp-823	102	16	8	8	NUM
bjp-823	102	17	(	(	PUNCT
bjp-823	102	18	25.6	25.6	NUM
bjp-823	102	19	%	%	NOUN
bjp-823	102	20	)	)	PUNCT
bjp-823	102	21	in	in	ADP
bjp-823	102	22	group	group	PROPN
bjp-823	102	23	ii	ii	PROPN
bjp-823	102	24	.	.	PUNCT
bjp-823	103	1	around	around	ADV
bjp-823	103	2	34	34	NUM
bjp-823	103	3	%	%	NOUN
bjp-823	103	4	of	of	ADP
bjp-823	103	5	the	the	DET
bjp-823	103	6	study	study	NOUN
bjp-823	103	7	subjects	subject	NOUN
bjp-823	103	8	were	be	AUX
bjp-823	103	9	diabetic	diabetic	ADJ
bjp-823	103	10	in	in	ADP
bjp-823	103	11	both	both	DET
bjp-823	103	12	groups	group	NOUN
bjp-823	103	13	,	,	PUNCT
bjp-823	103	14	while	while	SCONJ
bjp-823	103	15	42.9	42.9	NUM
bjp-823	103	16	%	%	NOUN
bjp-823	103	17	of	of	ADP
bjp-823	103	18	group	group	NOUN
bjp-823	103	19	і	і	PROPN
bjp-823	103	20	and	and	CCONJ
bjp-823	103	21	62.5	62.5	NUM
bjp-823	103	22	%	%	NOUN
bjp-823	103	23	of	of	ADP
bjp-823	103	24	group	group	NOUN
bjp-823	103	25	ii	ii	PROPN
bjp-823	103	26	were	be	AUX
bjp-823	103	27	hypertensive	hypertensive	ADJ
bjp-823	103	28	.	.	PUNCT
bjp-823	104	1	all	all	DET
bjp-823	104	2	patients	patient	NOUN
bjp-823	104	3	of	of	ADP
bjp-823	104	4	both	both	DET
bjp-823	104	5	groups	group	NOUN
bjp-823	104	6	were	be	AUX
bjp-823	104	7	match	match	VERB
bjp-823	104	8	in	in	ADP
bjp-823	104	9	respect	respect	NOUN
bjp-823	104	10	to	to	ADP
bjp-823	104	11	age	age	NOUN
bjp-823	104	12	,	,	PUNCT
bjp-823	104	13	risk	risk	NOUN
bjp-823	104	14	factors	factor	NOUN
bjp-823	104	15	(	(	PUNCT
bjp-823	104	16	history	history	NOUN
bjp-823	104	17	of	of	ADP
bjp-823	104	18	smoking	smoking	NOUN
bjp-823	104	19	,	,	PUNCT
bjp-823	104	20	family	family	NOUN
bjp-823	104	21	history	history	NOUN
bjp-823	104	22	of	of	ADP
bjp-823	104	23	coronary	coronary	ADJ
bjp-823	104	24	heart	heart	NOUN
bjp-823	104	25	disease	disease	NOUN
bjp-823	104	26	,	,	PUNCT
bjp-823	104	27	obesity	obesity	NOUN
bjp-823	104	28	,	,	PUNCT
bjp-823	104	29	sedentary	sedentary	ADJ
bjp-823	104	30	life	life	NOUN
bjp-823	104	31	style	style	NOUN
bjp-823	104	32	)	)	PUNCT
bjp-823	104	33	and	and	CCONJ
bjp-823	104	34	associated	associate	VERB
bjp-823	104	35	diseases	disease	NOUN
bjp-823	104	36	(	(	PUNCT
bjp-823	104	37	diabetes	diabetes	NOUN
bjp-823	104	38	,	,	PUNCT
bjp-823	104	39	hypertension	hypertension	NOUN
bjp-823	104	40	)	)	PUNCT
bjp-823	104	41	.	.	PUNCT
bjp-823	105	1	before	before	ADP
bjp-823	105	2	administration	administration	NOUN
bjp-823	105	3	of	of	ADP
bjp-823	105	4	niacin	niacin	PROPN
bjp-823	105	5	-	-	PUNCT
bjp-823	105	6	atorvastatin	atorvastatin	NOUN
bjp-823	105	7	combination	combination	NOUN
bjp-823	105	8	,	,	PUNCT
bjp-823	105	9	fasting	fast	VERB
bjp-823	105	10	serum	serum	NOUN
bjp-823	105	11	lipid	lipid	NOUN
bjp-823	105	12	profile	profile	NOUN
bjp-823	105	13	was	be	AUX
bjp-823	105	14	measured	measure	VERB
bjp-823	105	15	(	(	PUNCT
bjp-823	105	16	table	table	NOUN
bjp-823	105	17	i	i	NOUN
bjp-823	105	18	)	)	PUNCT
bjp-823	105	19	.	.	PUNCT
bjp-823	106	1	serum	serum	NOUN
bjp-823	106	2	levels	level	NOUN
bjp-823	106	3	of	of	ADP
bjp-823	106	4	triglyceride	triglyceride	ADJ
bjp-823	106	5	,	,	PUNCT
bjp-823	106	6	total	total	ADJ
bjp-823	106	7	cholesterol	cholesterol	NOUN
bjp-823	106	8	,	,	PUNCT
bjp-823	106	9	ldl	ldl	NOUN
bjp-823	106	10	-	-	PUNCT
bjp-823	106	11	c	c	PROPN
bjp-823	106	12	,	,	PUNCT
bjp-823	106	13	hdl	hdl	PROPN
bjp-823	106	14	-	-	PUNCT
bjp-823	106	15	c	c	PROPN
bjp-823	106	16	levels	level	NOUN
bjp-823	106	17	were	be	AUX
bjp-823	106	18	207.8	207.8	NUM
bjp-823	106	19	±	±	NUM
bjp-823	106	20	60.2	60.2	NUM
bjp-823	106	21	mg	mg	PROPN
bjp-823	106	22	/	/	SYM
bjp-823	106	23	dl	dl	PROPN
bjp-823	106	24	,	,	PUNCT
bjp-823	106	25	213.5	213.5	NUM
bjp-823	106	26	±	±	NUM
bjp-823	106	27	28.5	28.5	NUM
bjp-823	106	28	mg	mg	PROPN
bjp-823	106	29	/	/	SYM
bjp-823	106	30	dl	dl	PROPN
bjp-823	106	31	,	,	PUNCT
bjp-823	106	32	136.8	136.8	NUM
bjp-823	106	33	±	±	NUM
bjp-823	106	34	23.6	23.6	NUM
bjp-823	106	35	mg	mg	PROPN
bjp-823	106	36	/	/	SYM
bjp-823	106	37	dl	dl	PROPN
bjp-823	107	1	and	and	CCONJ
bjp-823	107	2	35.3	35.3	NUM
bjp-823	107	3	±	±	NUM
bjp-823	107	4	3.6	3.6	NUM
bjp-823	107	5	mg	mg	PROPN
bjp-823	107	6	/	/	SYM
bjp-823	107	7	dl	dl	PROPN
bjp-823	107	8	respectively	respectively	ADV
bjp-823	107	9	.	.	PUNCT
bjp-823	108	1	after	after	ADP
bjp-823	108	2	12	12	NUM
bjp-823	108	3	weeks	week	NOUN
bjp-823	108	4	of	of	ADP
bjp-823	108	5	treatment	treatment	NOUN
bjp-823	108	6	,	,	PUNCT
bjp-823	108	7	triglyceride	triglyceride	ADP
bjp-823	108	8	level	level	NOUN
bjp-823	108	9	was	be	AUX
bjp-823	108	10	reduced	reduce	VERB
bjp-823	108	11	from	from	ADP
bjp-823	108	12	207.8	207.8	NUM
bjp-823	108	13	±	±	NUM
bjp-823	108	14	60.2	60.2	NUM
bjp-823	108	15	mg	mg	PROPN
bjp-823	108	16	/	/	SYM
bjp-823	108	17	dl	dl	PROPN
bjp-823	108	18	to	to	ADP
bjp-823	108	19	178.6	178.6	NUM
bjp-823	108	20	±	±	NUM
bjp-823	108	21	52.8	52.8	NUM
bjp-823	108	22	mg	mg	PROPN
bjp-823	108	23	/	/	SYM
bjp-823	108	24	dl	dl	PROPN
bjp-823	108	25	.	.	PUNCT
bjp-823	109	1	this	this	DET
bjp-823	109	2	change	change	NOUN
bjp-823	109	3	was	be	AUX
bjp-823	109	4	statistically	statistically	ADV
bjp-823	109	5	significant	significant	ADJ
bjp-823	109	6	(	(	PUNCT
bjp-823	109	7	t=4.677	t=4.677	NOUN
bjp-823	109	8	,	,	PUNCT
bjp-823	109	9	p<0.001	p<0.001	PROPN
bjp-823	109	10	,	,	PUNCT
bjp-823	109	11	95	95	NUM
bjp-823	109	12	%	%	NOUN
bjp-823	109	13	ci	ci	NOUN
bjp-823	109	14	16.47	16.47	NUM
bjp-823	109	15	to	to	ADP
bjp-823	109	16	41.80	41.80	NUM
bjp-823	109	17	)	)	PUNCT
bjp-823	109	18	.	.	PUNCT
bjp-823	110	1	triglyceride	triglyceride	INTJ
bjp-823	110	2	decreased	decrease	VERB
bjp-823	110	3	by	by	ADP
bjp-823	110	4	14.03	14.03	NUM
bjp-823	110	5	%	%	NOUN
bjp-823	110	6	.	.	PUNCT
bjp-823	111	1	total	total	ADJ
bjp-823	111	2	cholesterol	cholesterol	NOUN
bjp-823	111	3	level	level	NOUN
bjp-823	111	4	was	be	AUX
bjp-823	111	5	reduced	reduce	VERB
bjp-823	111	6	from	from	ADP
bjp-823	111	7	213.5	213.5	NUM
bjp-823	111	8	±	±	NUM
bjp-823	111	9	28.5	28.5	NUM
bjp-823	111	10	mg	mg	PROPN
bjp-823	111	11	/	/	SYM
bjp-823	111	12	dl	dl	PROPN
bjp-823	111	13	to	to	ADP
bjp-823	111	14	158.6	158.6	NUM
bjp-823	111	15	±	±	NUM
bjp-823	111	16	19.5	19.5	NUM
bjp-823	111	17	mg	mg	PROPN
bjp-823	111	18	/	/	SYM
bjp-823	111	19	dl	dl	PROPN
bjp-823	112	1	and	and	CCONJ
bjp-823	112	2	this	this	DET
bjp-823	112	3	change	change	NOUN
bjp-823	112	4	was	be	AUX
bjp-823	112	5	statistically	statistically	ADV
bjp-823	112	6	significant	significant	ADJ
bjp-823	112	7	(	(	PUNCT
bjp-823	112	8	t=14.706	t=14.706	NUM
bjp-823	112	9	,	,	PUNCT
bjp-823	112	10	p<0.001	p<0.001	ADJ
bjp-823	112	11	,	,	PUNCT
bjp-823	112	12	95	95	NUM
bjp-823	112	13	%	%	NOUN
bjp-823	112	14	ci	ci	NOUN
bjp-823	112	15	47.350	47.350	NUM
bjp-823	112	16	to	to	ADP
bjp-823	112	17	62.535	62.535	NUM
bjp-823	112	18	)	)	PUNCT
bjp-823	112	19	.	.	PUNCT
bjp-823	113	1	reduction	reduction	NOUN
bjp-823	113	2	of	of	ADP
bjp-823	113	3	total	total	ADJ
bjp-823	113	4	cholesterol	cholesterol	NOUN
bjp-823	113	5	was	be	AUX
bjp-823	113	6	25.7	25.7	NUM
bjp-823	113	7	%	%	NOUN
bjp-823	113	8	from	from	ADP
bjp-823	113	9	the	the	DET
bjp-823	113	10	baseline	baseline	ADJ
bjp-823	113	11	level	level	NOUN
bjp-823	113	12	.	.	PUNCT
bjp-823	114	1	ldl	ldl	NOUN
bjp-823	114	2	-	-	PUNCT
bjp-823	114	3	c	c	NOUN
bjp-823	114	4	level	level	NOUN
bjp-823	114	5	was	be	AUX
bjp-823	114	6	observed	observe	VERB
bjp-823	114	7	to	to	PART
bjp-823	114	8	decrease	decrease	VERB
bjp-823	114	9	from	from	ADP
bjp-823	114	10	136.8	136.8	NUM
bjp-823	114	11	±	±	NUM
bjp-823	114	12	23.6	23.6	NUM
bjp-823	114	13	mg	mg	PROPN
bjp-823	114	14	/	/	SYM
bjp-823	114	15	dl	dl	PROPN
bjp-823	114	16	to	to	ADP
bjp-823	114	17	84.2	84.2	NUM
bjp-823	114	18	±	±	NUM
bjp-823	114	19	15.4	15.4	NUM
bjp-823	114	20	mg	mg	PROPN
bjp-823	114	21	/	/	SYM
bjp-823	114	22	dl	dl	PROPN
bjp-823	115	1	and	and	CCONJ
bjp-823	115	2	this	this	DET
bjp-823	115	3	reduction	reduction	NOUN
bjp-823	115	4	was	be	AUX
bjp-823	115	5	statistically	statistically	ADV
bjp-823	115	6	significant	significant	ADJ
bjp-823	115	7	(	(	PUNCT
bjp-823	115	8	t=15.448	t=15.448	X
bjp-823	115	9	,	,	PUNCT
bjp-823	115	10	p<0.001	p<0.001	ADJ
bjp-823	115	11	,	,	PUNCT
bjp-823	115	12	95	95	NUM
bjp-823	115	13	%	%	NOUN
bjp-823	115	14	ci	ci	NOUN
bjp-823	116	1	45.631	45.631	NUM
bjp-823	116	2	to	to	ADP
bjp-823	116	3	59.455	59.455	NUM
bjp-823	116	4	)	)	PUNCT
bjp-823	116	5	.	.	PUNCT
bjp-823	117	1	percentage	percentage	NOUN
bjp-823	117	2	change	change	NOUN
bjp-823	117	3	of	of	ADP
bjp-823	117	4	ldl	ldl	NOUN
bjp-823	117	5	-	-	PUNCT
bjp-823	117	6	c	c	PROPN
bjp-823	117	7	was	be	AUX
bjp-823	117	8	38.4	38.4	NUM
bjp-823	117	9	%	%	NOUN
bjp-823	117	10	decrease	decrease	NOUN
bjp-823	117	11	from	from	ADP
bjp-823	117	12	baseline	baseline	NOUN
bjp-823	117	13	.	.	PUNCT
bjp-823	118	1	hdl	hdl	PROPN
bjp-823	118	2	-	-	PUNCT
bjp-823	118	3	c	c	NOUN
bjp-823	118	4	level	level	NOUN
bjp-823	118	5	increased	increase	VERB
bjp-823	118	6	from	from	ADP
bjp-823	118	7	35.3	35.3	NUM
bjp-823	118	8	±	±	NUM
bjp-823	118	9	3.6	3.6	NUM
bjp-823	118	10	mg	mg	PROPN
bjp-823	118	11	/	/	SYM
bjp-823	118	12	dl	dl	PROPN
bjp-823	118	13	to	to	ADP
bjp-823	118	14	38.8	38.8	NUM
bjp-823	118	15	±	±	NUM
bjp-823	118	16	3.8	3.8	NUM
bjp-823	118	17	mg	mg	PROPN
bjp-823	118	18	/	/	SYM
bjp-823	118	19	dl	dl	PROPN
bjp-823	118	20	which	which	PRON
bjp-823	118	21	was	be	AUX
bjp-823	118	22	statistically	statistically	ADV
bjp-823	118	23	significant	significant	ADJ
bjp-823	118	24	(	(	PUNCT
bjp-823	118	25	t	t	NOUN
bjp-823	118	26	=	=	NUM
bjp-823	118	27	7.218	7.218	NUM
bjp-823	118	28	,	,	PUNCT
bjp-823	118	29	p<0.001	p<0.001	PROPN
bjp-823	118	30	,	,	PUNCT
bjp-823	118	31	95	95	NUM
bjp-823	118	32	%	%	NOUN
bjp-823	118	33	ci	ci	NOUN
bjp-823	118	34	4.540	4.540	NUM
bjp-823	118	35	to	to	ADP
bjp-823	118	36	2.545	2.545	NUM
bjp-823	118	37	)	)	PUNCT
bjp-823	118	38	.	.	PUNCT
bjp-823	119	1	niacin	niacin	PROPN
bjp-823	119	2	-	-	PUNCT
bjp-823	119	3	atorvastatin	atorvastatin	PROPN
bjp-823	119	4	treated	treat	VERB
bjp-823	119	5	group	group	NOUN
bjp-823	119	6	demonstrated	demonstrate	VERB
bjp-823	119	7	increase	increase	NOUN
bjp-823	119	8	in	in	ADP
bjp-823	119	9	hdl	hdl	PROPN
bjp-823	119	10	-	-	PUNCT
bjp-823	119	11	c	c	NOUN
bjp-823	119	12	level	level	NOUN
bjp-823	119	13	by	by	ADP
bjp-823	119	14	10.0	10.0	NUM
bjp-823	119	15	%	%	NOUN
bjp-823	119	16	from	from	ADP
bjp-823	119	17	pre	pre	ADJ
bjp-823	119	18	-	-	ADJ
bjp-823	119	19	treatment	treatment	ADJ
bjp-823	119	20	level	level	NOUN
bjp-823	119	21	.	.	PUNCT
bjp-823	120	1	before	before	ADP
bjp-823	120	2	initiation	initiation	NOUN
bjp-823	120	3	of	of	ADP
bjp-823	120	4	treatment	treatment	NOUN
bjp-823	120	5	of	of	ADP
bjp-823	120	6	fenofibrate	fenofibrate	NOUN
bjp-823	120	7	-	-	PUNCT
bjp-823	120	8	atorvastatin	atorvastatin	NOUN
bjp-823	120	9	combination	combination	NOUN
bjp-823	120	10	fasting	fast	VERB
bjp-823	120	11	serum	serum	NOUN
bjp-823	120	12	level	level	NOUN
bjp-823	120	13	of	of	ADP
bjp-823	120	14	triglyceride	triglyceride	ADJ
bjp-823	120	15	,	,	PUNCT
bjp-823	120	16	total	total	ADJ
bjp-823	120	17	cholesterol	cholesterol	NOUN
bjp-823	120	18	,	,	PUNCT
bjp-823	120	19	ldl	ldl	NOUN
bjp-823	120	20	-	-	PUNCT
bjp-823	120	21	c	c	PROPN
bjp-823	120	22	and	and	CCONJ
bjp-823	120	23	hdl	hdl	PROPN
bjp-823	120	24	-	-	PUNCT
bjp-823	120	25	c	c	PROPN
bjp-823	120	26	were	be	AUX
bjp-823	120	27	289.7	289.7	NUM
bjp-823	120	28	±	±	NUM
bjp-823	120	29	86.6	86.6	NUM
bjp-823	120	30	mg/	mg/	PROPN
bjp-823	120	31	dl	dl	PROPN
bjp-823	120	32	,	,	PUNCT
bjp-823	120	33	224.6	224.6	NUM
bjp-823	120	34	±	±	NUM
bjp-823	120	35	26.1	26.1	NUM
bjp-823	120	36	mg	mg	PROPN
bjp-823	120	37	/	/	SYM
bjp-823	120	38	dl	dl	PROPN
bjp-823	120	39	,	,	PUNCT
bjp-823	120	40	134.5	134.5	NUM
bjp-823	120	41	±	±	NUM
bjp-823	120	42	28.6	28.6	NUM
bjp-823	120	43	mg	mg	PROPN
bjp-823	120	44	/	/	SYM
bjp-823	120	45	dl	dl	PROPN
bjp-823	120	46	and	and	CCONJ
bjp-823	120	47	35.0	35.0	NUM
bjp-823	120	48	±	±	NUM
bjp-823	120	49	4.0	4.0	NUM
bjp-823	120	50	mg	mg	PROPN
bjp-823	120	51	/	/	SYM
bjp-823	120	52	dl	dl	PROPN
bjp-823	120	53	respectively	respectively	ADV
bjp-823	120	54	.	.	PUNCT
bjp-823	121	1	after	after	ADP
bjp-823	121	2	completion	completion	NOUN
bjp-823	121	3	of	of	ADP
bjp-823	121	4	12	12	NUM
bjp-823	121	5	weeks	week	NOUN
bjp-823	121	6	of	of	ADP
bjp-823	121	7	treatment	treatment	NOUN
bjp-823	121	8	,	,	PUNCT
bjp-823	121	9	triglyceride	triglyceride	ADP
bjp-823	121	10	level	level	NOUN
bjp-823	121	11	was	be	AUX
bjp-823	121	12	decreased	decrease	VERB
bjp-823	121	13	from	from	ADP
bjp-823	121	14	289.7	289.7	NUM
bjp-823	121	15	±	±	NUM
bjp-823	121	16	86.6	86.6	NUM
bjp-823	121	17	mg	mg	PROPN
bjp-823	121	18	/	/	SYM
bjp-823	121	19	dl	dl	PROPN
bjp-823	121	20	to	to	ADP
bjp-823	121	21	188.2	188.2	NUM
bjp-823	121	22	±	±	NUM
bjp-823	122	1	49.3	49.3	NUM
bjp-823	122	2	mg	mg	PROPN
bjp-823	122	3	/	/	SYM
bjp-823	122	4	dl	dl	PROPN
bjp-823	122	5	.	.	PUNCT
bjp-823	123	1	this	this	DET
bjp-823	123	2	change	change	NOUN
bjp-823	123	3	was	be	AUX
bjp-823	123	4	statistically	statistically	ADV
bjp-823	123	5	highly	highly	ADV
bjp-823	123	6	significant	significant	ADJ
bjp-823	123	7	(	(	PUNCT
bjp-823	123	8	t=6.854	t=6.854	NOUN
bjp-823	123	9	,	,	PUNCT
bjp-823	123	10	p<0.001	p<0.001	PROPN
bjp-823	123	11	,	,	PUNCT
bjp-823	123	12	95	95	NUM
bjp-823	123	13	%	%	NOUN
bjp-823	123	14	ci	ci	NOUN
bjp-823	123	15	71.276	71.276	NUM
bjp-823	123	16	to	to	ADP
bjp-823	123	17	131.661	131.661	NUM
bjp-823	123	18	)	)	PUNCT
bjp-823	123	19	.	.	PUNCT
bjp-823	124	1	triglyceride	triglyceride	INTJ
bjp-823	124	2	decreased	decrease	VERB
bjp-823	124	3	by	by	ADP
bjp-823	124	4	35.0	35.0	NUM
bjp-823	124	5	%	%	NOUN
bjp-823	124	6	.	.	PUNCT
bjp-823	125	1	total	total	ADJ
bjp-823	125	2	cholesterol	cholesterol	NOUN
bjp-823	125	3	level	level	NOUN
bjp-823	125	4	was	be	AUX
bjp-823	125	5	reduced	reduce	VERB
bjp-823	125	6	from	from	ADP
bjp-823	125	7	224.6	224.6	NUM
bjp-823	125	8	±	±	NUM
bjp-823	125	9	26.1	26.1	NUM
bjp-823	125	10	mg	mg	PROPN
bjp-823	125	11	/	/	SYM
bjp-823	125	12	dl	dl	PROPN
bjp-823	125	13	to	to	ADP
bjp-823	125	14	156.7	156.7	NUM
bjp-823	125	15	±	±	NUM
bjp-823	125	16	24.8	24.8	NUM
bjp-823	125	17	mg	mg	PROPN
bjp-823	125	18	/	/	SYM
bjp-823	125	19	dl	dl	PROPN
bjp-823	126	1	and	and	CCONJ
bjp-823	126	2	this	this	DET
bjp-823	126	3	changes	change	NOUN
bjp-823	126	4	was	be	AUX
bjp-823	126	5	statistically	statistically	ADV
bjp-823	126	6	significant	significant	ADJ
bjp-823	126	7	(	(	PUNCT
bjp-823	126	8	t=14.366	t=14.366	NUM
bjp-823	126	9	,	,	PUNCT
bjp-823	126	10	p<0.001	p<0.001	ADJ
bjp-823	126	11	;	;	PUNCT
bjp-823	126	12	95	95	NUM
bjp-823	126	13	%	%	NOUN
bjp-823	126	14	ci	ci	NOUN
bjp-823	126	15	58.239	58.239	NUM
bjp-823	126	16	to	to	ADP
bjp-823	126	17	77.511	77.511	NUM
bjp-823	126	18	)	)	PUNCT
bjp-823	126	19	.	.	PUNCT
bjp-823	127	1	percentage	percentage	NOUN
bjp-823	127	2	decrease	decrease	NOUN
bjp-823	127	3	of	of	ADP
bjp-823	127	4	total	total	ADJ
bjp-823	127	5	cholesterol	cholesterol	NOUN
bjp-823	127	6	was	be	AUX
bjp-823	127	7	30.2	30.2	NUM
bjp-823	127	8	%	%	NOUN
bjp-823	127	9	.	.	PUNCT
bjp-823	128	1	ldl	ldl	NOUN
bjp-823	128	2	-	-	PUNCT
bjp-823	128	3	c	c	NOUN
bjp-823	128	4	level	level	NOUN
bjp-823	128	5	reduced	reduce	VERB
bjp-823	128	6	from	from	ADP
bjp-823	128	7	134.5	134.5	NUM
bjp-823	128	8	±	±	NUM
bjp-823	128	9	28.6	28.6	NUM
bjp-823	128	10	mg	mg	PROPN
bjp-823	128	11	/	/	SYM
bjp-823	128	12	dl	dl	PROPN
bjp-823	128	13	to	to	ADP
bjp-823	128	14	82.6	82.6	NUM
bjp-823	128	15	±	±	NUM
bjp-823	128	16	20.1	20.1	NUM
bjp-823	128	17	mg	mg	PROPN
bjp-823	128	18	/	/	SYM
bjp-823	128	19	dl	dl	PROPN
bjp-823	128	20	and	and	CCONJ
bjp-823	128	21	the	the	DET
bjp-823	128	22	reduction	reduction	NOUN
bjp-823	128	23	was	be	AUX
bjp-823	128	24	statistically	statistically	ADV
bjp-823	128	25	highly	highly	ADV
bjp-823	128	26	significant	significant	ADJ
bjp-823	128	27	(	(	PUNCT
bjp-823	128	28	t=12.501	t=12.501	NUM
bjp-823	128	29	,	,	PUNCT
bjp-823	128	30	p<0.001	p<0.001	ADJ
bjp-823	128	31	;	;	PUNCT
bjp-823	128	32	95	95	NUM
bjp-823	128	33	%	%	NOUN
bjp-823	128	34	ci	ci	NOUN
bjp-823	128	35	43.438	43.438	NUM
bjp-823	128	36	to	to	ADP
bjp-823	128	37	60.375	60.375	NUM
bjp-823	128	38	)	)	PUNCT
bjp-823	128	39	.	.	PUNCT
bjp-823	129	1	percentage	percentage	NOUN
bjp-823	129	2	change	change	NOUN
bjp-823	129	3	of	of	ADP
bjp-823	129	4	ldl	ldl	NOUN
bjp-823	129	5	-	-	PUNCT
bjp-823	129	6	c	c	NOUN
bjp-823	129	7	by	by	ADP
bjp-823	129	8	38.6	38.6	NUM
bjp-823	129	9	%	%	NOUN
bjp-823	129	10	from	from	ADP
bjp-823	129	11	baseline	baseline	NOUN
bjp-823	129	12	was	be	AUX
bjp-823	129	13	observed	observe	VERB
bjp-823	129	14	.	.	PUNCT
bjp-823	130	1	hdl	hdl	PROPN
bjp-823	130	2	-	-	PUNCT
bjp-823	130	3	c	c	NOUN
bjp-823	130	4	level	level	NOUN
bjp-823	130	5	was	be	AUX
bjp-823	130	6	observed	observe	VERB
bjp-823	130	7	to	to	PART
bjp-823	130	8	be	be	AUX
bjp-823	130	9	increased	increase	VERB
bjp-823	130	10	from	from	ADP
bjp-823	130	11	35.0	35.0	NUM
bjp-823	130	12	±	±	NUM
bjp-823	130	13	4.0	4.0	NUM
bjp-823	130	14	mg	mg	PROPN
bjp-823	130	15	/	/	SYM
bjp-823	130	16	dl	dl	PROPN
bjp-823	130	17	to	to	ADP
bjp-823	130	18	37.6	37.6	NUM
bjp-823	130	19	±	±	NUM
bjp-823	131	1	3.5	3.5	NUM
bjp-823	131	2	mg	mg	PROPN
bjp-823	131	3	/	/	SYM
bjp-823	131	4	dl	dl	PROPN
bjp-823	131	5	.	.	PUNCT
bjp-823	132	1	these	these	DET
bjp-823	132	2	changes	change	NOUN
bjp-823	132	3	of	of	ADP
bjp-823	132	4	increment	increment	NOUN
bjp-823	132	5	was	be	AUX
bjp-823	132	6	statistically	statistically	ADV
bjp-823	132	7	significant	significant	ADJ
bjp-823	132	8	(	(	PUNCT
bjp-823	132	9	t=	t=	NOUN
bjp-823	132	10	4.079	4.079	NUM
bjp-823	132	11	,	,	PUNCT
bjp-823	132	12	p<0.001	p<0.001	ADJ
bjp-823	132	13	,	,	PUNCT
bjp-823	132	14	95	95	NUM
bjp-823	132	15	%	%	NOUN
bjp-823	132	16	ci	ci	NOUN
bjp-823	132	17	3.797	3.797	NUM
bjp-823	132	18	to	to	ADP
bjp-823	132	19	1.266	1.266	NUM
bjp-823	132	20	)	)	PUNCT
bjp-823	132	21	.	.	PUNCT
bjp-823	133	1	fenofibrate	fenofibrate	PROPN
bjp-823	133	2	-	-	PUNCT
bjp-823	133	3	atorvastatin	atorvastatin	PROPN
bjp-823	133	4	combina	combina	PROPN
bjp-823	133	5	-tion	-tion	PROPN
bjp-823	133	6	caused	cause	VERB
bjp-823	133	7	increase	increase	NOUN
bjp-823	133	8	of	of	ADP
bjp-823	133	9	hdl	hdl	NOUN
bjp-823	133	10	-	-	PUNCT
bjp-823	133	11	c	c	PROPN
bjp-823	133	12	by	by	ADP
bjp-823	133	13	7.2	7.2	NUM
bjp-823	133	14	%	%	NOUN
bjp-823	133	15	.	.	PUNCT
bjp-823	134	1	z	z	X
bjp-823	134	2	-	-	PUNCT
bjp-823	134	3	proportion	proportion	NOUN
bjp-823	134	4	test	test	NOUN
bjp-823	134	5	was	be	AUX
bjp-823	134	6	done	do	VERB
bjp-823	134	7	to	to	PART
bjp-823	134	8	see	see	VERB
bjp-823	134	9	the	the	DET
bjp-823	134	10	difference	difference	NOUN
bjp-823	134	11	in	in	ADP
bjp-823	134	12	percentage	percentage	NOUN
bjp-823	134	13	change	change	NOUN
bjp-823	134	14	of	of	ADP
bjp-823	134	15	lipid	lipid	NOUN
bjp-823	134	16	profile	profile	NOUN
bjp-823	134	17	between	between	ADP
bjp-823	134	18	two	two	NUM
bjp-823	134	19	treatment	treatment	NOUN
bjp-823	134	20	groups	group	NOUN
bjp-823	134	21	after	after	ADP
bjp-823	134	22	12	12	NUM
bjp-823	134	23	weeks	week	NOUN
bjp-823	134	24	of	of	ADP
bjp-823	134	25	administration	administration	NOUN
bjp-823	134	26	.	.	PUNCT
bjp-823	135	1	in	in	ADP
bjp-823	135	2	fenofibrate	fenofibrate	NOUN
bjp-823	135	3	-	-	PUNCT
bjp-823	135	4	atorvastatin	atorvastatin	PROPN
bjp-823	135	5	treatment	treatment	NOUN
bjp-823	135	6	group	group	NOUN
bjp-823	135	7	more	more	ADV
bjp-823	135	8	effective	effective	ADJ
bjp-823	135	9	reduction	reduction	NOUN
bjp-823	135	10	of	of	ADP
bjp-823	135	11	triglyceride	triglyceride	ADJ
bjp-823	135	12	level	level	NOUN
bjp-823	135	13	noted	note	VERB
bjp-823	135	14	,	,	PUNCT
bjp-823	135	15	compared	compare	VERB
bjp-823	135	16	to	to	ADP
bjp-823	135	17	table	table	NOUN
bjp-823	135	18	i	i	PROPN
bjp-823	135	19	effects	effect	NOUN
bjp-823	135	20	of	of	ADP
bjp-823	135	21	niacin	niacin	NOUN
bjp-823	135	22	or	or	CCONJ
bjp-823	135	23	fenofibrate	fenofibrate	NOUN
bjp-823	135	24	in	in	ADP
bjp-823	135	25	combination	combination	NOUN
bjp-823	135	26	with	with	ADP
bjp-823	135	27	atorvastatin	atorvastatin	NOUN
bjp-823	135	28	on	on	ADP
bjp-823	135	29	serum	serum	NOUN
bjp-823	135	30	lipid	lipid	NOUN
bjp-823	135	31	level	level	NOUN
bjp-823	135	32	lipid	lipid	NOUN
bjp-823	135	33	profile	profile	NOUN
bjp-823	135	34	(	(	PUNCT
bjp-823	135	35	mg	mg	PROPN
bjp-823	135	36	/	/	SYM
bjp-823	135	37	dl	dl	NOUN
bjp-823	135	38	)	)	PUNCT
bjp-823	135	39	niacin	niacin	PROPN
bjp-823	135	40	plus	plus	CCONJ
bjp-823	135	41	atorvastatin	atorvastatin	PROPN
bjp-823	135	42	%	%	PROPN
bjp-823	135	43	change	change	NOUN
bjp-823	135	44	%	%	NOUN
bjp-823	135	45	change	change	NOUN
bjp-823	135	46	fenofibrate	fenofibrate	NOUN
bjp-823	135	47	plus	plus	CCONJ
bjp-823	135	48	atorvastatin	atorvastatin	NOUN
bjp-823	135	49	before	before	ADP
bjp-823	135	50	treatment	treatment	NOUN
bjp-823	135	51	12	12	NUM
bjp-823	135	52	weeks	week	NOUN
bjp-823	135	53	after	after	ADP
bjp-823	135	54	treatment	treatment	NOUN
bjp-823	135	55	before	before	ADP
bjp-823	135	56	treatment	treatment	NOUN
bjp-823	135	57	12	12	NUM
bjp-823	135	58	weeks	week	NOUN
bjp-823	135	59	after	after	ADP
bjp-823	135	60	treatment	treatment	NOUN
bjp-823	135	61	triglyceride	triglyceride	ADP
bjp-823	135	62	207.8	207.8	NUM
bjp-823	135	63	±	±	NUM
bjp-823	135	64	60.2	60.2	NUM
bjp-823	135	65	178.6	178.6	NUM
bjp-823	135	66	±	±	NUM
bjp-823	135	67	52.8a	52.8a	NOUN
bjp-823	135	68	-14.0	-14.0	NUM
bjp-823	135	69	289.7	289.7	NUM
bjp-823	135	70	±	±	NUM
bjp-823	135	71	86.6	86.6	NUM
bjp-823	135	72	188.2	188.2	NUM
bjp-823	135	73	±	±	NOUN
bjp-823	135	74	49.3a	49.3a	NUM
bjp-823	135	75	-35.0	-35.0	NOUN
bjp-823	135	76	total	total	ADJ
bjp-823	135	77	cholesterol	cholesterol	NOUN
bjp-823	135	78	213.5	213.5	NUM
bjp-823	135	79	±	±	NUM
bjp-823	135	80	28.5	28.5	NUM
bjp-823	135	81	158.6	158.6	NUM
bjp-823	135	82	±	±	NUM
bjp-823	135	83	19.5a	19.5a	NUM
bjp-823	135	84	-25.7	-25.7	NOUN
bjp-823	135	85	224.6	224.6	NUM
bjp-823	135	86	±	±	NUM
bjp-823	135	87	26.1	26.1	NUM
bjp-823	135	88	156.7	156.7	NUM
bjp-823	135	89	±	±	NOUN
bjp-823	135	90	24.8a	24.8a	NUM
bjp-823	135	91	-30.2	-30.2	NOUN
bjp-823	135	92	ldl	ldl	PROPN
bjp-823	135	93	-	-	PUNCT
bjp-823	135	94	c	c	PROPN
bjp-823	135	95	136.8	136.8	NUM
bjp-823	135	96	±	±	NUM
bjp-823	135	97	23.6	23.6	NUM
bjp-823	135	98	84.2	84.2	NUM
bjp-823	135	99	±	±	NOUN
bjp-823	135	100	15.4a	15.4a	NUM
bjp-823	135	101	-38.4	-38.4	PUNCT
bjp-823	135	102	134.5	134.5	NUM
bjp-823	135	103	±	±	NUM
bjp-823	135	104	28.6	28.6	NUM
bjp-823	135	105	82.6	82.6	NUM
bjp-823	135	106	±	±	NOUN
bjp-823	135	107	20.1a	20.1a	NOUN
bjp-823	135	108	-38.6	-38.6	NUM
bjp-823	135	109	hdl	hdl	PROPN
bjp-823	135	110	-	-	PUNCT
bjp-823	135	111	c	c	PROPN
bjp-823	135	112	35.3	35.3	NUM
bjp-823	135	113	±	±	NUM
bjp-823	135	114	3.6	3.6	NUM
bjp-823	135	115	38.8	38.8	NUM
bjp-823	135	116	±	±	NUM
bjp-823	135	117	3.8a	3.8a	NUM
bjp-823	135	118	+10.0	+10.0	PROPN
bjp-823	135	119	35.0	35.0	NUM
bjp-823	135	120	±	±	NUM
bjp-823	135	121	4.0	4.0	NUM
bjp-823	135	122	37.6	37.6	NUM
bjp-823	135	123	±	±	NUM
bjp-823	135	124	3.5a	3.5a	NUM
bjp-823	135	125	+7.2	+7.2	NOUN
bjp-823	135	126	asignificance	asignificance	NOUN
bjp-823	135	127	of	of	ADP
bjp-823	135	128	difference	difference	NOUN
bjp-823	135	129	at	at	ADP
bjp-823	135	130	p<0.001	p<0.001	ADJ
bjp-823	135	131	;	;	PUNCT
bjp-823	135	132	‘	'	PUNCT
bjp-823	135	133	-	-	PUNCT
bjp-823	135	134	’	'	PUNCT
bjp-823	135	135	sign	sign	NOUN
bjp-823	135	136	indicates	indicate	VERB
bjp-823	135	137	reduction	reduction	NOUN
bjp-823	135	138	of	of	ADP
bjp-823	135	139	lipid	lipid	ADJ
bjp-823	135	140	level	level	NOUN
bjp-823	135	141	in	in	ADP
bjp-823	135	142	percentage	percentage	NOUN
bjp-823	135	143	;	;	PUNCT
bjp-823	135	144	‘	'	PUNCT
bjp-823	135	145	+	+	NOUN
bjp-823	135	146	’	'	PUNCT
bjp-823	135	147	sign	sign	NOUN
bjp-823	135	148	indicates	indicate	VERB
bjp-823	135	149	increase	increase	NOUN
bjp-823	135	150	of	of	ADP
bjp-823	135	151	lipid	lipid	ADJ
bjp-823	135	152	level	level	NOUN
bjp-823	135	153	in	in	ADP
bjp-823	135	154	percentage	percentage	NOUN
bjp-823	135	155	;	;	PUNCT
bjp-823	135	156	data	datum	NOUN
bjp-823	135	157	are	be	AUX
bjp-823	135	158	mean	mean	VERB
bjp-823	135	159	±	±	NUM
bjp-823	135	160	sd	sd	ADP
bjp-823	135	161	bangladesh	bangladesh	PROPN
bjp-823	135	162	j	j	PROPN
bjp-823	135	163	pharmacol	pharmacol	PROPN
bjp-823	135	164	2008	2008	NUM
bjp-823	135	165	;	;	PUNCT
bjp-823	135	166	3	3	NUM
bjp-823	135	167	:	:	SYM
bjp-823	135	168	8	8	NUM
bjp-823	135	169	-	-	SYM
bjp-823	135	170	16	16	NUM
bjp-823	135	171	11	11	NUM
bjp-823	135	172	niacin	niacin	NOUN
bjp-823	135	173	-	-	PUNCT
bjp-823	135	174	atorvastatin	atorvastatin	NOUN
bjp-823	135	175	combination	combination	NOUN
bjp-823	135	176	therapy	therapy	NOUN
bjp-823	135	177	(	(	PUNCT
bjp-823	135	178	z=2.05	z=2.05	NOUN
bjp-823	135	179	,	,	PUNCT
bjp-823	135	180	p<0.05	p<0.05	NOUN
bjp-823	135	181	)	)	PUNCT
bjp-823	135	182	.	.	PUNCT
bjp-823	136	1	but	but	CCONJ
bjp-823	136	2	there	there	PRON
bjp-823	136	3	was	be	VERB
bjp-823	136	4	no	no	DET
bjp-823	136	5	differences	difference	NOUN
bjp-823	136	6	in	in	ADP
bjp-823	136	7	total	total	ADJ
bjp-823	136	8	cholesterol	cholesterol	NOUN
bjp-823	136	9	,	,	PUNCT
bjp-823	136	10	ldl	ldl	NOUN
bjp-823	136	11	-	-	PUNCT
bjp-823	136	12	c	c	PROPN
bjp-823	136	13	and	and	CCONJ
bjp-823	136	14	hdl	hdl	PROPN
bjp-823	136	15	-	-	PUNCT
bjp-823	136	16	c	c	NOUN
bjp-823	136	17	modifying	modify	VERB
bjp-823	136	18	effects	effect	NOUN
bjp-823	136	19	between	between	ADP
bjp-823	136	20	these	these	DET
bjp-823	136	21	two	two	NUM
bjp-823	136	22	combination	combination	NOUN
bjp-823	136	23	treatment	treatment	NOUN
bjp-823	136	24	groups	group	NOUN
bjp-823	136	25	.	.	PUNCT
bjp-823	137	1	before	before	ADP
bjp-823	137	2	initiation	initiation	NOUN
bjp-823	137	3	of	of	ADP
bjp-823	137	4	niacin	niacin	NOUN
bjp-823	137	5	-	-	PUNCT
bjp-823	137	6	atorvastatin	atorvastatin	NOUN
bjp-823	137	7	combination	combination	NOUN
bjp-823	137	8	,	,	PUNCT
bjp-823	137	9	fasting	fast	VERB
bjp-823	137	10	blood	blood	NOUN
bjp-823	137	11	glucose	glucose	NOUN
bjp-823	137	12	level	level	NOUN
bjp-823	137	13	was	be	AUX
bjp-823	137	14	7.2	7.2	NUM
bjp-823	137	15	±	±	NUM
bjp-823	137	16	2.7	2.7	NUM
bjp-823	137	17	mmol	mmol	NOUN
bjp-823	137	18	/	/	SYM
bjp-823	137	19	l	l	NOUN
bjp-823	137	20	(	(	PUNCT
bjp-823	137	21	table	table	NOUN
bjp-823	137	22	ii	ii	PROPN
bjp-823	137	23	)	)	PUNCT
bjp-823	137	24	.	.	PUNCT
bjp-823	138	1	after	after	ADP
bjp-823	138	2	12	12	NUM
bjp-823	138	3	weeks	week	NOUN
bjp-823	138	4	of	of	ADP
bjp-823	138	5	treatment	treatment	NOUN
bjp-823	138	6	,	,	PUNCT
bjp-823	138	7	fasting	fast	VERB
bjp-823	138	8	blood	blood	NOUN
bjp-823	138	9	glucose	glucose	NOUN
bjp-823	138	10	was	be	AUX
bjp-823	138	11	detected	detect	VERB
bjp-823	138	12	as	as	ADP
bjp-823	138	13	6.6	6.6	NUM
bjp-823	138	14	±	±	NUM
bjp-823	138	15	1.3	1.3	NUM
bjp-823	138	16	mmol	mmol	NOUN
bjp-823	138	17	/	/	SYM
bjp-823	138	18	l.	l.	PROPN
bjp-823	138	19	there	there	PRON
bjp-823	138	20	was	be	VERB
bjp-823	138	21	no	no	DET
bjp-823	138	22	significant	significant	ADJ
bjp-823	138	23	change	change	NOUN
bjp-823	138	24	in	in	ADP
bjp-823	138	25	fasting	fast	VERB
bjp-823	138	26	blood	blood	NOUN
bjp-823	138	27	glucose	glucose	NOUN
bjp-823	138	28	(	(	PUNCT
bjp-823	138	29	t=1.71	t=1.71	NOUN
bjp-823	138	30	,	,	PUNCT
bjp-823	138	31	p>0.05	p>0.05	NOUN
bjp-823	138	32	;	;	PUNCT
bjp-823	138	33	95	95	NUM
bjp-823	138	34	%	%	NOUN
bjp-823	138	35	ci	ci	PROPN
bjp-823	138	36	0.111	0.111	NUM
bjp-823	138	37	to	to	ADP
bjp-823	138	38	1.30	1.30	NUM
bjp-823	138	39	)	)	PUNCT
bjp-823	138	40	level	level	NOUN
bjp-823	138	41	.	.	PUNCT
bjp-823	139	1	before	before	ADP
bjp-823	139	2	administration	administration	NOUN
bjp-823	139	3	of	of	ADP
bjp-823	139	4	niacin	niacin	PROPN
bjp-823	139	5	plus	plus	CCONJ
bjp-823	139	6	atorvastatin	atorvastatin	NOUN
bjp-823	139	7	,	,	PUNCT
bjp-823	139	8	mean	mean	ADJ
bjp-823	139	9	sgpt	sgpt	NOUN
bjp-823	139	10	was	be	AUX
bjp-823	139	11	36.8	36.8	NUM
bjp-823	139	12	±	±	NUM
bjp-823	139	13	16.4	16.4	NUM
bjp-823	139	14	u	u	NOUN
bjp-823	139	15	/	/	SYM
bjp-823	139	16	l.	l.	PROPN
bjp-823	139	17	after	after	SCONJ
bjp-823	139	18	12	12	NUM
bjp-823	139	19	weeks	week	NOUN
bjp-823	139	20	of	of	ADP
bjp-823	139	21	treatment	treatment	NOUN
bjp-823	139	22	sgpt	sgpt	NOUN
bjp-823	139	23	was	be	AUX
bjp-823	139	24	detected	detect	VERB
bjp-823	139	25	as	as	ADP
bjp-823	139	26	35.3	35.3	NUM
bjp-823	139	27	±	±	NUM
bjp-823	139	28	10.1	10.1	NUM
bjp-823	139	29	u	u	NOUN
bjp-823	139	30	/	/	SYM
bjp-823	139	31	l.	l.	PROPN
bjp-823	139	32	there	there	PRON
bjp-823	139	33	was	be	VERB
bjp-823	139	34	no	no	DET
bjp-823	139	35	significant	significant	ADJ
bjp-823	139	36	difference	difference	NOUN
bjp-823	139	37	of	of	ADP
bjp-823	139	38	sgpt	sgpt	NOUN
bjp-823	139	39	level	level	NOUN
bjp-823	139	40	(	(	PUNCT
bjp-823	139	41	t=0.561	t=0.561	ADV
bjp-823	139	42	,	,	PUNCT
bjp-823	139	43	p>0.05	p>0.05	NOUN
bjp-823	139	44	;	;	PUNCT
bjp-823	139	45	95	95	NUM
bjp-823	139	46	%	%	NOUN
bjp-823	139	47	ci	ci	NOUN
bjp-823	139	48	-4.048	-4.048	PUNCT
bjp-823	139	49	to	to	ADP
bjp-823	139	50	7.134	7.134	NUM
bjp-823	139	51	)	)	PUNCT
bjp-823	139	52	.	.	PUNCT
bjp-823	140	1	before	before	ADP
bjp-823	140	2	initiation	initiation	NOUN
bjp-823	140	3	of	of	ADP
bjp-823	140	4	group	group	NOUN
bjp-823	140	5	i	i	PRON
bjp-823	140	6	treatment	treatment	NOUN
bjp-823	140	7	serum	serum	NOUN
bjp-823	140	8	creatinine	creatinine	NOUN
bjp-823	140	9	level	level	NOUN
bjp-823	140	10	was	be	AUX
bjp-823	140	11	1.2	1.2	NUM
bjp-823	140	12	±	±	NUM
bjp-823	140	13	0.3	0.3	NUM
bjp-823	140	14	mg	mg	PROPN
bjp-823	140	15	/	/	SYM
bjp-823	140	16	dl	dl	PROPN
bjp-823	141	1	and	and	CCONJ
bjp-823	141	2	after	after	ADP
bjp-823	141	3	completion	completion	NOUN
bjp-823	141	4	of	of	ADP
bjp-823	141	5	12	12	NUM
bjp-823	141	6	weeks	week	NOUN
bjp-823	141	7	of	of	ADP
bjp-823	141	8	treatment	treatment	NOUN
bjp-823	141	9	,	,	PUNCT
bjp-823	141	10	serum	serum	NOUN
bjp-823	141	11	creatinine	creatinine	NOUN
bjp-823	141	12	level	level	NOUN
bjp-823	141	13	was	be	AUX
bjp-823	141	14	1.0	1.0	NUM
bjp-823	141	15	±	±	NUM
bjp-823	141	16	0.2	0.2	NUM
bjp-823	141	17	mg	mg	PROPN
bjp-823	141	18	/	/	SYM
bjp-823	141	19	dl	dl	PROPN
bjp-823	141	20	.	.	PROPN
bjp-823	141	21	serum	serum	PROPN
bjp-823	141	22	creatinine	creatinine	PROPN
bjp-823	141	23	level	level	NOUN
bjp-823	141	24	significantly	significantly	ADV
bjp-823	141	25	decreased	decrease	VERB
bjp-823	141	26	from	from	ADP
bjp-823	141	27	pre	pre	ADJ
bjp-823	141	28	-	-	ADJ
bjp-823	141	29	treatment	treatment	ADJ
bjp-823	141	30	level	level	NOUN
bjp-823	141	31	(	(	PUNCT
bjp-823	141	32	t=3.56	t=3.56	PRON
bjp-823	141	33	,	,	PUNCT
bjp-823	141	34	p<0.001	p<0.001	ADJ
bjp-823	141	35	;	;	PUNCT
bjp-823	141	36	95	95	NUM
bjp-823	141	37	%	%	NOUN
bjp-823	141	38	ci	ci	NOUN
bjp-823	141	39	0.073	0.073	NUM
bjp-823	141	40	to	to	ADP
bjp-823	141	41	0.269	0.269	NUM
bjp-823	141	42	)	)	PUNCT
bjp-823	141	43	.	.	PUNCT
bjp-823	142	1	but	but	CCONJ
bjp-823	142	2	the	the	DET
bjp-823	142	3	change	change	NOUN
bjp-823	142	4	was	be	AUX
bjp-823	142	5	not	not	PART
bjp-823	142	6	associated	associate	VERB
bjp-823	142	7	with	with	ADP
bjp-823	142	8	renal	renal	ADJ
bjp-823	142	9	impairment	impairment	NOUN
bjp-823	142	10	.	.	PUNCT
bjp-823	143	1	in	in	ADP
bjp-823	143	2	group	group	PROPN
bjp-823	143	3	ii	ii	PROPN
bjp-823	143	4	before	before	ADP
bjp-823	143	5	initiation	initiation	NOUN
bjp-823	143	6	of	of	ADP
bjp-823	143	7	treatment	treatment	NOUN
bjp-823	143	8	,	,	PUNCT
bjp-823	143	9	fasting	fast	VERB
bjp-823	143	10	blood	blood	NOUN
bjp-823	143	11	glucose	glucose	NOUN
bjp-823	143	12	was	be	AUX
bjp-823	143	13	8.5	8.5	NUM
bjp-823	143	14	±	±	NUM
bjp-823	143	15	4.4	4.4	NUM
bjp-823	143	16	mmol	mmol	NOUN
bjp-823	143	17	/	/	SYM
bjp-823	143	18	l.	l.	NOUN
bjp-823	143	19	after	after	ADP
bjp-823	143	20	completion	completion	NOUN
bjp-823	143	21	of	of	ADP
bjp-823	143	22	12	12	NUM
bjp-823	143	23	weeks	week	NOUN
bjp-823	143	24	of	of	ADP
bjp-823	143	25	treatment	treatment	NOUN
bjp-823	143	26	fasting	fast	VERB
bjp-823	143	27	blood	blood	NOUN
bjp-823	143	28	glucose	glucose	NOUN
bjp-823	143	29	was	be	AUX
bjp-823	143	30	6.5	6.5	NUM
bjp-823	143	31	±	±	NUM
bjp-823	143	32	2.0	2.0	NUM
bjp-823	143	33	mmol	mmol	NOUN
bjp-823	143	34	/	/	SYM
bjp-823	143	35	l.	l.	NOUN
bjp-823	144	1	the	the	DET
bjp-823	144	2	fasting	fast	VERB
bjp-823	144	3	blood	blood	NOUN
bjp-823	144	4	glucose	glucose	NOUN
bjp-823	144	5	decreased	decrease	VERB
bjp-823	144	6	significantly	significantly	ADV
bjp-823	144	7	(	(	PUNCT
bjp-823	144	8	t=3.82	t=3.82	ADJ
bjp-823	144	9	,	,	PUNCT
bjp-823	144	10	p<0.001	p<0.001	X
bjp-823	144	11	;	;	PUNCT
bjp-823	144	12	95	95	NUM
bjp-823	144	13	%	%	NOUN
bjp-823	144	14	ci	ci	NOUN
bjp-823	144	15	0.946	0.946	NUM
bjp-823	144	16	to	to	ADP
bjp-823	144	17	3.116	3.116	NUM
bjp-823	144	18	)	)	PUNCT
bjp-823	144	19	but	but	CCONJ
bjp-823	144	20	the	the	DET
bjp-823	144	21	change	change	NOUN
bjp-823	144	22	was	be	AUX
bjp-823	144	23	within	within	ADP
bjp-823	144	24	normal	normal	ADJ
bjp-823	144	25	limit	limit	NOUN
bjp-823	144	26	.	.	PUNCT
bjp-823	145	1	before	before	ADP
bjp-823	145	2	administration	administration	NOUN
bjp-823	145	3	of	of	ADP
bjp-823	145	4	fenofibrate	fenofibrate	PROPN
bjp-823	145	5	-	-	PUNCT
bjp-823	145	6	atorvastatin	atorvastatin	PROPN
bjp-823	145	7	combination	combination	NOUN
bjp-823	145	8	,	,	PUNCT
bjp-823	145	9	sgpt	sgpt	NOUN
bjp-823	145	10	was	be	AUX
bjp-823	145	11	30.2	30.2	NUM
bjp-823	145	12	±	±	NUM
bjp-823	145	13	7.8	7.8	NUM
bjp-823	145	14	u	u	NOUN
bjp-823	145	15	/	/	SYM
bjp-823	145	16	l.	l.	PROPN
bjp-823	145	17	after	after	ADP
bjp-823	145	18	12	12	NUM
bjp-823	145	19	weeks	week	NOUN
bjp-823	145	20	of	of	ADP
bjp-823	145	21	treatment	treatment	NOUN
bjp-823	145	22	,	,	PUNCT
bjp-823	145	23	sgpt	sgpt	NOUN
bjp-823	145	24	was	be	AUX
bjp-823	145	25	detected	detect	VERB
bjp-823	145	26	as	as	ADP
bjp-823	145	27	45.6	45.6	NUM
bjp-823	145	28	±	±	NUM
bjp-823	145	29	24.8	24.8	NUM
bjp-823	145	30	u	u	NOUN
bjp-823	145	31	/	/	SYM
bjp-823	145	32	l	l	NOUN
bjp-823	145	33	(	(	PUNCT
bjp-823	145	34	t=3.67	t=3.67	PROPN
bjp-823	145	35	,	,	PUNCT
bjp-823	145	36	p<0.001	p<0.001	PROPN
bjp-823	145	37	;	;	PUNCT
bjp-823	145	38	95	95	NUM
bjp-823	145	39	%	%	NOUN
bjp-823	145	40	ci	ci	NOUN
bjp-823	145	41	-23.96	-23.96	PUNCT
bjp-823	145	42	to	to	PART
bjp-823	145	43	-6.85	-6.85	NUM
bjp-823	145	44	)	)	PUNCT
bjp-823	145	45	.	.	PUNCT
bjp-823	146	1	sgpt	sgpt	NOUN
bjp-823	146	2	in	in	ADP
bjp-823	146	3	this	this	DET
bjp-823	146	4	group	group	NOUN
bjp-823	146	5	increased	increase	VERB
bjp-823	146	6	significantly	significantly	ADV
bjp-823	146	7	.	.	PUNCT
bjp-823	147	1	before	before	ADP
bjp-823	147	2	initiation	initiation	NOUN
bjp-823	147	3	of	of	ADP
bjp-823	147	4	treatment	treatment	NOUN
bjp-823	147	5	,	,	PUNCT
bjp-823	147	6	serum	serum	NOUN
bjp-823	147	7	creatinine	creatinine	NOUN
bjp-823	147	8	was	be	AUX
bjp-823	147	9	1.1	1.1	NUM
bjp-823	147	10	±	±	NUM
bjp-823	147	11	0.3	0.3	NUM
bjp-823	147	12	mg	mg	PROPN
bjp-823	147	13	/	/	SYM
bjp-823	147	14	dl	dl	PROPN
bjp-823	147	15	.	.	PUNCT
bjp-823	148	1	after	after	ADP
bjp-823	148	2	12	12	NUM
bjp-823	148	3	weeks	week	NOUN
bjp-823	148	4	of	of	ADP
bjp-823	148	5	treatment	treatment	NOUN
bjp-823	148	6	,	,	PUNCT
bjp-823	148	7	serum	serum	NOUN
bjp-823	148	8	creatinine	creatinine	NOUN
bjp-823	148	9	level	level	NOUN
bjp-823	148	10	was	be	AUX
bjp-823	148	11	detected	detect	VERB
bjp-823	148	12	as	as	ADP
bjp-823	148	13	1.0	1.0	NUM
bjp-823	148	14	±	±	NUM
bjp-823	148	15	0.1	0.1	NUM
bjp-823	148	16	mg	mg	PROPN
bjp-823	148	17	/	/	SYM
bjp-823	148	18	dl	dl	PROPN
bjp-823	148	19	.	.	PUNCT
bjp-823	149	1	the	the	DET
bjp-823	149	2	changes	change	NOUN
bjp-823	149	3	in	in	ADP
bjp-823	149	4	serum	serum	NOUN
bjp-823	149	5	creatinine	creatinine	NOUN
bjp-823	149	6	level	level	NOUN
bjp-823	149	7	was	be	AUX
bjp-823	149	8	not	not	PART
bjp-823	149	9	significant	significant	ADJ
bjp-823	149	10	(	(	PUNCT
bjp-823	149	11	t=1.69	t=1.69	NOUN
bjp-823	149	12	,	,	PUNCT
bjp-823	149	13	p>0.05	p>0.05	NOUN
bjp-823	149	14	;	;	PUNCT
bjp-823	149	15	95	95	NUM
bjp-823	149	16	%	%	NOUN
bjp-823	149	17	ci	ci	NOUN
bjp-823	149	18	-0.019	-0.019	PUNCT
bjp-823	149	19	to	to	ADP
bjp-823	149	20	0.201	0.201	NUM
bjp-823	149	21	)	)	PUNCT
bjp-823	149	22	.	.	PUNCT
bjp-823	150	1	treatment	treatment	NOUN
bjp-823	150	2	related	relate	VERB
bjp-823	150	3	adverse	adverse	ADJ
bjp-823	150	4	effect	effect	NOUN
bjp-823	150	5	was	be	AUX
bjp-823	150	6	reported	report	VERB
bjp-823	150	7	in	in	ADP
bjp-823	150	8	37.1	37.1	NUM
bjp-823	150	9	%	%	NOUN
bjp-823	150	10	of	of	ADP
bjp-823	150	11	patients	patient	NOUN
bjp-823	150	12	receiving	receive	VERB
bjp-823	150	13	niacin	niacin	NOUN
bjp-823	150	14	plus	plus	CCONJ
bjp-823	150	15	atorvastatin	atorvastatin	NOUN
bjp-823	150	16	therapy	therapy	NOUN
bjp-823	150	17	and	and	CCONJ
bjp-823	150	18	in	in	ADP
bjp-823	150	19	35	35	NUM
bjp-823	150	20	%	%	NOUN
bjp-823	150	21	of	of	ADP
bjp-823	150	22	patients	patient	NOUN
bjp-823	150	23	receiving	receive	VERB
bjp-823	150	24	another	another	DET
bjp-823	150	25	combination	combination	NOUN
bjp-823	150	26	of	of	ADP
bjp-823	150	27	fenofibrate	fenofibrate	NOUN
bjp-823	150	28	plus	plus	CCONJ
bjp-823	150	29	atorvastatin	atorvastatin	PROPN
bjp-823	150	30	(	(	PUNCT
bjp-823	150	31	table	table	NOUN
bjp-823	150	32	iii	iii	NOUN
bjp-823	150	33	)	)	PUNCT
bjp-823	150	34	.	.	PUNCT
bjp-823	151	1	14.3	14.3	NUM
bjp-823	151	2	%	%	NOUN
bjp-823	151	3	of	of	ADP
bjp-823	151	4	group	group	NOUN
bjp-823	151	5	i	i	PRON
bjp-823	151	6	treated	treat	VERB
bjp-823	151	7	patients	patient	NOUN
bjp-823	151	8	experienced	experience	VERB
bjp-823	151	9	transient	transient	PROPN
bjp-823	151	10	flushing	flush	VERB
bjp-823	151	11	which	which	PRON
bjp-823	151	12	was	be	AUX
bjp-823	151	13	a	a	DET
bjp-823	151	14	feeling	feeling	NOUN
bjp-823	151	15	of	of	ADP
bjp-823	151	16	warmth	warmth	NOUN
bjp-823	151	17	,	,	PUNCT
bjp-823	151	18	itching	itching	NOUN
bjp-823	151	19	and	and	CCONJ
bjp-823	151	20	redness	redness	NOUN
bjp-823	151	21	of	of	ADP
bjp-823	151	22	the	the	DET
bjp-823	151	23	skin	skin	NOUN
bjp-823	151	24	especially	especially	ADV
bjp-823	151	25	face	face	VERB
bjp-823	151	26	as	as	ADV
bjp-823	151	27	well	well	ADV
bjp-823	151	28	as	as	ADP
bjp-823	151	29	neck	neck	NOUN
bjp-823	151	30	while	while	SCONJ
bjp-823	151	31	none	none	NOUN
bjp-823	151	32	of	of	ADP
bjp-823	151	33	them	they	PRON
bjp-823	151	34	complaints	complaint	NOUN
bjp-823	151	35	in	in	ADP
bjp-823	151	36	group	group	PROPN
bjp-823	151	37	ii	ii	PROPN
bjp-823	151	38	.	.	PROPN
bjp-823	152	1	5.7	5.7	NUM
bjp-823	152	2	%	%	NOUN
bjp-823	152	3	of	of	ADP
bjp-823	152	4	niacin	niacin	NOUN
bjp-823	152	5	plus	plus	CCONJ
bjp-823	152	6	atorvastatintreated	atorvastatintreate	VERB
bjp-823	152	7	patients	patient	NOUN
bjp-823	152	8	and	and	CCONJ
bjp-823	152	9	3.6	3.6	NUM
bjp-823	152	10	%	%	NOUN
bjp-823	152	11	of	of	ADP
bjp-823	152	12	fenofibrate	fenofibrate	NOUN
bjp-823	152	13	plus	plus	CCONJ
bjp-823	152	14	atorvastatin	atorvastatin	PROPN
bjp-823	152	15	-	-	PUNCT
bjp-823	152	16	treated	treat	VERB
bjp-823	152	17	patients	patient	NOUN
bjp-823	152	18	experienced	experience	VERB
bjp-823	152	19	headache	headache	NOUN
bjp-823	152	20	.	.	PUNCT
bjp-823	153	1	11.4	11.4	NUM
bjp-823	153	2	%	%	NOUN
bjp-823	153	3	of	of	ADP
bjp-823	153	4	group	group	NOUN
bjp-823	153	5	i	i	PRON
bjp-823	153	6	treated	treat	VERB
bjp-823	153	7	patients	patient	NOUN
bjp-823	153	8	and	and	CCONJ
bjp-823	153	9	12.5	12.5	NUM
bjp-823	153	10	%	%	NOUN
bjp-823	153	11	of	of	ADP
bjp-823	153	12	group	group	PROPN
bjp-823	153	13	ii	ii	PROPN
bjp-823	153	14	treated	treat	VERB
bjp-823	153	15	patient	patient	NOUN
bjp-823	153	16	’s	’s	PART
bjp-823	153	17	had	have	AUX
bjp-823	153	18	complained	complain	VERB
bjp-823	153	19	of	of	ADP
bjp-823	153	20	fatigue	fatigue	NOUN
bjp-823	153	21	.	.	PUNCT
bjp-823	154	1	abdominal	abdominal	ADJ
bjp-823	154	2	pain	pain	NOUN
bjp-823	154	3	experienced	experience	VERB
bjp-823	154	4	by	by	ADP
bjp-823	154	5	5.7	5.7	NUM
bjp-823	154	6	%	%	NOUN
bjp-823	154	7	in	in	ADP
bjp-823	154	8	group	group	NOUN
bjp-823	154	9	i	i	PROPN
bjp-823	154	10	and	and	CCONJ
bjp-823	154	11	6.3	6.3	NUM
bjp-823	154	12	%	%	NOUN
bjp-823	154	13	in	in	ADP
bjp-823	154	14	group	group	PROPN
bjp-823	154	15	ii	ii	PROPN
bjp-823	154	16	.	.	PROPN
bjp-823	155	1	6.3	6.3	NUM
bjp-823	155	2	%	%	NOUN
bjp-823	155	3	of	of	ADP
bjp-823	155	4	fenofibrate	fenofibrate	NOUN
bjp-823	155	5	plus	plus	CCONJ
bjp-823	155	6	atorvastatin	atorvastatin	PROPN
bjp-823	155	7	treated	treat	VERB
bjp-823	155	8	patient	patient	NOUN
bjp-823	155	9	’s	’s	PART
bjp-823	155	10	complaints	complaint	NOUN
bjp-823	155	11	of	of	ADP
bjp-823	155	12	dyspepsia	dyspepsia	NOUN
bjp-823	155	13	and	and	CCONJ
bjp-823	155	14	myalgia	myalgia	NOUN
bjp-823	155	15	while	while	SCONJ
bjp-823	155	16	none	none	NOUN
bjp-823	155	17	of	of	ADP
bjp-823	155	18	the	the	DET
bjp-823	155	19	niacin	niacin	NOUN
bjp-823	155	20	plus	plus	CCONJ
bjp-823	155	21	atorvastatin	atorvastatin	PROPN
bjp-823	155	22	treated	treat	VERB
bjp-823	155	23	patients	patient	NOUN
bjp-823	155	24	,	,	PUNCT
bjp-823	155	25	experienced	experience	VERB
bjp-823	155	26	dyspepsia	dyspepsia	NOUN
bjp-823	155	27	or	or	CCONJ
bjp-823	155	28	myalgia	myalgia	NOUN
bjp-823	155	29	.	.	PUNCT
bjp-823	156	1	table	table	NOUN
bjp-823	156	2	ii	ii	PROPN
bjp-823	156	3	effects	effect	NOUN
bjp-823	156	4	of	of	ADP
bjp-823	156	5	niacin	niacin	NOUN
bjp-823	156	6	or	or	CCONJ
bjp-823	156	7	fenofibrate	fenofibrate	NOUN
bjp-823	156	8	in	in	ADP
bjp-823	156	9	combination	combination	NOUN
bjp-823	156	10	with	with	ADP
bjp-823	156	11	atorvastatin	atorvastatin	NOUN
bjp-823	156	12	on	on	ADP
bjp-823	156	13	blood	blood	NOUN
bjp-823	156	14	glucose	glucose	NOUN
bjp-823	156	15	,	,	PUNCT
bjp-823	156	16	sgpt	sgpt	NOUN
bjp-823	156	17	,	,	PUNCT
bjp-823	156	18	and	and	CCONJ
bjp-823	156	19	serum	serum	NOUN
bjp-823	156	20	creatinine	creatinine	NOUN
bjp-823	156	21	level	level	NOUN
bjp-823	156	22	niacin	niacin	PROPN
bjp-823	156	23	plus	plus	CCONJ
bjp-823	156	24	atorvastatin	atorvastatin	PROPN
bjp-823	156	25	fenofibrate	fenofibrate	NOUN
bjp-823	156	26	plus	plus	CCONJ
bjp-823	156	27	atorvastatin	atorvastatin	PROPN
bjp-823	156	28	biochemical	biochemical	ADJ
bjp-823	156	29	parameters	parameter	NOUN
bjp-823	156	30	before	before	ADP
bjp-823	156	31	administration	administration	NOUN
bjp-823	156	32	(	(	PUNCT
bjp-823	156	33	n	n	NOUN
bjp-823	156	34	=	=	NUM
bjp-823	156	35	35	35	NUM
bjp-823	156	36	)	)	PUNCT
bjp-823	156	37	after	after	ADP
bjp-823	156	38	12	12	NUM
bjp-823	156	39	weeks	week	NOUN
bjp-823	156	40	(	(	PUNCT
bjp-823	156	41	n	n	NOUN
bjp-823	156	42	=	=	NUM
bjp-823	156	43	35	35	NUM
bjp-823	156	44	)	)	PUNCT
bjp-823	156	45	before	before	ADP
bjp-823	156	46	administration	administration	NOUN
bjp-823	156	47	(	(	PUNCT
bjp-823	156	48	n	n	NOUN
bjp-823	156	49	=	=	NUM
bjp-823	156	50	35	35	NUM
bjp-823	156	51	)	)	PUNCT
bjp-823	156	52	after	after	ADP
bjp-823	156	53	12	12	NUM
bjp-823	156	54	weeks	week	NOUN
bjp-823	156	55	(	(	PUNCT
bjp-823	156	56	n	n	NOUN
bjp-823	156	57	=	=	SYM
bjp-823	156	58	35	35	NUM
bjp-823	156	59	)	)	PUNCT
bjp-823	156	60	fasting	fast	VERB
bjp-823	156	61	blood	blood	NOUN
bjp-823	156	62	glucose	glucose	NOUN
bjp-823	156	63	(	(	PUNCT
bjp-823	156	64	mmol	mmol	NOUN
bjp-823	156	65	/	/	SYM
bjp-823	156	66	l	l	NOUN
bjp-823	156	67	)	)	PUNCT
bjp-823	156	68	7.2	7.2	NUM
bjp-823	156	69	±	±	NUM
bjp-823	156	70	2.7	2.7	NUM
bjp-823	156	71	6.6	6.6	NUM
bjp-823	156	72	±	±	NUM
bjp-823	156	73	1.3ns	1.3ns	NUM
bjp-823	156	74	8.5	8.5	NUM
bjp-823	156	75	±	±	NUM
bjp-823	156	76	4.4	4.4	NUM
bjp-823	156	77	6.5	6.5	NUM
bjp-823	156	78	±	±	NUM
bjp-823	156	79	2.0a	2.0a	NUM
bjp-823	156	80	sgpt	sgpt	NOUN
bjp-823	156	81	(	(	PUNCT
bjp-823	156	82	u	u	NOUN
bjp-823	156	83	/	/	SYM
bjp-823	156	84	l	l	NOUN
bjp-823	156	85	)	)	PUNCT
bjp-823	156	86	36.8	36.8	NUM
bjp-823	156	87	±	±	NUM
bjp-823	156	88	16.4	16.4	NUM
bjp-823	156	89	35.3	35.3	NUM
bjp-823	156	90	±	±	NUM
bjp-823	156	91	10.1ns	10.1ns	NUM
bjp-823	156	92	30.2	30.2	NUM
bjp-823	156	93	±	±	NUM
bjp-823	156	94	7.8	7.8	NUM
bjp-823	156	95	45.6	45.6	NUM
bjp-823	156	96	±	±	NOUN
bjp-823	156	97	24.8a	24.8a	NUM
bjp-823	156	98	serum	serum	NOUN
bjp-823	156	99	creatinine	creatinine	NOUN
bjp-823	156	100	(	(	PUNCT
bjp-823	156	101	mg	mg	PROPN
bjp-823	156	102	/	/	SYM
bjp-823	156	103	dl	dl	NOUN
bjp-823	156	104	)	)	PUNCT
bjp-823	156	105	1.2	1.2	NUM
bjp-823	156	106	±	±	NUM
bjp-823	156	107	0.3	0.3	NUM
bjp-823	156	108	1.0	1.0	NUM
bjp-823	156	109	±	±	NOUN
bjp-823	156	110	0.2a	0.2a	NUM
bjp-823	156	111	1.1	1.1	NUM
bjp-823	156	112	±	±	NUM
bjp-823	156	113	0.3	0.3	NUM
bjp-823	156	114	1.0	1.0	NUM
bjp-823	156	115	±	±	NUM
bjp-823	156	116	0.1ns	0.1ns	PROPN
bjp-823	157	1	asignificant	asignificant	ADJ
bjp-823	157	2	difference	difference	NOUN
bjp-823	157	3	before	before	ADV
bjp-823	157	4	and	and	CCONJ
bjp-823	157	5	after	after	ADP
bjp-823	157	6	12	12	NUM
bjp-823	157	7	weeks	week	NOUN
bjp-823	157	8	administration	administration	NOUN
bjp-823	157	9	of	of	ADP
bjp-823	157	10	drug	drug	NOUN
bjp-823	157	11	at	at	ADP
bjp-823	157	12	p<0.001	p<0.001	PROPN
bjp-823	158	1	;	;	PUNCT
bjp-823	158	2	ns=	ns=	VERB
bjp-823	158	3	no	no	DET
bjp-823	158	4	significant	significant	ADJ
bjp-823	158	5	difference	difference	NOUN
bjp-823	158	6	at	at	ADP
bjp-823	158	7	p>0.05	p>0.05	NOUN
bjp-823	158	8	,	,	PUNCT
bjp-823	158	9	data	datum	NOUN
bjp-823	158	10	are	be	AUX
bjp-823	158	11	mean	mean	ADJ
bjp-823	158	12	±	±	NUM
bjp-823	158	13	sd	sd	ADP
bjp-823	158	14	table	table	NOUN
bjp-823	158	15	iii	iii	NUM
bjp-823	158	16	adverse	adverse	ADJ
bjp-823	158	17	drug	drug	NOUN
bjp-823	158	18	reactions	reaction	NOUN
bjp-823	158	19	in	in	ADP
bjp-823	158	20	course	course	NOUN
bjp-823	158	21	of	of	ADP
bjp-823	158	22	treatment	treatment	NOUN
bjp-823	158	23	symptoms	symptom	NOUN
bjp-823	158	24	niacin	niacin	NOUN
bjp-823	158	25	plus	plus	CCONJ
bjp-823	158	26	atorvastatin	atorvastatin	NOUN
bjp-823	158	27	(	(	PUNCT
bjp-823	158	28	n	n	NOUN
bjp-823	158	29	=	=	SYM
bjp-823	158	30	35	35	NUM
bjp-823	158	31	)	)	PUNCT
bjp-823	158	32	fenofibrate	fenofibrate	NOUN
bjp-823	158	33	plus	plus	CCONJ
bjp-823	158	34	atorvastatin	atorvastatin	PROPN
bjp-823	158	35	(	(	PUNCT
bjp-823	158	36	n	n	NOUN
bjp-823	158	37	=	=	SYM
bjp-823	158	38	32	32	NUM
bjp-823	158	39	)	)	PUNCT
bjp-823	158	40	flushing	flush	VERB
bjp-823	158	41	5	5	NUM
bjp-823	158	42	-	-	PUNCT
bjp-823	158	43	headache	headache	NOUN
bjp-823	158	44	2	2	NUM
bjp-823	158	45	1	1	NUM
bjp-823	158	46	fatigue	fatigue	NOUN
bjp-823	158	47	4	4	NUM
bjp-823	158	48	4	4	NUM
bjp-823	158	49	abdominal	abdominal	ADJ
bjp-823	158	50	pain	pain	NOUN
bjp-823	158	51	2	2	NUM
bjp-823	158	52	2	2	NUM
bjp-823	159	1	dyspepsia	dyspepsia	NOUN
bjp-823	159	2	-2	-2	NOUN
bjp-823	160	1	myalgia	myalgia	PROPN
bjp-823	161	1	-2	-2	INTJ
bjp-823	161	2	total	total	ADJ
bjp-823	161	3	13	13	NUM
bjp-823	161	4	11	11	NUM
bjp-823	161	5	12	12	NUM
bjp-823	161	6	bangladesh	bangladesh	NOUN
bjp-823	161	7	j	j	PROPN
bjp-823	161	8	pharmacol	pharmacol	PROPN
bjp-823	161	9	2008	2008	NUM
bjp-823	161	10	;	;	PUNCT
bjp-823	161	11	3	3	NUM
bjp-823	161	12	:	:	SYM
bjp-823	161	13	8	8	NUM
bjp-823	161	14	-	-	SYM
bjp-823	161	15	16	16	NUM
bjp-823	161	16	discussion	discussion	NOUN
bjp-823	161	17	this	this	DET
bjp-823	161	18	study	study	NOUN
bjp-823	161	19	shows	show	VERB
bjp-823	161	20	that	that	SCONJ
bjp-823	161	21	combined	combine	VERB
bjp-823	161	22	therapy	therapy	NOUN
bjp-823	161	23	of	of	ADP
bjp-823	161	24	either	either	PRON
bjp-823	161	25	niacin	niacin	NOUN
bjp-823	161	26	-	-	PUNCT
bjp-823	161	27	atorvastatin	atorvastatin	NOUN
bjp-823	161	28	or	or	CCONJ
bjp-823	161	29	fenofibrate	fenofibrate	NOUN
bjp-823	161	30	-	-	PUNCT
bjp-823	161	31	atorvastatin	atorvastatin	NOUN
bjp-823	161	32	for	for	ADP
bjp-823	161	33	12	12	NUM
bjp-823	161	34	weeks	week	NOUN
bjp-823	161	35	significantly	significantly	ADV
bjp-823	161	36	decreased	decrease	VERB
bjp-823	161	37	total	total	ADJ
bjp-823	161	38	cholesterol	cholesterol	NOUN
bjp-823	161	39	,	,	PUNCT
bjp-823	161	40	triglyceride	triglyceride	ADV
bjp-823	161	41	and	and	CCONJ
bjp-823	161	42	ldl	ldl	NOUN
bjp-823	161	43	-	-	PUNCT
bjp-823	161	44	c	c	NOUN
bjp-823	161	45	from	from	ADP
bjp-823	161	46	baseline	baseline	NOUN
bjp-823	161	47	in	in	ADP
bjp-823	161	48	dyslipidemic	dyslipidemic	ADJ
bjp-823	161	49	patients	patient	NOUN
bjp-823	161	50	.	.	PUNCT
bjp-823	162	1	the	the	DET
bjp-823	162	2	individual	individual	ADJ
bjp-823	162	3	combination	combination	NOUN
bjp-823	162	4	also	also	ADV
bjp-823	162	5	significantly	significantly	ADV
bjp-823	162	6	increased	increase	VERB
bjp-823	162	7	hdl	hdl	PROPN
bjp-823	162	8	-	-	PUNCT
bjp-823	162	9	c	c	PROPN
bjp-823	162	10	in	in	ADP
bjp-823	162	11	same	same	ADJ
bjp-823	162	12	groups	group	NOUN
bjp-823	162	13	of	of	ADP
bjp-823	162	14	patients	patient	NOUN
bjp-823	162	15	.	.	PUNCT
bjp-823	163	1	this	this	DET
bjp-823	163	2	study	study	NOUN
bjp-823	163	3	also	also	ADV
bjp-823	163	4	revealed	reveal	VERB
bjp-823	163	5	that	that	SCONJ
bjp-823	163	6	combined	combined	ADJ
bjp-823	163	7	fenofibrate	fenofibrate	NOUN
bjp-823	163	8	-	-	PUNCT
bjp-823	163	9	atorvastatin	atorvastatin	PROPN
bjp-823	163	10	appeared	appear	VERB
bjp-823	163	11	more	more	ADV
bjp-823	163	12	effective	effective	ADJ
bjp-823	163	13	than	than	ADP
bjp-823	163	14	niacin	niacin	NOUN
bjp-823	163	15	-	-	PUNCT
bjp-823	163	16	atorvastatin	atorvastatin	NOUN
bjp-823	163	17	in	in	ADP
bjp-823	163	18	reduction	reduction	NOUN
bjp-823	163	19	of	of	ADP
bjp-823	163	20	triglyceride	triglyceride	ADJ
bjp-823	163	21	.	.	PUNCT
bjp-823	164	1	previously	previously	ADV
bjp-823	164	2	,	,	PUNCT
bjp-823	164	3	similar	similar	ADJ
bjp-823	164	4	combinations	combination	NOUN
bjp-823	164	5	of	of	ADP
bjp-823	164	6	lipid	lipid	NOUN
bjp-823	164	7	lowering	lower	VERB
bjp-823	164	8	agents	agent	NOUN
bjp-823	164	9	produced	produce	VERB
bjp-823	164	10	qualitatively	qualitatively	ADV
bjp-823	164	11	similar	similar	ADJ
bjp-823	164	12	effects	effect	NOUN
bjp-823	164	13	in	in	ADP
bjp-823	164	14	dyslipidemic	dyslipidemic	ADJ
bjp-823	164	15	patients	patient	NOUN
bjp-823	164	16	(	(	PUNCT
bjp-823	164	17	stein	stein	PROPN
bjp-823	164	18	et	et	PROPN
bjp-823	164	19	al	al	PROPN
bjp-823	164	20	.	.	PROPN
bjp-823	164	21	,	,	PUNCT
bjp-823	164	22	1996	1996	NUM
bjp-823	164	23	;	;	PUNCT
bjp-823	164	24	guyton	guyton	PROPN
bjp-823	164	25	et	et	PROPN
bjp-823	164	26	al	al	PROPN
bjp-823	164	27	.	.	PROPN
bjp-823	164	28	,	,	PUNCT
bjp-823	164	29	1998	1998	NUM
bjp-823	164	30	;	;	PUNCT
bjp-823	164	31	athyros	athyros	PROPN
bjp-823	164	32	et	et	PROPN
bjp-823	164	33	al	al	PROPN
bjp-823	164	34	.	.	PROPN
bjp-823	164	35	,	,	PUNCT
bjp-823	164	36	2002	2002	NUM
bjp-823	164	37	;	;	PUNCT
bjp-823	164	38	klosiewicz	klosiewicz	VERB
bjp-823	164	39	-	-	PUNCT
bjp-823	164	40	latoszek	latoszek	PROPN
bjp-823	164	41	et	et	PROPN
bjp-823	164	42	al	al	PROPN
bjp-823	164	43	.	.	PROPN
bjp-823	164	44	,	,	PUNCT
bjp-823	164	45	2004	2004	NUM
bjp-823	164	46	)	)	PUNCT
bjp-823	164	47	.	.	PUNCT
bjp-823	165	1	however	however	ADV
bjp-823	165	2	,	,	PUNCT
bjp-823	165	3	a	a	DET
bjp-823	165	4	study	study	NOUN
bjp-823	165	5	conducted	conduct	VERB
bjp-823	165	6	by	by	ADP
bjp-823	165	7	deb	deb	PROPN
bjp-823	165	8	(	(	PUNCT
bjp-823	165	9	2006	2006	NUM
bjp-823	165	10	)	)	PUNCT
bjp-823	165	11	where	where	SCONJ
bjp-823	165	12	atorvastatin	atorvastatin	PROPN
bjp-823	165	13	administered	administer	VERB
bjp-823	165	14	in	in	ADP
bjp-823	165	15	combination	combination	NOUN
bjp-823	165	16	with	with	ADP
bjp-823	165	17	ezetimibe	ezetimibe	NOUN
bjp-823	165	18	produced	produce	VERB
bjp-823	165	19	significant	significant	ADJ
bjp-823	165	20	reduction	reduction	NOUN
bjp-823	165	21	of	of	ADP
bjp-823	165	22	ldl	ldl	NOUN
bjp-823	165	23	-	-	PUNCT
bjp-823	165	24	c	c	PROPN
bjp-823	165	25	and	and	CCONJ
bjp-823	165	26	total	total	ADJ
bjp-823	165	27	cholesterol	cholesterol	NOUN
bjp-823	165	28	,	,	PUNCT
bjp-823	165	29	but	but	CCONJ
bjp-823	165	30	did	do	AUX
bjp-823	165	31	not	not	PART
bjp-823	165	32	show	show	VERB
bjp-823	165	33	any	any	DET
bjp-823	165	34	significant	significant	ADJ
bjp-823	165	35	effect	effect	NOUN
bjp-823	165	36	on	on	ADP
bjp-823	165	37	hdl	hdl	PROPN
bjp-823	165	38	-	-	PUNCT
bjp-823	165	39	c	c	PROPN
bjp-823	165	40	and	and	CCONJ
bjp-823	165	41	triglyceride	triglyceride	ADJ
bjp-823	165	42	level	level	NOUN
bjp-823	165	43	compared	compare	VERB
bjp-823	165	44	to	to	PART
bjp-823	165	45	baseline	baseline	VERB
bjp-823	165	46	.	.	PUNCT
bjp-823	166	1	in	in	ADP
bjp-823	166	2	the	the	DET
bjp-823	166	3	present	present	ADJ
bjp-823	166	4	study	study	NOUN
bjp-823	166	5	,	,	PUNCT
bjp-823	166	6	niacin	niacin	NOUN
bjp-823	166	7	administered	administer	VERB
bjp-823	166	8	in	in	ADP
bjp-823	166	9	combination	combination	NOUN
bjp-823	166	10	with	with	ADP
bjp-823	166	11	atorvastatin	atorvastatin	NOUN
bjp-823	166	12	significantly	significantly	ADV
bjp-823	166	13	decreased	decrease	VERB
bjp-823	166	14	triglyceride	triglyceride	ADV
bjp-823	166	15	by	by	ADP
bjp-823	166	16	14.0	14.0	NUM
bjp-823	166	17	%	%	NOUN
bjp-823	166	18	,	,	PUNCT
bjp-823	166	19	total	total	ADJ
bjp-823	166	20	cholesterol	cholesterol	NOUN
bjp-823	166	21	by	by	ADP
bjp-823	166	22	25.7	25.7	NUM
bjp-823	166	23	%	%	NOUN
bjp-823	166	24	and	and	CCONJ
bjp-823	166	25	ldl	ldl	NOUN
bjp-823	166	26	-	-	PUNCT
bjp-823	166	27	c	c	NOUN
bjp-823	166	28	by	by	ADP
bjp-823	166	29	38.4	38.4	NUM
bjp-823	166	30	%	%	NOUN
bjp-823	166	31	and	and	CCONJ
bjp-823	166	32	increased	increase	VERB
bjp-823	166	33	hdl	hdl	PROPN
bjp-823	166	34	-	-	PUNCT
bjp-823	166	35	c	c	PROPN
bjp-823	166	36	by	by	ADP
bjp-823	166	37	10.0	10.0	NUM
bjp-823	166	38	%	%	NOUN
bjp-823	166	39	from	from	ADP
bjp-823	166	40	baseline	baseline	NOUN
bjp-823	166	41	.	.	PUNCT
bjp-823	167	1	this	this	DET
bjp-823	167	2	result	result	NOUN
bjp-823	167	3	was	be	AUX
bjp-823	167	4	similar	similar	ADJ
bjp-823	167	5	to	to	ADP
bjp-823	167	6	that	that	PRON
bjp-823	167	7	reported	report	VERB
bjp-823	167	8	by	by	ADP
bjp-823	167	9	stein	stein	PROPN
bjp-823	167	10	et	et	PROPN
bjp-823	167	11	al	al	PROPN
bjp-823	167	12	.	.	PROPN
bjp-823	167	13	,	,	PUNCT
bjp-823	167	14	(	(	PUNCT
bjp-823	167	15	1996	1996	NUM
bjp-823	167	16	)	)	PUNCT
bjp-823	167	17	who	who	PRON
bjp-823	167	18	observed	observe	VERB
bjp-823	167	19	that	that	SCONJ
bjp-823	167	20	niacin	niacin	NOUN
bjp-823	167	21	at	at	ADP
bjp-823	167	22	a	a	DET
bjp-823	167	23	dose	dose	NOUN
bjp-823	167	24	of	of	ADP
bjp-823	167	25	1.5	1.5	NUM
bjp-823	167	26	g	g	NOUN
bjp-823	167	27	administered	administer	VERB
bjp-823	167	28	in	in	ADP
bjp-823	167	29	combination	combination	NOUN
bjp-823	167	30	with	with	ADP
bjp-823	167	31	simvastatin	simvastatin	NOUN
bjp-823	167	32	at	at	ADP
bjp-823	167	33	a	a	DET
bjp-823	167	34	dose	dose	NOUN
bjp-823	167	35	of	of	ADP
bjp-823	167	36	10	10	NUM
bjp-823	167	37	mg	mg	NOUN
bjp-823	167	38	per	per	ADP
bjp-823	167	39	day	day	NOUN
bjp-823	167	40	was	be	AUX
bjp-823	167	41	highly	highly	ADV
bjp-823	167	42	effective	effective	ADJ
bjp-823	167	43	in	in	ADP
bjp-823	167	44	lowering	lower	VERB
bjp-823	167	45	the	the	DET
bjp-823	167	46	serum	serum	NOUN
bjp-823	167	47	lipids	lipid	NOUN
bjp-823	167	48	of	of	ADP
bjp-823	167	49	triglyceride	triglyceride	INTJ
bjp-823	167	50	by	by	ADP
bjp-823	167	51	31	31	NUM
bjp-823	167	52	%	%	NOUN
bjp-823	167	53	,	,	PUNCT
bjp-823	167	54	ldl	ldl	NOUN
bjp-823	167	55	-	-	PUNCT
bjp-823	167	56	c	c	NOUN
bjp-823	167	57	by	by	ADP
bjp-823	167	58	29	29	NUM
bjp-823	167	59	%	%	NOUN
bjp-823	167	60	while	while	SCONJ
bjp-823	167	61	hdl	hdl	PROPN
bjp-823	167	62	-	-	PUNCT
bjp-823	167	63	c	c	NOUN
bjp-823	167	64	level	level	NOUN
bjp-823	167	65	increased	increase	VERB
bjp-823	167	66	by	by	ADP
bjp-823	167	67	31	31	NUM
bjp-823	167	68	%	%	NOUN
bjp-823	167	69	after	after	ADP
bjp-823	167	70	17	17	NUM
bjp-823	167	71	weeks	week	NOUN
bjp-823	167	72	of	of	ADP
bjp-823	167	73	treatment	treatment	NOUN
bjp-823	167	74	.	.	PUNCT
bjp-823	168	1	the	the	DET
bjp-823	168	2	greater	great	ADJ
bjp-823	168	3	lipid	lipid	NOUN
bjp-823	168	4	modifying	modify	VERB
bjp-823	168	5	effects	effect	NOUN
bjp-823	168	6	might	might	AUX
bjp-823	168	7	be	be	AUX
bjp-823	168	8	due	due	ADJ
bjp-823	168	9	to	to	ADP
bjp-823	168	10	high	high	ADJ
bjp-823	168	11	doses	dose	NOUN
bjp-823	168	12	of	of	ADP
bjp-823	168	13	niacin	niacin	NOUN
bjp-823	168	14	and	and	CCONJ
bjp-823	168	15	long	long	ADJ
bjp-823	168	16	duration	duration	NOUN
bjp-823	168	17	of	of	ADP
bjp-823	168	18	treatment	treatment	NOUN
bjp-823	168	19	.	.	PUNCT
bjp-823	169	1	guyton	guyton	PROPN
bjp-823	169	2	et	et	PROPN
bjp-823	169	3	al	al	PROPN
bjp-823	169	4	.	.	PROPN
bjp-823	169	5	,	,	PUNCT
bjp-823	169	6	showed	show	VERB
bjp-823	169	7	that	that	SCONJ
bjp-823	169	8	1.5	1.5	NUM
bjp-823	169	9	g	g	PROPN
bjp-823	169	10	niacin	niacin	NOUN
bjp-823	169	11	in	in	ADP
bjp-823	169	12	combination	combination	NOUN
bjp-823	169	13	with	with	ADP
bjp-823	169	14	10	10	NUM
bjp-823	169	15	mg	mg	PROPN
bjp-823	169	16	simvastatin	simvastatin	NOUN
bjp-823	169	17	lowered	lower	VERB
bjp-823	169	18	level	level	NOUN
bjp-823	169	19	of	of	ADP
bjp-823	169	20	total	total	ADJ
bjp-823	169	21	cholesterol	cholesterol	NOUN
bjp-823	169	22	by	by	ADP
bjp-823	169	23	23	23	NUM
bjp-823	169	24	%	%	NOUN
bjp-823	169	25	,	,	PUNCT
bjp-823	169	26	ldl	ldl	NOUN
bjp-823	169	27	-	-	PUNCT
bjp-823	169	28	c	c	NOUN
bjp-823	169	29	by	by	ADP
bjp-823	169	30	32	32	NUM
bjp-823	169	31	%	%	NOUN
bjp-823	169	32	,	,	PUNCT
bjp-823	169	33	triglyceride	triglyceride	ADP
bjp-823	169	34	by	by	ADP
bjp-823	169	35	30	30	NUM
bjp-823	169	36	%	%	NOUN
bjp-823	169	37	and	and	CCONJ
bjp-823	169	38	increased	increase	VERB
bjp-823	169	39	levels	level	NOUN
bjp-823	169	40	of	of	ADP
bjp-823	169	41	hdl	hdl	PROPN
bjp-823	169	42	-	-	PUNCT
bjp-823	169	43	c	c	PROPN
bjp-823	169	44	by	by	ADP
bjp-823	169	45	26	26	NUM
bjp-823	169	46	%	%	NOUN
bjp-823	169	47	after	after	ADP
bjp-823	169	48	48	48	NUM
bjp-823	169	49	weeks	week	NOUN
bjp-823	169	50	of	of	ADP
bjp-823	169	51	therapy	therapy	NOUN
bjp-823	169	52	.	.	PUNCT
bjp-823	170	1	the	the	DET
bjp-823	170	2	difference	difference	NOUN
bjp-823	170	3	of	of	ADP
bjp-823	170	4	percentage	percentage	NOUN
bjp-823	170	5	of	of	ADP
bjp-823	170	6	lipid	lipid	NOUN
bjp-823	170	7	profile	profile	NOUN
bjp-823	170	8	was	be	AUX
bjp-823	170	9	probably	probably	ADV
bjp-823	170	10	due	due	ADJ
bjp-823	170	11	to	to	ADP
bjp-823	170	12	longer	long	ADJ
bjp-823	170	13	duration	duration	NOUN
bjp-823	170	14	and	and	CCONJ
bjp-823	170	15	higher	high	ADJ
bjp-823	170	16	dose	dose	NOUN
bjp-823	170	17	of	of	ADP
bjp-823	170	18	niacin	niacin	PROPN
bjp-823	170	19	.	.	PUNCT
bjp-823	171	1	niacin	niacin	PROPN
bjp-823	171	2	mainly	mainly	ADV
bjp-823	171	3	acts	act	VERB
bjp-823	171	4	by	by	ADP
bjp-823	171	5	inhibition	inhibition	NOUN
bjp-823	171	6	of	of	ADP
bjp-823	171	7	lipolysis	lipolysis	NOUN
bjp-823	171	8	of	of	ADP
bjp-823	171	9	triacylglycerol	triacylglycerol	NOUN
bjp-823	171	10	in	in	ADP
bjp-823	171	11	adipose	adipose	ADJ
bjp-823	171	12	tissue	tissue	NOUN
bjp-823	171	13	via	via	ADP
bjp-823	171	14	inhibition	inhibition	NOUN
bjp-823	171	15	of	of	ADP
bjp-823	171	16	hormone	hormone	NOUN
bjp-823	171	17	sensitive	sensitive	ADJ
bjp-823	171	18	triglyceride	triglyceride	ADP
bjp-823	171	19	lipase	lipase	NOUN
bjp-823	171	20	leading	lead	VERB
bjp-823	171	21	to	to	ADP
bjp-823	171	22	reduction	reduction	NOUN
bjp-823	171	23	in	in	ADP
bjp-823	171	24	circulating	circulate	VERB
bjp-823	171	25	levels	level	NOUN
bjp-823	171	26	of	of	ADP
bjp-823	171	27	non	non	ADJ
bjp-823	171	28	-	-	ADJ
bjp-823	171	29	esterified	esterify	VERB
bjp-823	171	30	fatty	fatty	NOUN
bjp-823	171	31	acid	acid	NOUN
bjp-823	171	32	.	.	PUNCT
bjp-823	172	1	as	as	ADP
bjp-823	172	2	a	a	DET
bjp-823	172	3	result	result	NOUN
bjp-823	172	4	,	,	PUNCT
bjp-823	172	5	there	there	PRON
bjp-823	172	6	is	be	VERB
bjp-823	172	7	a	a	DET
bjp-823	172	8	reduction	reduction	NOUN
bjp-823	172	9	in	in	ADP
bjp-823	172	10	plasma	plasma	NOUN
bjp-823	172	11	level	level	NOUN
bjp-823	172	12	of	of	ADP
bjp-823	172	13	vldltriglyceride	vldltriglyceride	NOUN
bjp-823	172	14	,	,	PUNCT
bjp-823	172	15	ldl	ldl	NOUN
bjp-823	172	16	and	and	CCONJ
bjp-823	172	17	decreases	decrease	VERB
bjp-823	172	18	the	the	DET
bjp-823	172	19	rate	rate	NOUN
bjp-823	172	20	of	of	ADP
bjp-823	172	21	removal	removal	NOUN
bjp-823	172	22	of	of	ADP
bjp-823	172	23	apoa-1	apoa-1	NUM
bjp-823	172	24	(	(	PUNCT
bjp-823	172	25	the	the	DET
bjp-823	172	26	major	major	ADJ
bjp-823	172	27	apolipoprotein	apolipoprotein	NOUN
bjp-823	172	28	of	of	ADP
bjp-823	172	29	hdl	hdl	PROPN
bjp-823	172	30	)	)	PUNCT
bjp-823	172	31	by	by	ADP
bjp-823	172	32	the	the	DET
bjp-823	172	33	liver	liver	NOUN
bjp-823	172	34	(	(	PUNCT
bjp-823	172	35	chapman	chapman	NOUN
bjp-823	172	36	et	et	PROPN
bjp-823	172	37	al	al	PROPN
bjp-823	172	38	.	.	PROPN
bjp-823	172	39	,	,	PUNCT
bjp-823	172	40	2004	2004	NUM
bjp-823	172	41	)	)	PUNCT
bjp-823	172	42	.	.	PUNCT
bjp-823	173	1	there	there	PRON
bjp-823	173	2	is	be	VERB
bjp-823	173	3	also	also	ADV
bjp-823	173	4	evidence	evidence	NOUN
bjp-823	173	5	that	that	SCONJ
bjp-823	173	6	nicotinic	nicotinic	ADJ
bjp-823	173	7	acid	acid	NOUN
bjp-823	173	8	stimulates	stimulate	VERB
bjp-823	173	9	cholesterol	cholesterol	NOUN
bjp-823	173	10	efflux	efflux	NOUN
bjp-823	173	11	via	via	ADP
bjp-823	173	12	an	an	DET
bjp-823	173	13	atpbinding	atpbinding	NOUN
bjp-823	173	14	cassette	cassette	NOUN
bjp-823	173	15	transporter	transporter	NOUN
bjp-823	173	16	a1	a1	NOUN
bjp-823	173	17	(	(	PUNCT
bjp-823	173	18	abca-1	abca-1	NOUN
bjp-823	173	19	)	)	PUNCT
bjp-823	173	20	mediated	mediate	VERB
bjp-823	173	21	mechanism	mechanism	NOUN
bjp-823	173	22	(	(	PUNCT
bjp-823	173	23	rubic	rubic	PROPN
bjp-823	173	24	et	et	PROPN
bjp-823	173	25	al	al	PROPN
bjp-823	173	26	.	.	PROPN
bjp-823	173	27	,	,	PUNCT
bjp-823	173	28	2004	2004	NUM
bjp-823	173	29	)	)	PUNCT
bjp-823	173	30	and	and	CCONJ
bjp-823	173	31	decrease	decrease	VERB
bjp-823	173	32	hdl	hdl	PROPN
bjp-823	173	33	uptake	uptake	NOUN
bjp-823	173	34	by	by	ADP
bjp-823	173	35	the	the	DET
bjp-823	173	36	liver	liver	NOUN
bjp-823	173	37	(	(	PUNCT
bjp-823	173	38	sakai	sakai	PROPN
bjp-823	173	39	et	et	PROPN
bjp-823	173	40	al	al	PROPN
bjp-823	173	41	.	.	PROPN
bjp-823	173	42	,	,	PUNCT
bjp-823	173	43	2001	2001	NUM
bjp-823	173	44	)	)	PUNCT
bjp-823	173	45	which	which	PRON
bjp-823	173	46	contribute	contribute	VERB
bjp-823	173	47	to	to	ADP
bjp-823	173	48	the	the	DET
bjp-823	173	49	hdl	hdl	NOUN
bjp-823	173	50	raising	raising	NOUN
bjp-823	173	51	effect	effect	NOUN
bjp-823	173	52	.	.	PUNCT
bjp-823	174	1	atorvastatin	atorvastatin	PROPN
bjp-823	174	2	inhibits	inhibit	VERB
bjp-823	174	3	hmgcoa	hmgcoa	PROPN
bjp-823	174	4	reductase	reductase	NOUN
bjp-823	174	5	,	,	PUNCT
bjp-823	174	6	the	the	DET
bjp-823	174	7	most	most	ADV
bjp-823	174	8	effective	effective	ADJ
bjp-823	174	9	agent	agent	NOUN
bjp-823	174	10	for	for	ADP
bjp-823	174	11	lowering	lower	VERB
bjp-823	174	12	ldl	ldl	NOUN
bjp-823	174	13	-	-	PUNCT
bjp-823	174	14	c	c	PROPN
bjp-823	174	15	(	(	PUNCT
bjp-823	174	16	miller	miller	PROPN
bjp-823	174	17	,	,	PUNCT
bjp-823	174	18	2003	2003	NUM
bjp-823	174	19	)	)	PUNCT
bjp-823	174	20	.	.	PUNCT
bjp-823	175	1	on	on	ADP
bjp-823	175	2	the	the	DET
bjp-823	175	3	other	other	ADJ
bjp-823	175	4	hand	hand	NOUN
bjp-823	175	5	,	,	PUNCT
bjp-823	175	6	the	the	DET
bjp-823	175	7	present	present	ADJ
bjp-823	175	8	study	study	NOUN
bjp-823	175	9	shows	show	VERB
bjp-823	175	10	that	that	PRON
bjp-823	175	11	fenofibrate	fenofibrate	PROPN
bjp-823	175	12	plus	plus	CCONJ
bjp-823	175	13	atorvastatin	atorvastatin	PROPN
bjp-823	175	14	therapy	therapy	NOUN
bjp-823	175	15	decreased	decrease	VERB
bjp-823	175	16	ldl	ldl	NOUN
bjp-823	175	17	by	by	ADP
bjp-823	175	18	38.6	38.6	NUM
bjp-823	175	19	%	%	NOUN
bjp-823	175	20	,	,	PUNCT
bjp-823	175	21	total	total	ADJ
bjp-823	175	22	cholesterol	cholesterol	NOUN
bjp-823	175	23	by	by	ADP
bjp-823	175	24	30.2	30.2	NUM
bjp-823	175	25	%	%	NOUN
bjp-823	175	26	,	,	PUNCT
bjp-823	175	27	triglyceride	triglyceride	ADP
bjp-823	175	28	by	by	ADP
bjp-823	175	29	35.0	35.0	NUM
bjp-823	175	30	%	%	NOUN
bjp-823	175	31	and	and	CCONJ
bjp-823	175	32	increased	increase	VERB
bjp-823	175	33	hdl	hdl	PROPN
bjp-823	175	34	-	-	PUNCT
bjp-823	175	35	c	c	PROPN
bjp-823	175	36	by	by	ADP
bjp-823	175	37	7.2	7.2	NUM
bjp-823	175	38	%	%	NOUN
bjp-823	175	39	from	from	ADP
bjp-823	175	40	the	the	DET
bjp-823	175	41	baseline	baseline	NOUN
bjp-823	175	42	.	.	PUNCT
bjp-823	176	1	the	the	DET
bjp-823	176	2	changes	change	NOUN
bjp-823	176	3	might	might	AUX
bjp-823	176	4	be	be	AUX
bjp-823	176	5	caused	cause	VERB
bjp-823	176	6	by	by	ADP
bjp-823	176	7	fenofibrate	fenofibrate	NOUN
bjp-823	176	8	that	that	PRON
bjp-823	176	9	activates	activate	VERB
bjp-823	176	10	peroxisome	peroxisome	VERB
bjp-823	176	11	proliferator	proliferator	NOUN
bjp-823	176	12	-	-	PUNCT
bjp-823	176	13	activator	activator	NOUN
bjp-823	176	14	receptors	receptor	NOUN
bjp-823	176	15	(	(	PUNCT
bjp-823	176	16	staels	stael	NOUN
bjp-823	176	17	and	and	CCONJ
bjp-823	176	18	auwerx	auwerx	NOUN
bjp-823	176	19	,	,	PUNCT
bjp-823	176	20	1998	1998	NUM
bjp-823	176	21	)	)	PUNCT
bjp-823	176	22	which	which	PRON
bjp-823	176	23	induce	induce	VERB
bjp-823	176	24	an	an	DET
bjp-823	176	25	increase	increase	NOUN
bjp-823	176	26	in	in	ADP
bjp-823	176	27	lipoprotein	lipoprotein	ADJ
bjp-823	176	28	lipase	lipase	NOUN
bjp-823	176	29	activity	activity	NOUN
bjp-823	176	30	causing	cause	VERB
bjp-823	176	31	hydrolysis	hydrolysis	NOUN
bjp-823	176	32	of	of	ADP
bjp-823	176	33	triglycerides	triglyceride	NOUN
bjp-823	176	34	in	in	ADP
bjp-823	176	35	chylomicron	chylomicron	NOUN
bjp-823	176	36	and	and	CCONJ
bjp-823	176	37	vldl	vldl	NOUN
bjp-823	176	38	particles	particle	NOUN
bjp-823	176	39	and	and	CCONJ
bjp-823	176	40	an	an	DET
bjp-823	176	41	increase	increase	NOUN
bjp-823	176	42	in	in	ADP
bjp-823	176	43	apo	apo	PROPN
bjp-823	176	44	a-1	a-1	PROPN
bjp-823	176	45	as	as	ADV
bjp-823	176	46	well	well	ADV
bjp-823	176	47	as	as	ADP
bjp-823	176	48	a	a	DET
bjp-823	176	49	reduction	reduction	NOUN
bjp-823	176	50	in	in	ADP
bjp-823	176	51	cholesterol	cholesterol	NOUN
bjp-823	176	52	ester	ester	NOUN
bjp-823	176	53	transfer	transfer	NOUN
bjp-823	176	54	protein	protein	NOUN
bjp-823	176	55	activity	activity	NOUN
bjp-823	176	56	;	;	PUNCT
bjp-823	176	57	thereby	thereby	ADV
bjp-823	176	58	reduction	reduction	NOUN
bjp-823	176	59	of	of	ADP
bjp-823	176	60	triglyceride	triglyceride	ADJ
bjp-823	176	61	,	,	PUNCT
bjp-823	176	62	total	total	ADJ
bjp-823	176	63	cholesterol	cholesterol	NOUN
bjp-823	176	64	and	and	CCONJ
bjp-823	176	65	increase	increase	VERB
bjp-823	176	66	hdl	hdl	PROPN
bjp-823	176	67	-	-	PUNCT
bjp-823	176	68	c.	c.	PROPN
bjp-823	176	69	atorvastatin	atorvastatin	PROPN
bjp-823	176	70	decreases	decrease	VERB
bjp-823	176	71	ldl	ldl	NOUN
bjp-823	176	72	-	-	PUNCT
bjp-823	176	73	c	c	NOUN
bjp-823	176	74	by	by	ADP
bjp-823	176	75	inhibition	inhibition	NOUN
bjp-823	176	76	of	of	ADP
bjp-823	176	77	hmg	hmg	NOUN
bjp-823	176	78	-	-	PUNCT
bjp-823	176	79	coa	coa	NOUN
bjp-823	176	80	reductase	reductase	NOUN
bjp-823	176	81	(	(	PUNCT
bjp-823	176	82	watts	watts	PROPN
bjp-823	176	83	and	and	CCONJ
bjp-823	176	84	dimmit	dimmit	ADJ
bjp-823	176	85	,	,	PUNCT
bjp-823	176	86	1999	1999	NUM
bjp-823	176	87	)	)	PUNCT
bjp-823	176	88	.	.	PUNCT
bjp-823	177	1	the	the	DET
bjp-823	177	2	study	study	NOUN
bjp-823	177	3	of	of	ADP
bjp-823	177	4	athyros	athyros	PROPN
bjp-823	177	5	et	et	PROPN
bjp-823	177	6	al	al	PROPN
bjp-823	177	7	.	.	PUNCT
bjp-823	177	8	(	(	PUNCT
bjp-823	177	9	2002	2002	NUM
bjp-823	177	10	)	)	PUNCT
bjp-823	177	11	showed	show	VERB
bjp-823	177	12	that	that	SCONJ
bjp-823	177	13	combination	combination	NOUN
bjp-823	177	14	therapy	therapy	NOUN
bjp-823	177	15	of	of	ADP
bjp-823	177	16	atorvastatin	atorvastatin	PROPN
bjp-823	177	17	(	(	PUNCT
bjp-823	177	18	20	20	NUM
bjp-823	177	19	mg)-fenofibrate	mg)-fenofibrate	NOUN
bjp-823	177	20	(	(	PUNCT
bjp-823	177	21	200	200	NUM
bjp-823	177	22	mg	mg	NOUN
bjp-823	177	23	)	)	PUNCT
bjp-823	177	24	causes	cause	VERB
bjp-823	177	25	reduction	reduction	NOUN
bjp-823	177	26	of	of	ADP
bjp-823	177	27	total	total	ADJ
bjp-823	177	28	cholesterol	cholesterol	NOUN
bjp-823	177	29	,	,	PUNCT
bjp-823	177	30	ldl	ldl	NOUN
bjp-823	177	31	-	-	PUNCT
bjp-823	177	32	c	c	NOUN
bjp-823	177	33	,	,	PUNCT
bjp-823	177	34	triglyceride	triglyceride	ADV
bjp-823	177	35	and	and	CCONJ
bjp-823	177	36	a	a	DET
bjp-823	177	37	significant	significant	ADJ
bjp-823	177	38	increase	increase	NOUN
bjp-823	177	39	in	in	ADP
bjp-823	177	40	hdl	hdl	PROPN
bjp-823	177	41	-	-	PUNCT
bjp-823	177	42	c	c	PROPN
bjp-823	177	43	which	which	PRON
bjp-823	177	44	was	be	AUX
bjp-823	177	45	highly	highly	ADV
bjp-823	177	46	beneficial	beneficial	ADJ
bjp-823	177	47	in	in	ADP
bjp-823	177	48	patients	patient	NOUN
bjp-823	177	49	with	with	ADP
bjp-823	177	50	type	type	NOUN
bjp-823	177	51	2	2	NUM
bjp-823	177	52	diabetes	diabetes	NOUN
bjp-823	177	53	and	and	CCONJ
bjp-823	177	54	dyslipidemia	dyslipidemia	NOUN
bjp-823	177	55	.	.	PUNCT
bjp-823	178	1	the	the	DET
bjp-823	178	2	differences	difference	NOUN
bjp-823	178	3	of	of	ADP
bjp-823	178	4	lipid	lipid	NOUN
bjp-823	178	5	profile	profile	NOUN
bjp-823	178	6	probably	probably	ADV
bjp-823	178	7	due	due	ADJ
bjp-823	178	8	to	to	ADP
bjp-823	178	9	higher	high	ADJ
bjp-823	178	10	doses	dose	NOUN
bjp-823	178	11	of	of	ADP
bjp-823	178	12	atorvastatin	atorvastatin	NOUN
bjp-823	178	13	and	and	CCONJ
bjp-823	178	14	longer	long	ADJ
bjp-823	178	15	duration	duration	NOUN
bjp-823	178	16	of	of	ADP
bjp-823	178	17	treatment	treatment	NOUN
bjp-823	178	18	which	which	PRON
bjp-823	178	19	was	be	AUX
bjp-823	178	20	twice	twice	DET
bjp-823	178	21	that	that	PRON
bjp-823	178	22	of	of	ADP
bjp-823	178	23	the	the	DET
bjp-823	178	24	present	present	ADJ
bjp-823	178	25	study	study	NOUN
bjp-823	178	26	.	.	PUNCT
bjp-823	179	1	another	another	DET
bjp-823	179	2	study	study	NOUN
bjp-823	179	3	conducted	conduct	VERB
bjp-823	179	4	by	by	ADP
bjp-823	179	5	klosiewicz	klosiewicz	NOUN
bjp-823	179	6	-	-	PUNCT
bjp-823	179	7	latoszek	latoszek	PROPN
bjp-823	179	8	et	et	PROPN
bjp-823	179	9	al	al	PROPN
bjp-823	179	10	.	.	PROPN
bjp-823	179	11	(	(	PUNCT
bjp-823	179	12	2004	2004	NUM
bjp-823	179	13	)	)	PUNCT
bjp-823	179	14	on	on	ADP
bjp-823	179	15	fenofibrate	fenofibrate	NOUN
bjp-823	179	16	(	(	PUNCT
bjp-823	179	17	200	200	NUM
bjp-823	179	18	mg	mg	NOUN
bjp-823	179	19	)	)	PUNCT
bjp-823	179	20	administered	administer	VERB
bjp-823	179	21	with	with	ADP
bjp-823	179	22	simvastatin	simvastatin	NOUN
bjp-823	179	23	(	(	PUNCT
bjp-823	179	24	20	20	NUM
bjp-823	179	25	mg	mg	NOUN
bjp-823	179	26	)	)	PUNCT
bjp-823	179	27	therapy	therapy	NOUN
bjp-823	179	28	observed	observe	VERB
bjp-823	179	29	reduction	reduction	NOUN
bjp-823	179	30	of	of	ADP
bjp-823	179	31	total	total	ADJ
bjp-823	179	32	cholesterol	cholesterol	NOUN
bjp-823	179	33	,	,	PUNCT
bjp-823	179	34	triglyceride	triglyceride	ADV
bjp-823	179	35	and	and	CCONJ
bjp-823	179	36	ldl	ldl	NOUN
bjp-823	179	37	-	-	PUNCT
bjp-823	179	38	c	c	PROPN
bjp-823	179	39	and	and	CCONJ
bjp-823	179	40	increased	increase	VERB
bjp-823	179	41	hdl	hdl	PROPN
bjp-823	179	42	-c	-c	PUNCT
bjp-823	179	43	from	from	ADP
bjp-823	179	44	baseline	baseline	ADJ
bjp-823	179	45	level	level	NOUN
bjp-823	179	46	.	.	PUNCT
bjp-823	180	1	this	this	DET
bjp-823	180	2	study	study	NOUN
bjp-823	180	3	apparently	apparently	ADV
bjp-823	180	4	consistent	consistent	ADJ
bjp-823	180	5	with	with	ADP
bjp-823	180	6	the	the	DET
bjp-823	180	7	present	present	ADJ
bjp-823	180	8	study	study	NOUN
bjp-823	180	9	where	where	SCONJ
bjp-823	180	10	simvastatin	simvastatin	NOUN
bjp-823	180	11	(	(	PUNCT
bjp-823	180	12	20	20	NUM
bjp-823	180	13	mg	mg	NOUN
bjp-823	180	14	)	)	PUNCT
bjp-823	180	15	used	use	VERB
bjp-823	180	16	in	in	ADP
bjp-823	180	17	place	place	NOUN
bjp-823	180	18	of	of	ADP
bjp-823	180	19	atorvastatin	atorvastatin	NOUN
bjp-823	180	20	(	(	PUNCT
bjp-823	180	21	10	10	NUM
bjp-823	180	22	mg	mg	NUM
bjp-823	180	23	)	)	PUNCT
bjp-823	180	24	and	and	CCONJ
bjp-823	180	25	duration	duration	NOUN
bjp-823	180	26	of	of	ADP
bjp-823	180	27	treatment	treatment	NOUN
bjp-823	180	28	was	be	AUX
bjp-823	180	29	12	12	NUM
bjp-823	180	30	months	month	NOUN
bjp-823	180	31	.	.	PUNCT
bjp-823	181	1	according	accord	VERB
bjp-823	181	2	to	to	ADP
bjp-823	181	3	ncep	ncep	PROPN
bjp-823	181	4	atp	atp	PROPN
bjp-823	181	5	-	-	PUNCT
bjp-823	181	6	iii	iii	PROPN
bjp-823	181	7	and	and	CCONJ
bjp-823	181	8	most	most	ADV
bjp-823	181	9	recent	recent	ADJ
bjp-823	181	10	guidelines	guideline	NOUN
bjp-823	181	11	of	of	ADP
bjp-823	181	12	european	european	ADJ
bjp-823	181	13	society	society	NOUN
bjp-823	181	14	of	of	ADP
bjp-823	181	15	cardiology	cardiology	NOUN
bjp-823	181	16	recommended	recommend	VERB
bjp-823	181	17	that	that	DET
bjp-823	181	18	reduction	reduction	NOUN
bjp-823	181	19	of	of	ADP
bjp-823	181	20	ldl	ldl	NOUN
bjp-823	181	21	-	-	PUNCT
bjp-823	181	22	c	c	NOUN
bjp-823	181	23	by	by	ADP
bjp-823	181	24	statin	statin	ADJ
bjp-823	181	25	and	and	CCONJ
bjp-823	181	26	simultaneously	simultaneously	ADV
bjp-823	181	27	elevation	elevation	NOUN
bjp-823	181	28	of	of	ADP
bjp-823	181	29	hdl	hdl	PROPN
bjp-823	181	30	-	-	PUNCT
bjp-823	181	31	c	c	PROPN
bjp-823	181	32	by	by	ADP
bjp-823	181	33	niacin	niacin	NOUN
bjp-823	181	34	or	or	CCONJ
bjp-823	181	35	fibrate	fibrate	NOUN
bjp-823	181	36	contributes	contribute	VERB
bjp-823	181	37	to	to	ADP
bjp-823	181	38	prevention	prevention	NOUN
bjp-823	181	39	of	of	ADP
bjp-823	181	40	cardiovascular	cardiovascular	ADJ
bjp-823	181	41	disease	disease	NOUN
bjp-823	181	42	and	and	CCONJ
bjp-823	181	43	atheromatous	atheromatous	ADJ
bjp-823	181	44	lesions	lesion	NOUN
bjp-823	181	45	,	,	PUNCT
bjp-823	181	46	consequently	consequently	ADV
bjp-823	181	47	decrease	decrease	VERB
bjp-823	181	48	morbidity	morbidity	NOUN
bjp-823	181	49	and	and	CCONJ
bjp-823	181	50	mortality	mortality	NOUN
bjp-823	181	51	(	(	PUNCT
bjp-823	181	52	grundy	grundy	PROPN
bjp-823	181	53	et	et	PROPN
bjp-823	181	54	al	al	PROPN
bjp-823	181	55	.	.	PROPN
bjp-823	181	56	,	,	PUNCT
bjp-823	181	57	2004	2004	NUM
bjp-823	181	58	;	;	PUNCT
bjp-823	181	59	sirtori	sirtori	NOUN
bjp-823	181	60	,	,	PUNCT
bjp-823	181	61	2006	2006	NUM
bjp-823	181	62	)	)	PUNCT
bjp-823	181	63	.	.	PUNCT
bjp-823	182	1	regarding	regard	VERB
bjp-823	182	2	these	these	DET
bjp-823	182	3	two	two	NUM
bjp-823	182	4	parameters	parameter	NOUN
bjp-823	182	5	niacin	niacin	NOUN
bjp-823	182	6	-	-	PUNCT
bjp-823	182	7	atorvastatin	atorvastatin	PROPN
bjp-823	182	8	has	have	VERB
bjp-823	182	9	similar	similar	ADJ
bjp-823	182	10	effect	effect	NOUN
bjp-823	182	11	in	in	ADP
bjp-823	182	12	relation	relation	NOUN
bjp-823	182	13	to	to	ADP
bjp-823	182	14	fenofibrate	fenofibrate	NOUN
bjp-823	182	15	-	-	PUNCT
bjp-823	182	16	atorvastatin	atorvastatin	PROPN
bjp-823	182	17	combination	combination	NOUN
bjp-823	182	18	.	.	PUNCT
bjp-823	183	1	a	a	DET
bjp-823	183	2	study	study	NOUN
bjp-823	183	3	conducted	conduct	VERB
bjp-823	183	4	by	by	ADP
bjp-823	183	5	barter	barter	NOUN
bjp-823	183	6	and	and	CCONJ
bjp-823	183	7	rye	rye	PROPN
bjp-823	183	8	(	(	PUNCT
bjp-823	183	9	2006	2006	NUM
bjp-823	183	10	)	)	PUNCT
bjp-823	183	11	showed	show	VERB
bjp-823	183	12	that	that	SCONJ
bjp-823	183	13	an	an	DET
bjp-823	183	14	8	8	NUM
bjp-823	183	15	%	%	NOUN
bjp-823	183	16	increase	increase	NOUN
bjp-823	183	17	in	in	ADP
bjp-823	183	18	hdl	hdl	PROPN
bjp-823	183	19	-	-	PUNCT
bjp-823	183	20	c	c	PROPN
bjp-823	183	21	predicted	predict	VERB
bjp-823	183	22	a	a	DET
bjp-823	183	23	coronary	coronary	ADJ
bjp-823	183	24	heart	heart	NOUN
bjp-823	183	25	disease	disease	NOUN
bjp-823	183	26	risk	risk	NOUN
bjp-823	183	27	reduction	reduction	NOUN
bjp-823	183	28	of	of	ADP
bjp-823	183	29	23	23	NUM
bjp-823	183	30	%	%	NOUN
bjp-823	183	31	whereas	whereas	SCONJ
bjp-823	183	32	a	a	DET
bjp-823	183	33	7	7	NUM
bjp-823	183	34	%	%	NOUN
bjp-823	183	35	reduction	reduction	NOUN
bjp-823	183	36	in	in	ADP
bjp-823	183	37	ldl	ldl	NOUN
bjp-823	183	38	-	-	PUNCT
bjp-823	183	39	c	c	PROPN
bjp-823	183	40	predicted	predict	VERB
bjp-823	183	41	a	a	DET
bjp-823	183	42	15	15	NUM
bjp-823	183	43	%	%	NOUN
bjp-823	183	44	reduction	reduction	NOUN
bjp-823	183	45	in	in	ADP
bjp-823	183	46	bangladesh	bangladesh	PROPN
bjp-823	183	47	j	j	PROPN
bjp-823	183	48	pharmacol	pharmacol	PROPN
bjp-823	183	49	2008	2008	NUM
bjp-823	183	50	;	;	PUNCT
bjp-823	183	51	3	3	NUM
bjp-823	183	52	:	:	SYM
bjp-823	183	53	8	8	NUM
bjp-823	183	54	-	-	SYM
bjp-823	183	55	16	16	NUM
bjp-823	183	56	13	13	NUM
bjp-823	183	57	coronary	coronary	ADJ
bjp-823	183	58	heart	heart	NOUN
bjp-823	183	59	disease	disease	NOUN
bjp-823	183	60	events	event	NOUN
bjp-823	183	61	.	.	PUNCT
bjp-823	184	1	another	another	DET
bjp-823	184	2	study	study	NOUN
bjp-823	184	3	reported	report	VERB
bjp-823	184	4	by	by	ADP
bjp-823	184	5	gordon	gordon	PROPN
bjp-823	184	6	et	et	PROPN
bjp-823	184	7	al	al	PROPN
bjp-823	184	8	.	.	PROPN
bjp-823	185	1	(	(	PUNCT
bjp-823	185	2	1977	1977	NUM
bjp-823	185	3	)	)	PUNCT
bjp-823	185	4	suggests	suggest	VERB
bjp-823	185	5	that	that	SCONJ
bjp-823	185	6	a	a	DET
bjp-823	185	7	one	one	NUM
bjp-823	185	8	percent	percent	NOUN
bjp-823	185	9	increment	increment	NOUN
bjp-823	185	10	in	in	ADP
bjp-823	185	11	hdl	hdl	PROPN
bjp-823	185	12	-	-	PUNCT
bjp-823	185	13	c	c	PROPN
bjp-823	185	14	equated	equate	VERB
bjp-823	185	15	with	with	ADP
bjp-823	185	16	a	a	DET
bjp-823	185	17	1	1	NUM
bjp-823	185	18	%	%	NOUN
bjp-823	185	19	lowering	lowering	NOUN
bjp-823	185	20	of	of	ADP
bjp-823	185	21	cardiovascular	cardiovascular	ADJ
bjp-823	185	22	risk	risk	NOUN
bjp-823	185	23	.	.	PUNCT
bjp-823	186	1	in	in	ADP
bjp-823	186	2	our	our	PRON
bjp-823	186	3	study	study	NOUN
bjp-823	186	4	niacin	niacin	NOUN
bjp-823	186	5	-	-	PUNCT
bjp-823	186	6	atorvastatin	atorvastatin	NOUN
bjp-823	186	7	treated	treat	VERB
bjp-823	186	8	subjects	subject	NOUN
bjp-823	186	9	exhibit	exhibit	VERB
bjp-823	186	10	some	some	DET
bjp-823	186	11	adverse	adverse	ADJ
bjp-823	186	12	effects	effect	NOUN
bjp-823	186	13	such	such	ADJ
bjp-823	186	14	as	as	ADP
bjp-823	186	15	,	,	PUNCT
bjp-823	186	16	transient	transient	ADJ
bjp-823	186	17	flushing	flushing	NOUN
bjp-823	186	18	,	,	PUNCT
bjp-823	186	19	headache	headache	NOUN
bjp-823	186	20	,	,	PUNCT
bjp-823	186	21	fatigue	fatigue	NOUN
bjp-823	186	22	and	and	CCONJ
bjp-823	186	23	abdominal	abdominal	ADJ
bjp-823	186	24	pain	pain	NOUN
bjp-823	186	25	.	.	PUNCT
bjp-823	187	1	in	in	ADP
bjp-823	187	2	addition	addition	NOUN
bjp-823	187	3	,	,	PUNCT
bjp-823	187	4	this	this	DET
bjp-823	187	5	group	group	NOUN
bjp-823	187	6	did	do	AUX
bjp-823	187	7	not	not	PART
bjp-823	187	8	experience	experience	VERB
bjp-823	187	9	either	either	CCONJ
bjp-823	187	10	myalgia	myalgia	NOUN
bjp-823	187	11	or	or	CCONJ
bjp-823	187	12	dyspepsia	dyspepsia	NOUN
bjp-823	187	13	.	.	PUNCT
bjp-823	188	1	in	in	ADP
bjp-823	188	2	the	the	DET
bjp-823	188	3	study	study	NOUN
bjp-823	188	4	conducted	conduct	VERB
bjp-823	188	5	by	by	ADP
bjp-823	188	6	millers	miller	NOUN
bjp-823	188	7	,	,	PUNCT
bjp-823	188	8	(	(	PUNCT
bjp-823	188	9	2003	2003	NUM
bjp-823	188	10	)	)	PUNCT
bjp-823	188	11	,	,	PUNCT
bjp-823	188	12	the	the	DET
bjp-823	188	13	incidence	incidence	NOUN
bjp-823	188	14	of	of	ADP
bjp-823	188	15	flushing	flush	VERB
bjp-823	188	16	was	be	AUX
bjp-823	188	17	10	10	NUM
bjp-823	188	18	%	%	NOUN
bjp-823	188	19	,	,	PUNCT
bjp-823	188	20	which	which	PRON
bjp-823	188	21	was	be	AUX
bjp-823	188	22	almost	almost	ADV
bjp-823	188	23	similar	similar	ADJ
bjp-823	188	24	to	to	ADP
bjp-823	188	25	the	the	DET
bjp-823	188	26	present	present	ADJ
bjp-823	188	27	observation	observation	NOUN
bjp-823	188	28	and	and	CCONJ
bjp-823	188	29	mediated	mediate	VERB
bjp-823	188	30	by	by	ADP
bjp-823	188	31	pgd2	pgd2	PROPN
bjp-823	188	32	.	.	PUNCT
bjp-823	189	1	millers	miller	NOUN
bjp-823	189	2	,	,	PUNCT
bjp-823	189	3	(	(	PUNCT
bjp-823	189	4	2003	2003	NUM
bjp-823	189	5	)	)	PUNCT
bjp-823	189	6	also	also	ADV
bjp-823	189	7	reported	report	VERB
bjp-823	189	8	that	that	SCONJ
bjp-823	189	9	there	there	PRON
bjp-823	189	10	was	be	VERB
bjp-823	189	11	no	no	DET
bjp-823	189	12	complaints	complaint	NOUN
bjp-823	189	13	of	of	ADP
bjp-823	189	14	myopathy	myopathy	ADJ
bjp-823	189	15	and	and	CCONJ
bjp-823	189	16	0.5	0.5	NUM
bjp-823	189	17	%	%	NOUN
bjp-823	189	18	of	of	ADP
bjp-823	189	19	patients	patient	NOUN
bjp-823	189	20	had	have	AUX
bjp-823	189	21	increased	increase	VERB
bjp-823	189	22	aminotransferase	aminotransferase	NOUN
bjp-823	189	23	level	level	NOUN
bjp-823	189	24	three	three	NUM
bjp-823	189	25	times	time	NOUN
bjp-823	189	26	more	more	ADJ
bjp-823	189	27	than	than	ADP
bjp-823	189	28	the	the	DET
bjp-823	189	29	upper	upper	ADJ
bjp-823	189	30	limit	limit	NOUN
bjp-823	189	31	of	of	ADP
bjp-823	189	32	normal	normal	ADJ
bjp-823	189	33	.	.	PUNCT
bjp-823	190	1	the	the	DET
bjp-823	190	2	present	present	ADJ
bjp-823	190	3	study	study	NOUN
bjp-823	190	4	differs	differ	VERB
bjp-823	190	5	from	from	ADP
bjp-823	190	6	miller	miller	PROPN
bjp-823	190	7	,	,	PUNCT
bjp-823	190	8	(	(	PUNCT
bjp-823	190	9	2003	2003	NUM
bjp-823	190	10	)	)	PUNCT
bjp-823	190	11	where	where	SCONJ
bjp-823	190	12	there	there	PRON
bjp-823	190	13	was	be	VERB
bjp-823	190	14	neither	neither	CCONJ
bjp-823	190	15	significant	significant	ADJ
bjp-823	190	16	increment	increment	NOUN
bjp-823	190	17	of	of	ADP
bjp-823	190	18	aminotransferase	aminotransferase	NOUN
bjp-823	190	19	nor	nor	CCONJ
bjp-823	190	20	any	any	DET
bjp-823	190	21	sorts	sort	NOUN
bjp-823	190	22	of	of	ADP
bjp-823	190	23	clinical	clinical	ADJ
bjp-823	190	24	events	event	NOUN
bjp-823	190	25	.	.	PUNCT
bjp-823	191	1	fenofibrate	fenofibrate	NOUN
bjp-823	191	2	in	in	ADP
bjp-823	191	3	combination	combination	NOUN
bjp-823	191	4	with	with	ADP
bjp-823	191	5	atorvastatin	atorvastatin	PROPN
bjp-823	191	6	treated	treat	VERB
bjp-823	191	7	group	group	NOUN
bjp-823	191	8	complaints	complaint	NOUN
bjp-823	191	9	of	of	ADP
bjp-823	191	10	headache	headache	NOUN
bjp-823	191	11	,	,	PUNCT
bjp-823	191	12	fatigue	fatigue	NOUN
bjp-823	191	13	,	,	PUNCT
bjp-823	191	14	abdominal	abdominal	ADJ
bjp-823	191	15	pain	pain	NOUN
bjp-823	191	16	,	,	PUNCT
bjp-823	191	17	dyspepsia	dyspepsia	NOUN
bjp-823	191	18	and	and	CCONJ
bjp-823	191	19	myalgia	myalgia	NOUN
bjp-823	191	20	.	.	PUNCT
bjp-823	192	1	however	however	ADV
bjp-823	192	2	,	,	PUNCT
bjp-823	192	3	flushing	flush	VERB
bjp-823	192	4	was	be	AUX
bjp-823	192	5	not	not	PART
bjp-823	192	6	observed	observe	VERB
bjp-823	192	7	in	in	ADP
bjp-823	192	8	this	this	DET
bjp-823	192	9	study	study	NOUN
bjp-823	192	10	group	group	NOUN
bjp-823	192	11	.	.	PUNCT
bjp-823	193	1	davidson	davidson	PROPN
bjp-823	193	2	,	,	PUNCT
bjp-823	193	3	(	(	PUNCT
bjp-823	193	4	2003	2003	NUM
bjp-823	193	5	)	)	PUNCT
bjp-823	193	6	observed	observe	VERB
bjp-823	193	7	that	that	SCONJ
bjp-823	193	8	long	long	ADJ
bjp-823	193	9	duration	duration	NOUN
bjp-823	193	10	of	of	ADP
bjp-823	193	11	treatment	treatment	NOUN
bjp-823	193	12	by	by	ADP
bjp-823	193	13	fenofibrate	fenofibrate	NOUN
bjp-823	193	14	with	with	ADP
bjp-823	193	15	high	high	ADJ
bjp-823	193	16	dose	dose	PROPN
bjp-823	193	17	of	of	ADP
bjp-823	193	18	statin	statin	PROPN
bjp-823	193	19	combination	combination	NOUN
bjp-823	193	20	causes	cause	VERB
bjp-823	193	21	myopathy	myopathy	ADJ
bjp-823	193	22	and	and	CCONJ
bjp-823	193	23	rhabdomyolysis	rhabdomyolysis	NOUN
bjp-823	193	24	.	.	PUNCT
bjp-823	194	1	there	there	PRON
bjp-823	194	2	was	be	VERB
bjp-823	194	3	a	a	DET
bjp-823	194	4	significant	significant	ADJ
bjp-823	194	5	difference	difference	NOUN
bjp-823	194	6	of	of	ADP
bjp-823	194	7	serum	serum	NOUN
bjp-823	194	8	creatinine	creatinine	NOUN
bjp-823	194	9	level	level	NOUN
bjp-823	194	10	after	after	ADP
bjp-823	194	11	12	12	NUM
bjp-823	194	12	weeks	week	NOUN
bjp-823	194	13	of	of	ADP
bjp-823	194	14	treatment	treatment	NOUN
bjp-823	194	15	with	with	ADP
bjp-823	194	16	niacin	niacin	NOUN
bjp-823	194	17	-	-	PUNCT
bjp-823	194	18	atorvastatin	atorvastatin	NOUN
bjp-823	194	19	while	while	SCONJ
bjp-823	194	20	no	no	DET
bjp-823	194	21	significant	significant	ADJ
bjp-823	194	22	difference	difference	NOUN
bjp-823	194	23	was	be	AUX
bjp-823	194	24	observed	observe	VERB
bjp-823	194	25	in	in	ADP
bjp-823	194	26	fenofibrate	fenofibrate	NOUN
bjp-823	194	27	-	-	PUNCT
bjp-823	194	28	atorvastatin	atorvastatin	PROPN
bjp-823	194	29	.	.	PUNCT
bjp-823	195	1	however	however	ADV
bjp-823	195	2	,	,	PUNCT
bjp-823	195	3	this	this	DET
bjp-823	195	4	change	change	NOUN
bjp-823	195	5	was	be	AUX
bjp-823	195	6	within	within	ADP
bjp-823	195	7	normal	normal	ADJ
bjp-823	195	8	limit	limit	NOUN
bjp-823	195	9	.	.	PUNCT
bjp-823	196	1	after	after	ADP
bjp-823	196	2	12	12	NUM
bjp-823	196	3	weeks	week	NOUN
bjp-823	196	4	of	of	ADP
bjp-823	196	5	treatment	treatment	NOUN
bjp-823	196	6	neither	neither	PRON
bjp-823	196	7	of	of	ADP
bjp-823	196	8	the	the	DET
bjp-823	196	9	treated	treat	VERB
bjp-823	196	10	group	group	NOUN
bjp-823	196	11	shows	show	VERB
bjp-823	196	12	any	any	DET
bjp-823	196	13	significant	significant	ADJ
bjp-823	196	14	increment	increment	NOUN
bjp-823	196	15	of	of	ADP
bjp-823	196	16	plasma	plasma	NOUN
bjp-823	196	17	glucose	glucose	NOUN
bjp-823	196	18	level	level	NOUN
bjp-823	196	19	.	.	PUNCT
bjp-823	197	1	this	this	DET
bjp-823	197	2	study	study	NOUN
bjp-823	197	3	also	also	ADV
bjp-823	197	4	analyzed	analyze	VERB
bjp-823	197	5	serum	serum	NOUN
bjp-823	197	6	alanine	alanine	NOUN
bjp-823	197	7	aminotransferase	aminotransferase	PROPN
bjp-823	197	8	to	to	PART
bjp-823	197	9	assess	assess	VERB
bjp-823	197	10	liver	liver	NOUN
bjp-823	197	11	function	function	NOUN
bjp-823	197	12	test	test	NOUN
bjp-823	197	13	in	in	ADP
bjp-823	197	14	both	both	DET
bjp-823	197	15	groups	group	NOUN
bjp-823	197	16	.	.	PUNCT
bjp-823	198	1	persistent	persistent	ADJ
bjp-823	198	2	elevation	elevation	NOUN
bjp-823	198	3	of	of	ADP
bjp-823	198	4	alt	alt	ADJ
bjp-823	198	5	,	,	PUNCT
bjp-823	198	6	three	three	NUM
bjp-823	198	7	times	time	NOUN
bjp-823	198	8	higher	high	ADJ
bjp-823	198	9	than	than	ADP
bjp-823	198	10	the	the	DET
bjp-823	198	11	upper	upper	ADJ
bjp-823	198	12	limit	limit	NOUN
bjp-823	198	13	of	of	ADP
bjp-823	198	14	normal	normal	ADJ
bjp-823	198	15	is	be	AUX
bjp-823	198	16	considered	consider	VERB
bjp-823	198	17	clinically	clinically	ADV
bjp-823	198	18	important	important	ADJ
bjp-823	198	19	(	(	PUNCT
bjp-823	198	20	illingworth	illingworth	PROPN
bjp-823	198	21	et	et	PROPN
bjp-823	198	22	al	al	PROPN
bjp-823	198	23	.	.	PROPN
bjp-823	198	24	,	,	PUNCT
bjp-823	198	25	2001	2001	NUM
bjp-823	198	26	)	)	PUNCT
bjp-823	198	27	.	.	PUNCT
bjp-823	199	1	the	the	DET
bjp-823	199	2	present	present	ADJ
bjp-823	199	3	study	study	NOUN
bjp-823	199	4	showed	show	VERB
bjp-823	199	5	that	that	SCONJ
bjp-823	199	6	after	after	ADP
bjp-823	199	7	completion	completion	NOUN
bjp-823	199	8	of	of	ADP
bjp-823	199	9	niacin	niacin	NOUN
bjp-823	199	10	-	-	PUNCT
bjp-823	199	11	atorvastatin	atorvastatin	NOUN
bjp-823	199	12	treatment	treatment	NOUN
bjp-823	199	13	,	,	PUNCT
bjp-823	199	14	there	there	PRON
bjp-823	199	15	was	be	VERB
bjp-823	199	16	no	no	DET
bjp-823	199	17	significant	significant	ADJ
bjp-823	199	18	difference	difference	NOUN
bjp-823	199	19	in	in	ADP
bjp-823	199	20	sgpt	sgpt	NOUN
bjp-823	199	21	level	level	NOUN
bjp-823	199	22	.	.	PUNCT
bjp-823	200	1	but	but	CCONJ
bjp-823	200	2	sgpt	sgpt	NOUN
bjp-823	200	3	level	level	NOUN
bjp-823	200	4	was	be	AUX
bjp-823	200	5	significantly	significantly	ADV
bjp-823	200	6	increased	increase	VERB
bjp-823	200	7	in	in	ADP
bjp-823	200	8	fenofibrate	fenofibrate	NOUN
bjp-823	200	9	-	-	PUNCT
bjp-823	200	10	atorvastatin	atorvastatin	PROPN
bjp-823	200	11	treated	treat	VERB
bjp-823	200	12	group	group	NOUN
bjp-823	200	13	.	.	PUNCT
bjp-823	201	1	adverse	adverse	ADJ
bjp-823	201	2	effect	effect	NOUN
bjp-823	201	3	did	do	AUX
bjp-823	201	4	not	not	PART
bjp-823	201	5	require	require	VERB
bjp-823	201	6	withdrawal	withdrawal	NOUN
bjp-823	201	7	of	of	ADP
bjp-823	201	8	drugs	drug	NOUN
bjp-823	201	9	in	in	ADP
bjp-823	201	10	any	any	DET
bjp-823	201	11	group	group	NOUN
bjp-823	201	12	.	.	PUNCT
bjp-823	202	1	but	but	CCONJ
bjp-823	202	2	significantly	significantly	ADV
bjp-823	202	3	raised	raise	VERB
bjp-823	202	4	sgpt	sgpt	NOUN
bjp-823	202	5	level	level	NOUN
bjp-823	202	6	in	in	ADP
bjp-823	202	7	fenofibrate	fenofibrate	NOUN
bjp-823	202	8	-	-	PUNCT
bjp-823	202	9	atorvastatin	atorvastatin	NOUN
bjp-823	202	10	combination	combination	NOUN
bjp-823	202	11	implies	imply	VERB
bjp-823	202	12	that	that	SCONJ
bjp-823	202	13	monitoring	monitoring	NOUN
bjp-823	202	14	of	of	ADP
bjp-823	202	15	liver	liver	NOUN
bjp-823	202	16	function	function	NOUN
bjp-823	202	17	should	should	AUX
bjp-823	202	18	be	be	AUX
bjp-823	202	19	done	do	VERB
bjp-823	202	20	to	to	PART
bjp-823	202	21	assess	assess	VERB
bjp-823	202	22	hepatic	hepatic	ADJ
bjp-823	202	23	impairment	impairment	NOUN
bjp-823	202	24	with	with	ADP
bjp-823	202	25	this	this	DET
bjp-823	202	26	regimen	regiman	NOUN
bjp-823	202	27	.	.	PUNCT
bjp-823	203	1	this	this	DET
bjp-823	203	2	study	study	NOUN
bjp-823	203	3	suggests	suggest	VERB
bjp-823	203	4	that	that	SCONJ
bjp-823	203	5	both	both	DET
bjp-823	203	6	combinations	combination	NOUN
bjp-823	203	7	are	be	AUX
bjp-823	203	8	equally	equally	ADV
bjp-823	203	9	effective	effective	ADJ
bjp-823	203	10	in	in	ADP
bjp-823	203	11	dyslipidemia	dyslipidemia	NOUN
bjp-823	203	12	.	.	PUNCT
bjp-823	204	1	although	although	SCONJ
bjp-823	204	2	,	,	PUNCT
bjp-823	204	3	fenofibrateatorvastatin	fenofibrateatorvastatin	NOUN
bjp-823	204	4	combination	combination	NOUN
bjp-823	204	5	decreased	decrease	VERB
bjp-823	204	6	more	more	ADV
bjp-823	204	7	triglyceride	triglyceride	ADP
bjp-823	204	8	level	level	NOUN
bjp-823	204	9	and	and	CCONJ
bjp-823	204	10	niacin	niacin	NOUN
bjp-823	204	11	-	-	PUNCT
bjp-823	204	12	atorvastatin	atorvastatin	NOUN
bjp-823	204	13	combination	combination	NOUN
bjp-823	204	14	appeared	appear	VERB
bjp-823	204	15	safer	safe	ADJ
bjp-823	204	16	considering	consider	VERB
bjp-823	204	17	some	some	DET
bjp-823	204	18	adverse	adverse	ADJ
bjp-823	204	19	effects	effect	NOUN
bjp-823	204	20	.	.	PUNCT
bjp-823	205	1	conclusion	conclusion	NOUN
bjp-823	205	2	this	this	DET
bjp-823	205	3	study	study	NOUN
bjp-823	205	4	was	be	AUX
bjp-823	205	5	conducted	conduct	VERB
bjp-823	205	6	on	on	ADP
bjp-823	205	7	a	a	DET
bjp-823	205	8	small	small	ADJ
bjp-823	205	9	number	number	NOUN
bjp-823	205	10	of	of	ADP
bjp-823	205	11	patients	patient	NOUN
bjp-823	205	12	,	,	PUNCT
bjp-823	205	13	in	in	ADP
bjp-823	205	14	a	a	DET
bjp-823	205	15	single	single	ADJ
bjp-823	205	16	center	center	NOUN
bjp-823	205	17	and	and	CCONJ
bjp-823	205	18	follow	follow	VERB
bjp-823	205	19	-	-	PUNCT
bjp-823	205	20	up	up	NOUN
bjp-823	205	21	was	be	AUX
bjp-823	205	22	limited	limit	VERB
bjp-823	205	23	for	for	ADP
bjp-823	205	24	12	12	NUM
bjp-823	205	25	weeks	week	NOUN
bjp-823	205	26	only	only	ADV
bjp-823	205	27	.	.	PUNCT
bjp-823	206	1	as	as	SCONJ
bjp-823	206	2	the	the	DET
bjp-823	206	3	trial	trial	NOUN
bjp-823	206	4	duration	duration	NOUN
bjp-823	206	5	was	be	AUX
bjp-823	206	6	short	short	ADJ
bjp-823	206	7	,	,	PUNCT
bjp-823	206	8	analysis	analysis	NOUN
bjp-823	206	9	of	of	ADP
bjp-823	206	10	long	long	ADJ
bjp-823	206	11	-	-	PUNCT
bjp-823	206	12	term	term	NOUN
bjp-823	206	13	effects	effect	NOUN
bjp-823	206	14	and	and	CCONJ
bjp-823	206	15	safety	safety	NOUN
bjp-823	206	16	was	be	AUX
bjp-823	206	17	not	not	PART
bjp-823	206	18	possible	possible	ADJ
bjp-823	206	19	.	.	PUNCT
bjp-823	207	1	other	other	ADJ
bjp-823	207	2	limitations	limitation	NOUN
bjp-823	207	3	were	be	AUX
bjp-823	207	4	lack	lack	NOUN
bjp-823	207	5	of	of	ADP
bjp-823	207	6	randomization	randomization	NOUN
bjp-823	207	7	and	and	CCONJ
bjp-823	207	8	matching	matching	NOUN
bjp-823	207	9	of	of	ADP
bjp-823	207	10	sex	sex	NOUN
bjp-823	207	11	in	in	ADP
bjp-823	207	12	female	female	NOUN
bjp-823	207	13	as	as	ADP
bjp-823	207	14	a	a	DET
bjp-823	207	15	risk	risk	NOUN
bjp-823	207	16	factor	factor	NOUN
bjp-823	207	17	.	.	PUNCT
bjp-823	208	1	assessment	assessment	NOUN
bjp-823	208	2	of	of	ADP
bjp-823	208	3	creatinine	creatinine	NOUN
bjp-823	208	4	phosphokinase	phosphokinase	NOUN
bjp-823	208	5	level	level	NOUN
bjp-823	208	6	for	for	ADP
bjp-823	208	7	evaluation	evaluation	NOUN
bjp-823	208	8	of	of	ADP
bjp-823	208	9	muscle	muscle	NOUN
bjp-823	208	10	related	relate	VERB
bjp-823	208	11	adverse	adverse	ADJ
bjp-823	208	12	events	event	NOUN
bjp-823	208	13	was	be	AUX
bjp-823	208	14	not	not	PART
bjp-823	208	15	done	do	VERB
bjp-823	208	16	in	in	ADP
bjp-823	208	17	this	this	DET
bjp-823	208	18	study	study	NOUN
bjp-823	208	19	.	.	PUNCT
bjp-823	209	1	this	this	DET
bjp-823	209	2	study	study	NOUN
bjp-823	209	3	needs	need	VERB
bjp-823	209	4	further	further	ADJ
bjp-823	209	5	extensive	extensive	ADJ
bjp-823	209	6	investigation	investigation	NOUN
bjp-823	209	7	with	with	ADP
bjp-823	209	8	randomized	randomized	ADJ
bjp-823	209	9	double	double	ADJ
bjp-823	209	10	blind	blind	ADJ
bjp-823	209	11	,	,	PUNCT
bjp-823	209	12	multicentre	multicentre	NOUN
bjp-823	209	13	trials	trial	NOUN
bjp-823	209	14	with	with	ADP
bjp-823	209	15	different	different	ADJ
bjp-823	209	16	dose	dose	NOUN
bjp-823	209	17	schedule	schedule	NOUN
bjp-823	209	18	and	and	CCONJ
bjp-823	209	19	different	different	ADJ
bjp-823	209	20	combination	combination	NOUN
bjp-823	209	21	for	for	ADP
bjp-823	209	22	better	well	ADJ
bjp-823	209	23	assessment	assessment	NOUN
bjp-823	209	24	of	of	ADP
bjp-823	209	25	long	long	ADJ
bjp-823	209	26	-	-	PUNCT
bjp-823	209	27	term	term	NOUN
bjp-823	209	28	effects	effect	NOUN
bjp-823	209	29	and	and	CCONJ
bjp-823	209	30	safety	safety	NOUN
bjp-823	209	31	profile	profile	NOUN
bjp-823	209	32	.	.	PUNCT
bjp-823	210	1	references	reference	NOUN
bjp-823	210	2	athyros	athyros	VERB
bjp-823	210	3	vg	vg	ADP
bjp-823	210	4	,	,	PUNCT
bjp-823	210	5	papageorgiou	papageorgiou	NOUN
bjp-823	210	6	aa	aa	NOUN
bjp-823	210	7	,	,	PUNCT
bjp-823	210	8	athyrou	athyrou	NOUN
bjp-823	210	9	vv	vv	NOUN
bjp-823	210	10	,	,	PUNCT
bjp-823	210	11	demitriadis	demitriadi	NOUN
bjp-823	210	12	ds	ds	PROPN
bjp-823	210	13	,	,	PUNCT
bjp-823	210	14	kontopoulos	kontopoulos	PROPN
bjp-823	210	15	ag	ag	PROPN
bjp-823	210	16	.	.	PROPN
bjp-823	210	17	atorvastatin	atorvastatin	PROPN
bjp-823	210	18	and	and	CCONJ
bjp-823	210	19	micronized	micronized	ADJ
bjp-823	210	20	fenofibrate	fenofibrate	NOUN
bjp-823	210	21	alone	alone	ADV
bjp-823	210	22	and	and	CCONJ
bjp-823	210	23	in	in	ADP
bjp-823	210	24	combination	combination	NOUN
bjp-823	210	25	in	in	ADP
bjp-823	210	26	type	type	NOUN
bjp-823	210	27	2	2	NUM
bjp-823	210	28	diabetes	diabetes	NOUN
bjp-823	210	29	with	with	ADP
bjp-823	210	30	combined	combined	ADJ
bjp-823	210	31	hyperlipidemia	hyperlipidemia	NOUN
bjp-823	210	32	.	.	PUNCT
bjp-823	211	1	diabetic	diabetic	ADJ
bjp-823	211	2	care	care	NOUN
bjp-823	211	3	2002	2002	NUM
bjp-823	211	4	;	;	PUNCT
bjp-823	211	5	25	25	NUM
bjp-823	211	6	:	:	SYM
bjp-823	211	7	1198	1198	NUM
bjp-823	211	8	-	-	SYM
bjp-823	211	9	1202	1202	NUM
bjp-823	211	10	.	.	PUNCT
bjp-823	212	1	http://	http://	PROPN
bjp-823	212	2	dx.doi.org/10.2337/diacare.25.7.1198	dx.doi.org/10.2337/diacare.25.7.1198	PROPN
bjp-823	212	3	barter	barter	PROPN
bjp-823	212	4	pj	pj	PROPN
bjp-823	212	5	,	,	PUNCT
bjp-823	212	6	rye	rye	PROPN
bjp-823	212	7	ka	ka	PROPN
bjp-823	212	8	.	.	PROPN
bjp-823	212	9	cardioprotective	cardioprotective	ADJ
bjp-823	212	10	properties	property	NOUN
bjp-823	212	11	of	of	ADP
bjp-823	212	12	fibrates	fibrate	NOUN
bjp-823	212	13	;	;	PUNCT
bjp-823	212	14	which	which	PRON
bjp-823	212	15	fibrate	fibrate	VERB
bjp-823	212	16	,	,	PUNCT
bjp-823	212	17	which	which	PRON
bjp-823	212	18	patients	patient	NOUN
bjp-823	212	19	,	,	PUNCT
bjp-823	212	20	what	what	DET
bjp-823	212	21	mechanism	mechanism	NOUN
bjp-823	212	22	?	?	PUNCT
bjp-823	213	1	circulation	circulation	NOUN
bjp-823	213	2	2006	2006	NUM
bjp-823	213	3	;	;	PUNCT
bjp-823	213	4	113	113	NUM
bjp-823	213	5	:	:	PUNCT
bjp-823	213	6	1553	1553	NUM
bjp-823	213	7	-	-	SYM
bjp-823	213	8	55	55	NUM
bjp-823	213	9	.	.	PUNCT
bjp-823	214	1	http://dx.doi.org/10.1161/	http://dx.doi.org/10.1161/	PROPN
bjp-823	214	2	circulationaha.105.620450	circulationaha.105.620450	PRON
bjp-823	214	3	bovet	bovet	NOUN
bjp-823	214	4	p	p	NOUN
bjp-823	214	5	,	,	PUNCT
bjp-823	214	6	shamlaye	shamlaye	VERB
bjp-823	214	7	c	c	PROPN
bjp-823	214	8	,	,	PUNCT
bjp-823	214	9	gabriel	gabriel	PROPN
bjp-823	214	10	a	a	PROPN
bjp-823	214	11	,	,	PUNCT
bjp-823	214	12	riesen	riesen	PROPN
bjp-823	214	13	w	w	PROPN
bjp-823	214	14	,	,	PUNCT
bjp-823	214	15	paccaud	paccaud	NOUN
bjp-823	214	16	f.	f.	NOUN
bjp-823	214	17	prevalence	prevalence	NOUN
bjp-823	214	18	of	of	ADP
bjp-823	214	19	cardiovascular	cardiovascular	ADJ
bjp-823	214	20	risk	risk	NOUN
bjp-823	214	21	factors	factor	NOUN
bjp-823	214	22	in	in	ADP
bjp-823	214	23	a	a	DET
bjp-823	214	24	middle	middle	ADJ
bjp-823	214	25	-	-	PUNCT
bjp-823	214	26	income	income	NOUN
bjp-823	214	27	country	country	NOUN
bjp-823	214	28	and	and	CCONJ
bjp-823	214	29	estimated	estimate	VERB
bjp-823	214	30	cost	cost	NOUN
bjp-823	214	31	of	of	ADP
bjp-823	214	32	a	a	DET
bjp-823	214	33	treatment	treatment	NOUN
bjp-823	214	34	strategy	strategy	NOUN
bjp-823	214	35	.	.	PUNCT
bjp-823	215	1	bmc	bmc	ADJ
bjp-823	215	2	public	public	ADJ
bjp-823	215	3	health	health	NOUN
bjp-823	215	4	2006	2006	NUM
bjp-823	215	5	;	;	PUNCT
bjp-823	215	6	6	6	NUM
bjp-823	215	7	:	:	SYM
bjp-823	215	8	9	9	NUM
bjp-823	215	9	.	.	X
bjp-823	215	10	http://dx.doi.org/10.1186/14712458-6-9	http://dx.doi.org/10.1186/14712458-6-9	NOUN
bjp-823	215	11	bruckert	bruckert	PROPN
bjp-823	215	12	e.	e.	PROPN
bjp-823	215	13	epidemiology	epidemiology	PROPN
bjp-823	215	14	of	of	ADP
bjp-823	215	15	low	low	ADJ
bjp-823	215	16	hdl	hdl	NOUN
bjp-823	215	17	-	-	PUNCT
bjp-823	215	18	cholesterol	cholesterol	NOUN
bjp-823	215	19	:	:	PUNCT
bjp-823	215	20	results	result	NOUN
bjp-823	215	21	of	of	ADP
bjp-823	215	22	studies	study	NOUN
bjp-823	215	23	and	and	CCONJ
bjp-823	215	24	surveys	survey	NOUN
bjp-823	215	25	.	.	PUNCT
bjp-823	216	1	eur	eur	PROPN
bjp-823	216	2	heart	heart	NOUN
bjp-823	216	3	j	j	PROPN
bjp-823	216	4	suppl	suppl	PROPN
bjp-823	216	5	.	.	PUNCT
bjp-823	217	1	2006	2006	NUM
bjp-823	217	2	;	;	PUNCT
bjp-823	217	3	8f	8f	NUM
bjp-823	217	4	:	:	PUNCT
bjp-823	217	5	17	17	NUM
bjp-823	217	6	-	-	SYM
bjp-823	217	7	22	22	NUM
bjp-823	217	8	.	.	PUNCT
bjp-823	218	1	http://dx.doi.org/10.1093/eurheartj/sul036	http://dx.doi.org/10.1093/eurheartj/sul036	PROPN
bjp-823	218	2	chapman	chapman	PROPN
bjp-823	218	3	mj	mj	PROPN
bjp-823	218	4	,	,	PUNCT
bjp-823	218	5	assmann	assmann	PROPN
bjp-823	218	6	g	g	PROPN
bjp-823	218	7	,	,	PUNCT
bjp-823	218	8	fruchart	fruchart	PROPN
bjp-823	218	9	jc	jc	PROPN
bjp-823	218	10	.	.	PROPN
bjp-823	218	11	raising	raise	VERB
bjp-823	218	12	high	high	ADJ
bjp-823	218	13	-	-	PUNCT
bjp-823	218	14	density	density	NOUN
bjp-823	218	15	cholesterol	cholesterol	NOUN
bjp-823	218	16	with	with	ADP
bjp-823	218	17	reduction	reduction	NOUN
bjp-823	218	18	of	of	ADP
bjp-823	218	19	cardiovascular	cardiovascular	ADJ
bjp-823	218	20	risk	risk	NOUN
bjp-823	218	21	:	:	PUNCT
bjp-823	218	22	the	the	DET
bjp-823	218	23	role	role	NOUN
bjp-823	218	24	of	of	ADP
bjp-823	218	25	nicotinic	nicotinic	ADJ
bjp-823	218	26	acida	acida	NOUN
bjp-823	218	27	position	position	NOUN
bjp-823	218	28	paper	paper	NOUN
bjp-823	218	29	development	development	NOUN
bjp-823	218	30	by	by	ADP
bjp-823	218	31	the	the	DET
bjp-823	218	32	european	european	PROPN
bjp-823	218	33	consensus	consensus	PROPN
bjp-823	218	34	panel	panel	NOUN
bjp-823	218	35	on	on	ADP
bjp-823	218	36	hdl	hdl	PROPN
bjp-823	218	37	-	-	PUNCT
bjp-823	218	38	c.	c.	PROPN
bjp-823	218	39	curr	curr	PROPN
bjp-823	218	40	med	med	PROPN
bjp-823	218	41	res	re	NOUN
bjp-823	218	42	opin	opin	NOUN
bjp-823	218	43	.	.	PUNCT
bjp-823	219	1	2	2	NUM
bjp-823	219	2	0	0	NUM
bjp-823	219	3	0	0	NUM
bjp-823	219	4	4	4	NUM
bjp-823	219	5	;	;	PUNCT
bjp-823	219	6	2	2	NUM
bjp-823	219	7	0	0	NUM
bjp-823	219	8	:	:	SYM
bjp-823	219	9	1	1	NUM
bjp-823	219	10	2	2	NUM
bjp-823	219	11	5	5	NUM
bjp-823	219	12	3	3	NUM
bjp-823	219	13	6	6	NUM
bjp-823	219	14	8	8	NUM
bjp-823	219	15	.	.	PUNCT
bjp-823	220	1	h	h	PROPN
bjp-823	220	2	t	t	PROPN
bjp-823	220	3	t	t	PROPN
bjp-823	220	4	p	p	X
bjp-823	220	5	:	:	PUNCT
bjp-823	220	6	/	/	SYM
bjp-823	220	7	/	/	SYM
bjp-823	220	8	dx.doi.org/10.1185/030079904125004402	dx.doi.org/10.1185/030079904125004402	NOUN
bjp-823	220	9	chockalingam	chockalingam	VERB
bjp-823	220	10	a	a	PRON
bjp-823	220	11	,	,	PUNCT
bjp-823	220	12	campbell	campbell	PROPN
bjp-823	220	13	n.	n.	PROPN
bjp-823	220	14	management	management	NOUN
bjp-823	220	15	of	of	ADP
bjp-823	220	16	hypertension	hypertension	NOUN
bjp-823	220	17	:	:	PUNCT
bjp-823	220	18	diagnosis	diagnosis	NOUN
bjp-823	220	19	and	and	CCONJ
bjp-823	220	20	lifestyle	lifestyle	NOUN
bjp-823	220	21	modification	modification	NOUN
bjp-823	220	22	.	.	PUNCT
bjp-823	221	1	indian	indian	ADJ
bjp-823	221	2	heart	heart	NOUN
bjp-823	221	3	j.	j.	PROPN
bjp-823	221	4	2005	2005	NUM
bjp-823	221	5	;	;	PUNCT
bjp-823	221	6	57	57	NUM
bjp-823	221	7	:	:	PUNCT
bjp-823	221	8	639	639	NUM
bjp-823	221	9	-	-	SYM
bjp-823	221	10	43	43	NUM
bjp-823	221	11	.	.	PUNCT
bjp-823	221	12	davidson	davidson	PROPN
bjp-823	221	13	m.	m.	PROPN
bjp-823	221	14	statin	statin	PROPN
bjp-823	221	15	,	,	PUNCT
bjp-823	221	16	fibrate	fibrate	ADJ
bjp-823	221	17	combination	combination	NOUN
bjp-823	221	18	therapy	therapy	NOUN
bjp-823	221	19	:	:	PUNCT
bjp-823	221	20	what	what	PRON
bjp-823	221	21	is	be	AUX
bjp-823	221	22	the	the	DET
bjp-823	221	23	real	real	ADJ
bjp-823	221	24	story	story	NOUN
bjp-823	221	25	?	?	PUNCT
bjp-823	222	1	cardiology	cardiology	NOUN
bjp-823	222	2	express	express	PROPN
bjp-823	222	3	report	report	NOUN
bjp-823	222	4	.	.	PUNCT
bjp-823	223	1	usa	usa	PROPN
bjp-823	223	2	,	,	PUNCT
bjp-823	223	3	mmc	mmc	PROPN
bjp-823	223	4	,	,	PUNCT
bjp-823	223	5	inc	inc	PROPN
bjp-823	223	6	.	.	PROPN
bjp-823	223	7	,	,	PUNCT
bjp-823	223	8	14	14	NUM
bjp-823	223	9	bangladesh	bangladesh	PROPN
bjp-823	223	10	j	j	PROPN
bjp-823	223	11	pharmacol	pharmacol	PROPN
bjp-823	223	12	2008	2008	NUM
bjp-823	223	13	;	;	PUNCT
bjp-823	223	14	3	3	NUM
bjp-823	223	15	:	:	SYM
bjp-823	223	16	8	8	NUM
bjp-823	223	17	-	-	SYM
bjp-823	223	18	16	16	NUM
bjp-823	223	19	2003	2003	NUM
bjp-823	223	20	,	,	PUNCT
bjp-823	223	21	pp	pp	ADP
bjp-823	223	22	1	1	NUM
bjp-823	223	23	-	-	SYM
bjp-823	223	24	4	4	NUM
bjp-823	223	25	.	.	PUNCT
bjp-823	224	1	david	david	PROPN
bjp-823	224	2	jn	jn	PROPN
bjp-823	224	3	,	,	PUNCT
bjp-823	224	4	chistopher	chistopher	VERB
bjp-823	224	5	pp	pp	ADV
bjp-823	224	6	.	.	PUNCT
bjp-823	225	1	renal	renal	ADJ
bjp-823	225	2	function	function	NOUN
bjp-823	225	3	and	and	CCONJ
bjp-823	225	4	nitrogen	nitrogen	NOUN
bjp-823	225	5	metabolites	metabolite	NOUN
bjp-823	225	6	.	.	PUNCT
bjp-823	226	1	in	in	ADP
bjp-823	226	2	:	:	PUNCT
bjp-823	226	3	tietz	tietz	VERB
bjp-823	226	4	textbook	textbook	NOUN
bjp-823	226	5	of	of	ADP
bjp-823	226	6	clinical	clinical	ADJ
bjp-823	226	7	chemistry	chemistry	NOUN
bjp-823	226	8	.	.	PUNCT
bjp-823	227	1	5th	5th	ADJ
bjp-823	227	2	ed	ed	NOUN
bjp-823	227	3	.	.	PUNCT
bjp-823	228	1	burtis	burtis	PROPN
bjp-823	228	2	ca	can	AUX
bjp-823	228	3	,	,	PUNCT
bjp-823	228	4	ashwood	ashwood	PROPN
bjp-823	228	5	er	er	INTJ
bjp-823	228	6	(	(	PUNCT
bjp-823	228	7	eds	ed	NOUN
bjp-823	228	8	)	)	PUNCT
bjp-823	228	9	.	.	PUNCT
bjp-823	229	1	india	india	PROPN
bjp-823	229	2	,	,	PUNCT
bjp-823	229	3	harcourt	harcourt	PROPN
bjp-823	229	4	brace	brace	PROPN
bjp-823	229	5	and	and	CCONJ
bjp-823	229	6	company	company	PROPN
bjp-823	229	7	asia	asia	PROPN
bjp-823	229	8	ltd	ltd	PROPN
bjp-823	229	9	,	,	PUNCT
bjp-823	229	10	2001	2001	NUM
bjp-823	229	11	,	,	PUNCT
bjp-823	229	12	pp	pp	ADP
bjp-823	229	13	1241	1241	NUM
bjp-823	229	14	-	-	SYM
bjp-823	229	15	45	45	NUM
bjp-823	229	16	.	.	PUNCT
bjp-823	230	1	deb	deb	PROPN
bjp-823	230	2	mr	mr	PROPN
bjp-823	230	3	.	.	PROPN
bjp-823	230	4	a	a	DET
bjp-823	230	5	comparative	comparative	ADJ
bjp-823	230	6	study	study	NOUN
bjp-823	230	7	on	on	ADP
bjp-823	230	8	the	the	DET
bjp-823	230	9	effects	effect	NOUN
bjp-823	230	10	of	of	ADP
bjp-823	230	11	atorvastatin	atorvastatin	NOUN
bjp-823	230	12	administered	administer	VERB
bjp-823	230	13	alone	alone	ADV
bjp-823	230	14	and	and	CCONJ
bjp-823	230	15	in	in	ADP
bjp-823	230	16	combination	combination	NOUN
bjp-823	230	17	with	with	ADP
bjp-823	230	18	ezetimibe	ezetimibe	NOUN
bjp-823	230	19	in	in	ADP
bjp-823	230	20	the	the	DET
bjp-823	230	21	management	management	NOUN
bjp-823	230	22	of	of	ADP
bjp-823	230	23	dyslipidemia	dyslipidemia	NOUN
bjp-823	230	24	.	.	PUNCT
bjp-823	231	1	mphil	mphil	PROPN
bjp-823	231	2	thesis	thesis	PROPN
bjp-823	231	3	,	,	PUNCT
bjp-823	231	4	shahjalal	shahjalal	PROPN
bjp-823	231	5	university	university	PROPN
bjp-823	231	6	of	of	ADP
bjp-823	231	7	science	science	PROPN
bjp-823	231	8	&	&	CCONJ
bjp-823	231	9	technology	technology	PROPN
bjp-823	231	10	,	,	PUNCT
bjp-823	231	11	bangladesh	bangladesh	NOUN
bjp-823	231	12	,	,	PUNCT
bjp-823	231	13	2006	2006	NUM
bjp-823	231	14	.	.	PUNCT
bjp-823	232	1	deedwania	deedwania	PROPN
bjp-823	232	2	p	p	X
bjp-823	232	3	,	,	PUNCT
bjp-823	232	4	singh	singh	PROPN
bjp-823	232	5	v.	v.	ADP
bjp-823	232	6	coronary	coronary	ADJ
bjp-823	232	7	artery	artery	NOUN
bjp-823	232	8	disease	disease	NOUN
bjp-823	232	9	in	in	ADP
bjp-823	232	10	south	south	PROPN
bjp-823	232	11	asians	asians	PROPN
bjp-823	232	12	:	:	PUNCT
bjp-823	232	13	evolving	evolve	VERB
bjp-823	232	14	strategies	strategy	NOUN
bjp-823	232	15	for	for	ADP
bjp-823	232	16	treatment	treatment	NOUN
bjp-823	232	17	and	and	CCONJ
bjp-823	232	18	prevention	prevention	NOUN
bjp-823	232	19	.	.	PUNCT
bjp-823	233	1	indian	indian	ADJ
bjp-823	233	2	heart	heart	NOUN
bjp-823	233	3	j.	j.	PROPN
bjp-823	233	4	2005	2005	NUM
bjp-823	233	5	;	;	PUNCT
bjp-823	233	6	57	57	NUM
bjp-823	233	7	:	:	SYM
bjp-823	233	8	617	617	NUM
bjp-823	233	9	-	-	SYM
bjp-823	233	10	31	31	NUM
bjp-823	233	11	.	.	PUNCT
bjp-823	234	1	derosa	derosa	PROPN
bjp-823	234	2	g	g	PROPN
bjp-823	234	3	,	,	PUNCT
bjp-823	234	4	cicero	cicero	PROPN
bjp-823	234	5	ae	ae	PROPN
bjp-823	234	6	,	,	PUNCT
bjp-823	234	7	bertone	bertone	PROPN
bjp-823	234	8	g.	g.	PROPN
bjp-823	234	9	comparision	comparision	NOUN
bjp-823	234	10	of	of	ADP
bjp-823	234	11	fluvastatin	fluvastatin	NOUN
bjp-823	234	12	plus	plus	CCONJ
bjp-823	234	13	fenofibrate	fenofibrate	NOUN
bjp-823	234	14	combination	combination	NOUN
bjp-823	234	15	therapy	therapy	NOUN
bjp-823	234	16	and	and	CCONJ
bjp-823	234	17	fluvastatin	fluvastatin	NOUN
bjp-823	234	18	monotherapy	monotherapy	NOUN
bjp-823	234	19	in	in	ADP
bjp-823	234	20	the	the	DET
bjp-823	234	21	treatment	treatment	NOUN
bjp-823	234	22	of	of	ADP
bjp-823	234	23	combined	combined	ADJ
bjp-823	234	24	hyperlipidaemia	hyperlipidaemia	NOUN
bjp-823	234	25	,	,	PUNCT
bjp-823	234	26	type	type	NOUN
bjp-823	234	27	2	2	NUM
bjp-823	234	28	diabetes	diabetes	NOUN
bjp-823	234	29	mellitus	mellitus	NOUN
bjp-823	234	30	,	,	PUNCT
bjp-823	234	31	and	and	CCONJ
bjp-823	234	32	coronary	coronary	ADJ
bjp-823	234	33	heart	heart	NOUN
bjp-823	234	34	disease	disease	NOUN
bjp-823	234	35	:	:	PUNCT
bjp-823	234	36	a	a	DET
bjp-823	234	37	12month	12month	NOUN
bjp-823	234	38	randomized	randomized	ADJ
bjp-823	234	39	,	,	PUNCT
bjp-823	234	40	double	double	ADJ
bjp-823	234	41	-	-	PUNCT
bjp-823	234	42	blind	blind	ADJ
bjp-823	234	43	,	,	PUNCT
bjp-823	234	44	controlled	control	VERB
bjp-823	234	45	trial	trial	NOUN
bjp-823	234	46	.	.	PUNCT
bjp-823	235	1	clin	clin	PROPN
bjp-823	235	2	ther	ther	ADV
bjp-823	235	3	.	.	PUNCT
bjp-823	236	1	2004	2004	NUM
bjp-823	236	2	;	;	PUNCT
bjp-823	236	3	26	26	NUM
bjp-823	236	4	:	:	SYM
bjp-823	236	5	1599	1599	NUM
bjp-823	236	6	-	-	SYM
bjp-823	236	7	1607	1607	NUM
bjp-823	236	8	.	.	PUNCT
bjp-823	237	1	http://dx.doi.org/10.1016/	http://dx.doi.org/10.1016/	NOUN
bjp-823	237	2	j.clinthera.2004.10.008	j.clinthera.2004.10.008	VERB
bjp-823	237	3	eckardstein	eckardstein	NOUN
bjp-823	237	4	av	av	PROPN
bjp-823	237	5	.	.	PUNCT
bjp-823	237	6	introduction	introduction	NOUN
bjp-823	237	7	:	:	PUNCT
bjp-823	237	8	new	new	ADJ
bjp-823	237	9	thinking	thinking	NOUN
bjp-823	237	10	for	for	ADP
bjp-823	237	11	managing	manage	VERB
bjp-823	237	12	dyslipidemia	dyslipidemia	NOUN
bjp-823	237	13	.	.	PUNCT
bjp-823	238	1	curr	curr	PROPN
bjp-823	238	2	med	med	PROPN
bjp-823	238	3	res	re	NOUN
bjp-823	238	4	opin	opin	NOUN
bjp-823	238	5	.	.	PUNCT
bjp-823	239	1	2005	2005	NUM
bjp-823	239	2	;	;	PUNCT
bjp-823	239	3	21	21	NUM
bjp-823	239	4	s	s	NOUN
bjp-823	239	5	:	:	PUNCT
bjp-823	239	6	1	1	NUM
bjp-823	239	7	-	-	SYM
bjp-823	239	8	2	2	NUM
bjp-823	239	9	.	.	PUNCT
bjp-823	240	1	fodor	fodor	PROPN
bjp-823	240	2	jg	jg	PROPN
bjp-823	240	3	,	,	PUNCT
bjp-823	240	4	frohlich	frohlich	PROPN
bjp-823	240	5	jj	jj	PROPN
bjp-823	240	6	,	,	PUNCT
bjp-823	240	7	genest	genest	PROPN
bjp-823	240	8	jjg	jjg	PROPN
bjp-823	240	9	jr	jr	PROPN
bjp-823	240	10	,	,	PUNCT
bjp-823	240	11	mcpherson	mcpherson	PROPN
bjp-823	240	12	pr	pr	PROPN
bjp-823	240	13	.	.	PUNCT
bjp-823	241	1	recommendations	recommendation	NOUN
bjp-823	241	2	for	for	ADP
bjp-823	241	3	the	the	DET
bjp-823	241	4	management	management	NOUN
bjp-823	241	5	and	and	CCONJ
bjp-823	241	6	treatment	treatment	NOUN
bjp-823	241	7	of	of	ADP
bjp-823	241	8	dyslipidemia	dyslipidemia	NOUN
bjp-823	241	9	.	.	PUNCT
bjp-823	242	1	cmaj	cmaj	PROPN
bjp-823	242	2	.	.	PROPN
bjp-823	242	3	2000	2000	NUM
bjp-823	242	4	;	;	PUNCT
bjp-823	242	5	162	162	NUM
bjp-823	242	6	:	:	PUNCT
bjp-823	242	7	1441	1441	NUM
bjp-823	242	8	-	-	SYM
bjp-823	242	9	47	47	NUM
bjp-823	242	10	.	.	PUNCT
bjp-823	243	1	gordon	gordon	PROPN
bjp-823	243	2	t	t	PROPN
bjp-823	243	3	,	,	PUNCT
bjp-823	243	4	castalli	castalli	PROPN
bjp-823	243	5	wp	wp	PROPN
bjp-823	243	6	,	,	PUNCT
bjp-823	243	7	hjortland	hjortland	PROPN
bjp-823	243	8	mc	mc	PROPN
bjp-823	243	9	,	,	PUNCT
bjp-823	243	10	kannel	kannel	PROPN
bjp-823	243	11	wb	wb	PROPN
bjp-823	243	12	,	,	PUNCT
bjp-823	243	13	dawber	dawber	NOUN
bjp-823	243	14	tr	tr	VERB
bjp-823	243	15	.	.	NOUN
bjp-823	243	16	high	high	ADJ
bjp-823	243	17	density	density	NOUN
bjp-823	243	18	lipoprotein	lipoprotein	ADJ
bjp-823	243	19	as	as	ADP
bjp-823	243	20	a	a	DET
bjp-823	243	21	protective	protective	ADJ
bjp-823	243	22	factor	factor	NOUN
bjp-823	243	23	against	against	ADP
bjp-823	243	24	coronary	coronary	ADJ
bjp-823	243	25	heart	heart	NOUN
bjp-823	243	26	disease	disease	NOUN
bjp-823	243	27	:	:	PUNCT
bjp-823	243	28	the	the	DET
bjp-823	243	29	framingham	framingham	PROPN
bjp-823	243	30	study	study	PROPN
bjp-823	243	31	.	.	PUNCT
bjp-823	244	1	am	be	AUX
bjp-823	244	2	j	j	PROPN
bjp-823	244	3	med	med	PROPN
bjp-823	244	4	.	.	PUNCT
bjp-823	245	1	1977	1977	NUM
bjp-823	245	2	;	;	PUNCT
bjp-823	245	3	62	62	NUM
bjp-823	245	4	:	:	PUNCT
bjp-823	245	5	707	707	NUM
bjp-823	245	6	-	-	SYM
bjp-823	245	7	14	14	NUM
bjp-823	245	8	.	.	PUNCT
bjp-823	246	1	http://dx.doi.org/10.1016/0002-9343(77	http://dx.doi.org/10.1016/0002-9343(77	NUM
bjp-823	246	2	)	)	PUNCT
bjp-823	246	3	90874	90874	NUM
bjp-823	246	4	-	-	SYM
bjp-823	246	5	9	9	NUM
bjp-823	246	6	gowland	gowland	NOUN
bjp-823	246	7	e.	e.	PROPN
bjp-823	246	8	lipid	lipid	PROPN
bjp-823	246	9	and	and	CCONJ
bjp-823	246	10	lipoprotein	lipoprotein	ADJ
bjp-823	246	11	.	.	PUNCT
bjp-823	247	1	in	in	ADP
bjp-823	247	2	:	:	PUNCT
bjp-823	247	3	varley	varley	PROPN
bjp-823	247	4	’s	’s	PART
bjp-823	247	5	practical	practical	ADJ
bjp-823	247	6	clinical	clinical	ADJ
bjp-823	247	7	biochemistry	biochemistry	NOUN
bjp-823	247	8	.	.	PUNCT
bjp-823	248	1	6th	6th	ADJ
bjp-823	248	2	ed	ed	NOUN
bjp-823	248	3	.	.	PUNCT
bjp-823	249	1	gowenlock	gowenlock	VERB
bjp-823	249	2	ah	ah	INTJ
bjp-823	249	3	(	(	PUNCT
bjp-823	249	4	ed	ed	NOUN
bjp-823	249	5	)	)	PUNCT
bjp-823	249	6	.	.	PUNCT
bjp-823	250	1	london	london	PROPN
bjp-823	250	2	,	,	PUNCT
bjp-823	250	3	butterworth	butterworth	PROPN
bjp-823	250	4	heinemann	heinemann	PROPN
bjp-823	250	5	,	,	PUNCT
bjp-823	250	6	1998	1998	NUM
bjp-823	250	7	,	,	PUNCT
bjp-823	250	8	pp	pp	ADV
bjp-823	250	9	452	452	NUM
bjp-823	250	10	-	-	SYM
bjp-823	250	11	76	76	NUM
bjp-823	250	12	.	.	PUNCT
bjp-823	251	1	grundy	grundy	PROPN
bjp-823	251	2	sm	sm	PROPN
bjp-823	251	3	,	,	PUNCT
bjp-823	251	4	cleeman	cleeman	PROPN
bjp-823	251	5	ji	ji	PROPN
bjp-823	251	6	,	,	PUNCT
bjp-823	251	7	merz	merz	PROPN
bjp-823	251	8	cnb	cnb	PROPN
bjp-823	251	9	,	,	PUNCT
bjp-823	251	10	brewer	brewer	PROPN
bjp-823	251	11	hb	hb	PROPN
bjp-823	251	12	jr	jr	PROPN
bjp-823	251	13	,	,	PUNCT
bjp-823	251	14	clark	clark	PROPN
bjp-823	251	15	lt	lt	PROPN
bjp-823	251	16	,	,	PUNCT
bjp-823	251	17	hunninghake	hunninghake	NOUN
bjp-823	251	18	db	db	PROPN
bjp-823	251	19	,	,	PUNCT
bjp-823	251	20	et	et	PROPN
bjp-823	251	21	al	al	PROPN
bjp-823	251	22	.	.	PUNCT
bjp-823	251	23	implications	implication	NOUN
bjp-823	251	24	of	of	ADP
bjp-823	251	25	recent	recent	ADJ
bjp-823	251	26	clinical	clinical	ADJ
bjp-823	251	27	trials	trial	NOUN
bjp-823	251	28	for	for	ADP
bjp-823	251	29	the	the	DET
bjp-823	251	30	national	national	ADJ
bjp-823	251	31	cholesterol	cholesterol	PROPN
bjp-823	251	32	education	education	PROPN
bjp-823	251	33	program	program	NOUN
bjp-823	251	34	adult	adult	NOUN
bjp-823	251	35	panel	panel	NOUN
bjp-823	251	36	iii	iii	NUM
bjp-823	251	37	guidelines	guideline	NOUN
bjp-823	251	38	.	.	PUNCT
bjp-823	252	1	circulation	circulation	NOUN
bjp-823	252	2	2004	2004	NUM
bjp-823	252	3	;	;	PUNCT
bjp-823	252	4	110	110	NUM
bjp-823	252	5	:	:	PUNCT
bjp-823	252	6	227	227	NUM
bjp-823	252	7	-	-	SYM
bjp-823	252	8	39	39	NUM
bjp-823	252	9	.	.	PUNCT
bjp-823	253	1	h	h	PROPN
bjp-823	253	2	t	t	PROPN
bjp-823	253	3	t	t	PROPN
bjp-823	253	4	p	p	X
bjp-823	253	5	:	:	PUNCT
bjp-823	253	6	/	/	SYM
bjp-823	253	7	/	/	SYM
bjp-823	253	8	dx.doi.org/10.1161/01.cir.0000133317.49796.0e	dx.doi.org/10.1161/01.cir.0000133317.49796.0e	PROPN
bjp-823	253	9	guyton	guyton	PROPN
bjp-823	253	10	jr	jr	PROPN
bjp-823	253	11	,	,	PUNCT
bjp-823	253	12	goldberg	goldberg	PROPN
bjp-823	253	13	ac	ac	PROPN
bjp-823	253	14	,	,	PUNCT
bjp-823	253	15	kreisberg	kreisberg	PROPN
bjp-823	253	16	ra	ra	PROPN
bjp-823	253	17	,	,	PUNCT
bjp-823	253	18	sprecher	sprecher	PROPN
bjp-823	253	19	dl	dl	PROPN
bjp-823	253	20	,	,	PUNCT
bjp-823	253	21	superko	superko	PROPN
bjp-823	253	22	hr	hr	PROPN
bjp-823	253	23	,	,	PUNCT
bjp-823	253	24	o’connor	o’connor	ADV
bjp-823	253	25	cm	cm	PROPN
bjp-823	253	26	.	.	PUNCT
bjp-823	253	27	effectiveness	effectiveness	NOUN
bjp-823	253	28	of	of	ADP
bjp-823	253	29	once	once	ADV
bjp-823	253	30	-	-	PUNCT
bjp-823	253	31	nightly	nightly	ADV
bjp-823	253	32	dosing	dosing	NOUN
bjp-823	253	33	of	of	ADP
bjp-823	253	34	extended	extend	VERB
bjp-823	253	35	-	-	PUNCT
bjp-823	253	36	release	release	NOUN
bjp-823	253	37	niacin	niacin	NOUN
bjp-823	253	38	alone	alone	ADJ
bjp-823	253	39	and	and	CCONJ
bjp-823	253	40	in	in	ADP
bjp-823	253	41	combination	combination	NOUN
bjp-823	253	42	for	for	ADP
bjp-823	253	43	hypercholesterolemia	hypercholesterolemia	NOUN
bjp-823	253	44	.	.	PUNCT
bjp-823	254	1	am	be	AUX
bjp-823	254	2	j	j	PROPN
bjp-823	254	3	cardiol	cardiol	NOUN
bjp-823	254	4	.	.	PUNCT
bjp-823	255	1	1998	1998	NUM
bjp-823	255	2	;	;	PUNCT
bjp-823	255	3	82	82	NUM
bjp-823	255	4	:	:	SYM
bjp-823	255	5	737	737	NUM
bjp-823	255	6	-	-	SYM
bjp-823	255	7	43	43	NUM
bjp-823	255	8	.	.	PUNCT
bjp-823	256	1	http://	http://	PROPN
bjp-823	256	2	dx.doi.org/10.1016/s0002-9149(98)00448-2	dx.doi.org/10.1016/s0002-9149(98)00448-2	VERB
bjp-823	256	3	handerson	handerson	PROPN
bjp-823	256	4	ar	ar	PROPN
bjp-823	256	5	,	,	PUNCT
bjp-823	256	6	donald	donald	PROPN
bjp-823	256	7	wm	wm	PROPN
bjp-823	256	8	.	.	PROPN
bjp-823	256	9	enzymes	enzyme	NOUN
bjp-823	256	10	.	.	PUNCT
bjp-823	257	1	in	in	ADP
bjp-823	257	2	:	:	PUNCT
bjp-823	257	3	tietz	tietz	VERB
bjp-823	257	4	textbook	textbook	NOUN
bjp-823	257	5	of	of	ADP
bjp-823	257	6	clinical	clinical	ADJ
bjp-823	257	7	chemistry	chemistry	NOUN
bjp-823	257	8	.	.	PUNCT
bjp-823	258	1	5th	5th	ADJ
bjp-823	258	2	ed	ed	NOUN
bjp-823	258	3	.	.	PUNCT
bjp-823	259	1	burtis	burtis	PROPN
bjp-823	259	2	ca	can	AUX
bjp-823	259	3	,	,	PUNCT
bjp-823	259	4	ashwood	ashwood	PROPN
bjp-823	259	5	er	er	INTJ
bjp-823	259	6	(	(	PUNCT
bjp-823	259	7	eds	ed	NOUN
bjp-823	259	8	)	)	PUNCT
bjp-823	259	9	.	.	PUNCT
bjp-823	260	1	india	india	PROPN
bjp-823	260	2	,	,	PUNCT
bjp-823	260	3	harcourt	harcourt	PROPN
bjp-823	260	4	brace	brace	PROPN
bjp-823	260	5	and	and	CCONJ
bjp-823	260	6	company	company	PROPN
bjp-823	260	7	asia	asia	PROPN
bjp-823	260	8	ltd	ltd	PROPN
bjp-823	260	9	,	,	PUNCT
bjp-823	260	10	2001	2001	NUM
bjp-823	260	11	,	,	PUNCT
bjp-823	260	12	pp	pp	ADP
bjp-823	260	13	35289	35289	NUM
bjp-823	260	14	.	.	PUNCT
bjp-823	261	1	illingworth	illingworth	PROPN
bjp-823	261	2	dr	dr	PROPN
bjp-823	261	3	,	,	PUNCT
bjp-823	261	4	crouse	crouse	PROPN
bjp-823	261	5	jr	jr	PROPN
bjp-823	261	6	,	,	PUNCT
bjp-823	261	7	hunninghake	hunninghake	PROPN
bjp-823	261	8	db	db	PROPN
bjp-823	261	9	,	,	PUNCT
bjp-823	261	10	davidson	davidson	PROPN
bjp-823	261	11	mh	mh	PROPN
bjp-823	261	12	,	,	PUNCT
bjp-823	261	13	escobar	escobar	PROPN
bjp-823	261	14	i	i	PROPN
bjp-823	261	15	d	d	PROPN
bjp-823	261	16	,	,	PUNCT
bjp-823	261	17	stalenhoef	stalenhoef	PROPN
bjp-823	261	18	afh	afh	PROPN
bjp-823	261	19	,	,	PUNCT
bjp-823	261	20	et	et	PROPN
bjp-823	261	21	al	al	PROPN
bjp-823	261	22	.	.	PUNCT
bjp-823	262	1	a	a	DET
bjp-823	262	2	comparison	comparison	NOUN
bjp-823	262	3	of	of	ADP
bjp-823	262	4	simvastatin	simvastatin	NOUN
bjp-823	262	5	and	and	CCONJ
bjp-823	262	6	atorvastatin	atorvastatin	NOUN
bjp-823	262	7	up	up	ADP
bjp-823	262	8	to	to	ADP
bjp-823	262	9	maximal	maximal	ADJ
bjp-823	262	10	recommended	recommend	VERB
bjp-823	262	11	doses	dose	NOUN
bjp-823	262	12	in	in	ADP
bjp-823	262	13	a	a	DET
bjp-823	262	14	large	large	ADJ
bjp-823	262	15	multicenter	multicenter	NOUN
bjp-823	262	16	randomized	randomize	VERB
bjp-823	262	17	clinical	clinical	ADJ
bjp-823	262	18	trial	trial	NOUN
bjp-823	262	19	.	.	PUNCT
bjp-823	263	1	curr	curr	PROPN
bjp-823	263	2	med	med	PROPN
bjp-823	263	3	res	re	NOUN
bjp-823	263	4	opin	opin	NOUN
bjp-823	263	5	.	.	PUNCT
bjp-823	264	1	2001	2001	NUM
bjp-823	264	2	;	;	PUNCT
bjp-823	264	3	17	17	NUM
bjp-823	264	4	:	:	SYM
bjp-823	264	5	43	43	NUM
bjp-823	264	6	-50	-50	NUM
bjp-823	264	7	.	.	PUNCT
bjp-823	265	1	http://	http://	PROPN
bjp-823	265	2	dx.doi.org/10.1185/03007990152005351	dx.doi.org/10.1185/03007990152005351	NOUN
bjp-823	265	3	klosiewicz	klosiewicz	NOUN
bjp-823	265	4	-	-	PUNCT
bjp-823	265	5	latoszek	latoszek	PROPN
bjp-823	265	6	l	l	NOUN
bjp-823	265	7	,	,	PUNCT
bjp-823	265	8	szostak	szostak	PROPN
bjp-823	265	9	wb	wb	PROPN
bjp-823	265	10	,	,	PUNCT
bjp-823	265	11	grzybowska	grzybowska	ADJ
bjp-823	265	12	b	b	NOUN
bjp-823	265	13	,	,	PUNCT
bjp-823	265	14	bialobrzeska	bialobrzeska	NOUN
bjp-823	265	15	-	-	PUNCT
bjp-823	265	16	paluszkiewicz	paluszkiewicz	PROPN
bjp-823	265	17	j	j	PROPN
bjp-823	265	18	,	,	PUNCT
bjp-823	265	19	wisniewska	wisniewska	PROPN
bjp-823	265	20	b	b	NOUN
bjp-823	265	21	,	,	PUNCT
bjp-823	265	22	et	et	PROPN
bjp-823	265	23	al	al	PROPN
bjp-823	265	24	.	.	PROPN
bjp-823	265	25	comparision	comparision	NOUN
bjp-823	265	26	of	of	ADP
bjp-823	265	27	combined	combine	VERB
bjp-823	265	28	statin	statin	ADJ
bjp-823	265	29	-	-	PUNCT
bjp-823	265	30	fibrate	fibrate	NOUN
bjp-823	265	31	treatment	treatment	NOUN
bjp-823	265	32	to	to	ADP
bjp-823	265	33	monotherapy	monotherapy	NOUN
bjp-823	265	34	in	in	ADP
bjp-823	265	35	patients	patient	NOUN
bjp-823	265	36	with	with	ADP
bjp-823	265	37	mixed	mixed	ADJ
bjp-823	265	38	hyperlipidemia	hyperlipidemia	NOUN
bjp-823	265	39	.	.	PUNCT
bjp-823	266	1	kardiol	kardiol	NOUN
bjp-823	266	2	pol	pol	PROPN
bjp-823	266	3	.	.	PUNCT
bjp-823	267	1	2004	2004	NUM
bjp-823	267	2	;	;	PUNCT
bjp-823	267	3	60	60	NUM
bjp-823	267	4	:	:	SYM
bjp-823	267	5	567	567	NUM
bjp-823	267	6	-	-	SYM
bjp-823	267	7	77	77	NUM
bjp-823	267	8	.	.	PUNCT
bjp-823	268	1	koh	koh	PROPN
bjp-823	268	2	kk	kk	PROPN
bjp-823	268	3	,	,	PUNCT
bjp-823	268	4	michael	michael	PROPN
bjp-823	268	5	j	j	PROPN
bjp-823	268	6	,	,	PUNCT
bjp-823	268	7	han	han	PROPN
bjp-823	268	8	sh	sh	PROPN
bjp-823	268	9	,	,	PUNCT
bjp-823	268	10	chung	chung	PROPN
bjp-823	268	11	wj	wj	PROPN
bjp-823	268	12	,	,	PUNCT
bjp-823	268	13	ahn	ahn	PROPN
bjp-823	268	14	jy	jy	PROPN
bjp-823	268	15	,	,	PUNCT
bjp-823	268	16	seo	seo	PROPN
bjp-823	268	17	yh	yh	PROPN
bjp-823	268	18	,	,	PUNCT
bjp-823	268	19	et	et	PROPN
bjp-823	268	20	al	al	PROPN
bjp-823	268	21	.	.	PROPN
bjp-823	268	22	additive	additive	ADJ
bjp-823	268	23	beneficial	beneficial	ADJ
bjp-823	268	24	effects	effect	NOUN
bjp-823	268	25	of	of	ADP
bjp-823	268	26	fenofibrate	fenofibrate	NOUN
bjp-823	268	27	combined	combine	VERB
bjp-823	268	28	with	with	ADP
bjp-823	268	29	atorvastatin	atorvastatin	NOUN
bjp-823	268	30	in	in	ADP
bjp-823	268	31	the	the	DET
bjp-823	268	32	treatment	treatment	NOUN
bjp-823	268	33	of	of	ADP
bjp-823	268	34	combined	combined	ADJ
bjp-823	268	35	hyperlipidemia	hyperlipidemia	NOUN
bjp-823	268	36	.	.	PUNCT
bjp-823	269	1	j	j	PROPN
bjp-823	269	2	am	be	AUX
bjp-823	269	3	coll	coll	PROPN
bjp-823	269	4	cardiol	cardiol	NOUN
bjp-823	269	5	.	.	PUNCT
bjp-823	270	1	2005	2005	NUM
bjp-823	270	2	;	;	PUNCT
bjp-823	270	3	45	45	NUM
bjp-823	270	4	:	:	SYM
bjp-823	270	5	1649	1649	NUM
bjp-823	270	6	-	-	SYM
bjp-823	270	7	53	53	NUM
bjp-823	270	8	.	.	PUNCT
bjp-823	271	1	http://	http://	PROPN
bjp-823	271	2	dx.doi.org/10.1016/j.jacc.2005.02.052	dx.doi.org/10.1016/j.jacc.2005.02.052	PROPN
bjp-823	271	3	mckeigue	mckeigue	PROPN
bjp-823	271	4	pm	pm	NOUN
bjp-823	271	5	,	,	PUNCT
bjp-823	271	6	miller	miller	PROPN
bjp-823	271	7	gj	gj	PROPN
bjp-823	271	8	,	,	PUNCT
bjp-823	271	9	marmot	marmot	NOUN
bjp-823	271	10	mg	mg	PROPN
bjp-823	271	11	.	.	PUNCT
bjp-823	272	1	coronary	coronary	ADJ
bjp-823	272	2	heart	heart	NOUN
bjp-823	272	3	disease	disease	NOUN
bjp-823	272	4	in	in	ADP
bjp-823	272	5	south	south	PROPN
bjp-823	272	6	asians	asians	PROPN
bjp-823	272	7	overseas	overseas	ADV
bjp-823	272	8	:	:	PUNCT
bjp-823	272	9	a	a	DET
bjp-823	272	10	review	review	NOUN
bjp-823	272	11	.	.	PUNCT
bjp-823	273	1	j	j	PROPN
bjp-823	273	2	clin	clin	PROPN
bjp-823	273	3	epidemiol	epidemiol	PROPN
bjp-823	273	4	.	.	PROPN
bjp-823	273	5	1989	1989	NUM
bjp-823	273	6	;	;	PUNCT
bjp-823	273	7	42	42	NUM
bjp-823	273	8	:	:	PUNCT
bjp-823	273	9	597	597	NUM
bjp-823	273	10	-	-	SYM
bjp-823	273	11	609	609	NUM
bjp-823	273	12	.	.	PUNCT
bjp-823	274	1	http://dx.doi.org/10.1016/0895-4356(89)90002-4	http://dx.doi.org/10.1016/0895-4356(89)90002-4	PROPN
bjp-823	274	2	mclauchlam	mclauchlam	PROPN
bjp-823	274	3	dm	dm	PROPN
bjp-823	274	4	.	.	PUNCT
bjp-823	274	5	glucose	glucose	NOUN
bjp-823	274	6	,	,	PUNCT
bjp-823	274	7	other	other	ADJ
bjp-823	274	8	sugars	sugar	NOUN
bjp-823	274	9	and	and	CCONJ
bjp-823	274	10	ketone	ketone	NOUN
bjp-823	274	11	.	.	PUNCT
bjp-823	275	1	in	in	ADP
bjp-823	275	2	:	:	PUNCT
bjp-823	275	3	varley	varley	NOUN
bjp-823	275	4	’	'	PUNCT
bjp-823	275	5	practical	practical	ADJ
bjp-823	275	6	clinical	clinical	ADJ
bjp-823	275	7	biochemistry	biochemistry	NOUN
bjp-823	275	8	.	.	PUNCT
bjp-823	276	1	6th	6th	ADJ
bjp-823	276	2	ed	ed	NOUN
bjp-823	276	3	.	.	PUNCT
bjp-823	277	1	gowenlock	gowenlock	VERB
bjp-823	277	2	ah	ah	INTJ
bjp-823	277	3	(	(	PUNCT
bjp-823	277	4	ed	ed	NOUN
bjp-823	277	5	)	)	PUNCT
bjp-823	277	6	.	.	PUNCT
bjp-823	278	1	london	london	PROPN
bjp-823	278	2	,	,	PUNCT
bjp-823	278	3	butterworth	butterworth	PROPN
bjp-823	278	4	heinemann	heinemann	PROPN
bjp-823	278	5	,	,	PUNCT
bjp-823	278	6	1998	1998	NUM
bjp-823	278	7	;	;	PUNCT
bjp-823	278	8	pp	pp	ADP
bjp-823	278	9	320	320	NUM
bjp-823	278	10	-	-	SYM
bjp-823	278	11	32	32	NUM
bjp-823	278	12	.	.	PUNCT
bjp-823	279	1	miller	miller	PROPN
bjp-823	279	2	m.	m.	PROPN
bjp-823	279	3	niacin	niacin	PROPN
bjp-823	279	4	as	as	ADP
bjp-823	279	5	a	a	DET
bjp-823	279	6	component	component	NOUN
bjp-823	279	7	of	of	ADP
bjp-823	279	8	combination	combination	NOUN
bjp-823	279	9	therapy	therapy	NOUN
bjp-823	279	10	for	for	ADP
bjp-823	279	11	dyslipidemia	dyslipidemia	NOUN
bjp-823	279	12	.	.	PUNCT
bjp-823	280	1	mayo	mayo	NOUN
bjp-823	280	2	clinic	clinic	PROPN
bjp-823	280	3	proceedings	proceeding	NOUN
bjp-823	280	4	.	.	PUNCT
bjp-823	281	1	2003	2003	NUM
bjp-823	281	2	;	;	PUNCT
bjp-823	281	3	78	78	NUM
bjp-823	281	4	:	:	PUNCT
bjp-823	281	5	735	735	NUM
bjp-823	281	6	-	-	SYM
bjp-823	281	7	42	42	NUM
bjp-823	281	8	.	.	PUNCT
bjp-823	282	1	misra	misra	PROPN
bjp-823	282	2	a	a	PRON
bjp-823	282	3	,	,	PUNCT
bjp-823	282	4	vikram	vikram	PROPN
bjp-823	282	5	nk	nk	PROPN
bjp-823	282	6	,	,	PUNCT
bjp-823	282	7	arya	arya	PROPN
bjp-823	282	8	s	s	PROPN
bjp-823	282	9	,	,	PUNCT
bjp-823	282	10	pandey	pandey	PROPN
bjp-823	282	11	rm	rm	PROPN
bjp-823	282	12	,	,	PUNCT
bjp-823	282	13	dhingra	dhingra	PROPN
bjp-823	282	14	v.	v.	ADP
bjp-823	282	15	high	high	ADJ
bjp-823	282	16	prevalence	prevalence	NOUN
bjp-823	282	17	of	of	ADP
bjp-823	282	18	insulin	insulin	NOUN
bjp-823	282	19	resistance	resistance	NOUN
bjp-823	282	20	in	in	ADP
bjp-823	282	21	post	post	ADJ
bjp-823	282	22	-	-	ADJ
bjp-823	282	23	pubertal	pubertal	ADJ
bjp-823	282	24	asian	asian	ADJ
bjp-823	282	25	indian	indian	ADJ
bjp-823	282	26	children	child	NOUN
bjp-823	282	27	is	be	AUX
bjp-823	282	28	associated	associate	VERB
bjp-823	282	29	with	with	ADP
bjp-823	282	30	adverse	adverse	ADJ
bjp-823	282	31	truncal	truncal	ADJ
bjp-823	282	32	body	body	NOUN
bjp-823	282	33	fat	fat	NOUN
bjp-823	282	34	patterning	patterning	NOUN
bjp-823	282	35	,	,	PUNCT
bjp-823	282	36	abdominal	abdominal	ADJ
bjp-823	282	37	adiposity	adiposity	NOUN
bjp-823	282	38	and	and	CCONJ
bjp-823	282	39	excess	excess	ADJ
bjp-823	282	40	body	body	NOUN
bjp-823	282	41	fat	fat	ADJ
bjp-823	282	42	.	.	PUNCT
bjp-823	283	1	int	int	PROPN
bjp-823	284	1	j	j	PROPN
bjp-823	284	2	obes	obes	PROPN
bjp-823	284	3	relat	relat	PROPN
bjp-823	284	4	metab	metab	PROPN
bjp-823	284	5	disord	disord	NOUN
bjp-823	284	6	.	.	PUNCT
bjp-823	285	1	2004	2004	NUM
bjp-823	285	2	;	;	PUNCT
bjp-823	285	3	28	28	NUM
bjp-823	285	4	:	:	SYM
bjp-823	285	5	1217	1217	NUM
bjp-823	285	6	-	-	SYM
bjp-823	285	7	26	26	NUM
bjp-823	285	8	.	.	PUNCT
bjp-823	286	1	http://	http://	PROPN
bjp-823	286	2	dx.doi.org/10.1038/sj.ijo.0802704	dx.doi.org/10.1038/sj.ijo.0802704	PROPN
bjp-823	286	3	patel	patel	PROPN
bjp-823	286	4	jv	jv	PROPN
bjp-823	286	5	,	,	PUNCT
bjp-823	286	6	kirby	kirby	PROPN
bjp-823	286	7	m	m	PROPN
bjp-823	286	8	,	,	PUNCT
bjp-823	286	9	hughes	hughes	PROPN
bjp-823	286	10	ea	ea	PROPN
bjp-823	286	11	.	.	PUNCT
bjp-823	287	1	the	the	DET
bjp-823	287	2	lipid	lipid	ADJ
bjp-823	287	3	adults	adult	NOUN
bjp-823	287	4	:	:	PUNCT
bjp-823	287	5	analysis	analysis	NOUN
bjp-823	287	6	of	of	ADP
bjp-823	287	7	lipid	lipid	ADJ
bjp-823	287	8	management	management	NOUN
bjp-823	287	9	in	in	ADP
bjp-823	287	10	two	two	NUM
bjp-823	287	11	centres	centre	NOUN
bjp-823	287	12	in	in	ADP
bjp-823	287	13	britain	britain	PROPN
bjp-823	287	14	2003	2003	NUM
bjp-823	287	15	.	.	PUNCT
bjp-823	288	1	br	br	PROPN
bjp-823	288	2	j	j	PROPN
bjp-823	288	3	cardiol	cardiol	NOUN
bjp-823	288	4	.	.	PUNCT
bjp-823	289	1	2004	2004	NUM
bjp-823	289	2	;	;	PUNCT
bjp-823	289	3	11	11	NUM
bjp-823	289	4	:	:	SYM
bjp-823	289	5	214	214	NUM
bjp-823	289	6	-	-	SYM
bjp-823	289	7	17	17	NUM
bjp-823	289	8	.	.	PUNCT
bjp-823	290	1	rubins	rubin	NOUN
bjp-823	290	2	hb	hb	PROPN
bjp-823	290	3	,	,	PUNCT
bjp-823	290	4	robins	robin	NOUN
bjp-823	290	5	sj	sj	PROPN
bjp-823	290	6	,	,	PUNCT
bjp-823	290	7	collins	collins	PROPN
bjp-823	290	8	d	d	PROPN
bjp-823	290	9	,	,	PUNCT
bjp-823	290	10	iranmanesh	iranmanesh	ADJ
bjp-823	290	11	a	a	DET
bjp-823	290	12	,	,	PUNCT
bjp-823	290	13	wilt	wilt	ADJ
bjp-823	290	14	tj	tj	NOUN
bjp-823	290	15	,	,	PUNCT
bjp-823	290	16	rutan	rutan	PROPN
bjp-823	290	17	gh	gh	PROPN
bjp-823	290	18	,	,	PUNCT
bjp-823	290	19	et	et	PROPN
bjp-823	290	20	al	al	PROPN
bjp-823	290	21	.	.	PUNCT
bjp-823	291	1	distributions	distribution	NOUN
bjp-823	291	2	of	of	ADP
bjp-823	291	3	lipids	lipid	NOUN
bjp-823	291	4	in	in	ADP
bjp-823	291	5	8,500	8,500	NUM
bjp-823	291	6	men	man	NOUN
bjp-823	291	7	with	with	ADP
bjp-823	291	8	coronary	coronary	ADJ
bjp-823	291	9	artery	artery	NOUN
bjp-823	291	10	disease	disease	NOUN
bjp-823	291	11	.	.	PUNCT
bjp-823	292	1	department	department	PROPN
bjp-823	292	2	of	of	ADP
bjp-823	292	3	veterans	veterans	PROPN
bjp-823	292	4	affairs	affairs	PROPN
bjp-823	292	5	hdl	hdl	PROPN
bjp-823	292	6	’	'	PUNCT
bjp-823	292	7	intervention	intervention	NOUN
bjp-823	292	8	trial	trial	NOUN
bjp-823	292	9	study	study	NOUN
bjp-823	292	10	group	group	NOUN
bjp-823	292	11	.	.	PUNCT
bjp-823	293	1	am	be	AUX
bjp-823	293	2	j	j	PROPN
bjp-823	293	3	cardiol	cardiol	NOUN
bjp-823	293	4	.	.	PUNCT
bjp-823	294	1	1995	1995	NUM
bjp-823	294	2	;	;	PUNCT
bjp-823	294	3	75	75	NUM
bjp-823	294	4	:	:	SYM
bjp-823	294	5	11961201	11961201	NUM
bjp-823	294	6	.	.	PUNCT
bjp-823	295	1	rubic	rubic	PROPN
bjp-823	295	2	t	t	PROPN
bjp-823	295	3	,	,	PUNCT
bjp-823	295	4	trottmann	trottmann	PROPN
bjp-823	295	5	m	m	PROPN
bjp-823	295	6	,	,	PUNCT
bjp-823	295	7	lorenz	lorenz	PROPN
bjp-823	295	8	rl	rl	PROPN
bjp-823	295	9	.	.	PROPN
bjp-823	295	10	stimulation	stimulation	NOUN
bjp-823	295	11	of	of	ADP
bjp-823	295	12	cd36	cd36	PROPN
bjp-823	295	13	and	and	CCONJ
bjp-823	295	14	the	the	DET
bjp-823	295	15	key	key	ADJ
bjp-823	295	16	effector	effector	NOUN
bjp-823	295	17	of	of	ADP
bjp-823	295	18	reverse	reverse	ADJ
bjp-823	295	19	cholesterol	cholesterol	NOUN
bjp-823	295	20	transport	transport	NOUN
bjp-823	295	21	atp	atp	NOUN
bjp-823	295	22	-	-	PUNCT
bjp-823	295	23	binding	bind	VERB
bjp-823	295	24	cassette	cassette	NOUN
bjp-823	295	25	a1	a1	NOUN
bjp-823	295	26	in	in	ADP
bjp-823	295	27	monocytoid	monocytoid	NOUN
bjp-823	295	28	cells	cell	NOUN
bjp-823	295	29	by	by	ADP
bjp-823	295	30	niacin	niacin	PROPN
bjp-823	295	31	.	.	PUNCT
bjp-823	296	1	biochem	biochem	PROPN
bjp-823	296	2	pharmacol	pharmacol	PROPN
bjp-823	296	3	.	.	PUNCT
bjp-823	297	1	2004	2004	NUM
bjp-823	297	2	;	;	PUNCT
bjp-823	297	3	67	67	NUM
bjp-823	297	4	:	:	SYM
bjp-823	297	5	411	411	NUM
bjp-823	297	6	.	.	PUNCT
bjp-823	298	1	http://dx.doi.org/10.1016/	http://dx.doi.org/10.1016/	NOUN
bjp-823	298	2	j.bcp.2003.09.014	j.bcp.2003.09.014	VERB
bjp-823	298	3	sakai	sakai	PROPN
bjp-823	298	4	t	t	PROPN
bjp-823	298	5	,	,	PUNCT
bjp-823	298	6	kamanna	kamanna	PROPN
bjp-823	298	7	vs	vs	ADP
bjp-823	298	8	,	,	PUNCT
bjp-823	298	9	kashyap	kashyap	PROPN
bjp-823	298	10	ml	ml	PROPN
bjp-823	298	11	.	.	PUNCT
bjp-823	298	12	niacin	niacin	PROPN
bjp-823	298	13	,	,	PUNCT
bjp-823	298	14	but	but	CCONJ
bjp-823	298	15	not	not	PART
bjp-823	298	16	gemfibrozil	gemfibrozil	NOUN
bjp-823	298	17	,	,	PUNCT
bjp-823	298	18	selectively	selectively	ADV
bjp-823	298	19	increases	increase	VERB
bjp-823	298	20	lp	lp	NOUN
bjp-823	298	21	-	-	PUNCT
bjp-823	298	22	ai	ai	NOUN
bjp-823	298	23	,	,	PUNCT
bjp-823	298	24	a	a	DET
bjp-823	298	25	cardioprotective	cardioprotective	ADJ
bjp-823	298	26	subfraction	subfraction	NOUN
bjp-823	298	27	of	of	ADP
bjp-823	298	28	hdl	hdl	PROPN
bjp-823	298	29	,	,	PUNCT
bjp-823	298	30	in	in	ADP
bjp-823	298	31	patients	patient	NOUN
bjp-823	298	32	with	with	ADP
bjp-823	298	33	low	low	ADJ
bjp-823	298	34	hdl	hdl	PROPN
bjp-823	298	35	cholesterol	cholesterol	PROPN
bjp-823	298	36	.	.	PUNCT
bjp-823	299	1	arterioscler	arterioscler	PROPN
bjp-823	299	2	thromb	thromb	PROPN
bjp-823	299	3	vasc	vasc	PROPN
bjp-823	299	4	biol	biol	PROPN
bjp-823	299	5	.	.	PUNCT
bjp-823	300	1	2001	2001	NUM
bjp-823	300	2	;	;	PUNCT
bjp-823	300	3	21	21	NUM
bjp-823	300	4	:	:	PUNCT
bjp-823	300	5	73	73	NUM
bjp-823	300	6	-	-	SYM
bjp-823	300	7	79	79	NUM
bjp-823	300	8	.	.	PUNCT
bjp-823	301	1	sirtori	sirtori	PROPN
bjp-823	301	2	cr	cr	PROPN
bjp-823	301	3	.	.	PROPN
bjp-823	301	4	hdl	hdl	PROPN
bjp-823	301	5	and	and	CCONJ
bjp-823	301	6	the	the	DET
bjp-823	301	7	progression	progression	NOUN
bjp-823	301	8	of	of	ADP
bjp-823	301	9	atherosclerosis	atherosclerosis	NOUN
bjp-823	301	10	:	:	PUNCT
bjp-823	301	11	new	new	ADJ
bjp-823	301	12	insights	insight	NOUN
bjp-823	301	13	.	.	PUNCT
bjp-823	302	1	eur	eur	PROPN
bjp-823	302	2	heart	heart	NOUN
bjp-823	302	3	j	j	PROPN
bjp-823	302	4	suppl	suppl	PROPN
bjp-823	302	5	.	.	PUNCT
bjp-823	303	1	2006	2006	NUM
bjp-823	303	2	,	,	PUNCT
bjp-823	303	3	8	8	NUM
bjp-823	303	4	f	f	NOUN
bjp-823	303	5	:	:	PUNCT
bjp-823	303	6	4	4	NUM
bjp-823	303	7	-	-	SYM
bjp-823	303	8	9	9	NUM
bjp-823	303	9	.	.	PUNCT
bjp-823	303	10	staels	staels	PROPN
bjp-823	303	11	b	b	PROPN
bjp-823	303	12	,	,	PUNCT
bjp-823	303	13	auwerx	auwerx	ADJ
bjp-823	303	14	j.	j.	PROPN
bjp-823	303	15	regulation	regulation	PROPN
bjp-823	303	16	of	of	ADP
bjp-823	303	17	apoa-1gene	apoa-1gene	PROPN
bjp-823	303	18	expression	expression	NOUN
bjp-823	303	19	by	by	ADP
bjp-823	303	20	fibrates	fibrate	NOUN
bjp-823	303	21	.	.	PUNCT
bjp-823	304	1	atherosclerosis	atherosclerosis	NOUN
bjp-823	304	2	1998	1998	NUM
bjp-823	304	3	;	;	PUNCT
bjp-823	304	4	137	137	NUM
bjp-823	304	5	:	:	PUNCT
bjp-823	304	6	19	19	NUM
bjp-823	304	7	-	-	SYM
bjp-823	304	8	23	23	NUM
bjp-823	304	9	.	.	PUNCT
bjp-823	305	1	http://	http://	PROPN
bjp-823	305	2	dx.doi.org/10.1016/s0021-9150(97)00313-4	dx.doi.org/10.1016/s0021-9150(97)00313-4	NUM
bjp-823	305	3	stein	stein	PROPN
bjp-823	305	4	ea	ea	PROPN
bjp-823	305	5	,	,	PUNCT
bjp-823	305	6	davidson	davidson	PROPN
bjp-823	305	7	mh	mh	PROPN
bjp-823	305	8	,	,	PUNCT
bjp-823	305	9	dujovne	dujovne	ADJ
bjp-823	305	10	ca	ca	NOUN
bjp-823	305	11	.	.	PUNCT
bjp-823	306	1	efficacy	efficacy	NOUN
bjp-823	306	2	and	and	CCONJ
bjp-823	306	3	tolerability	tolerability	NOUN
bjp-823	306	4	of	of	ADP
bjp-823	306	5	low	low	ADJ
bjp-823	306	6	-	-	PUNCT
bjp-823	306	7	dose	dose	NOUN
bjp-823	306	8	simvastatin	simvastatin	NOUN
bjp-823	306	9	and	and	CCONJ
bjp-823	306	10	niacin	niacin	NOUN
bjp-823	306	11	,	,	PUNCT
bjp-823	306	12	alone	alone	ADJ
bjp-823	306	13	and	and	CCONJ
bjp-823	306	14	in	in	ADP
bjp-823	306	15	combination	combination	NOUN
bjp-823	306	16	,	,	PUNCT
bjp-823	306	17	in	in	ADP
bjp-823	306	18	patients	patient	NOUN
bjp-823	306	19	with	with	ADP
bjp-823	306	20	combined	combined	ADJ
bjp-823	306	21	hyperlipidemia	hyperlipidemia	NOUN
bjp-823	306	22	:	:	PUNCT
bjp-823	306	23	a	a	DET
bjp-823	306	24	bangladesh	bangladesh	NOUN
bjp-823	306	25	j	j	PROPN
bjp-823	306	26	pharmacol	pharmacol	PROPN
bjp-823	306	27	2008	2008	NUM
bjp-823	306	28	;	;	PUNCT
bjp-823	306	29	3	3	NUM
bjp-823	306	30	:	:	SYM
bjp-823	306	31	8	8	NUM
bjp-823	306	32	-	-	SYM
bjp-823	306	33	16	16	NUM
bjp-823	306	34	15	15	NUM
bjp-823	306	35	http://dx.doi.org/10.1016/j.clinthera.2004.10.008	http://dx.doi.org/10.1016/j.clinthera.2004.10.008	NOUN
bjp-823	306	36	http://dx.doi.org/10.1016/j.clinthera.2004.10.008	http://dx.doi.org/10.1016/j.clinthera.2004.10.008	NOUN
bjp-823	306	37	http://dx.doi.org/10.1016/0002-9343(77)90874-9	http://dx.doi.org/10.1016/0002-9343(77)90874-9	PROPN
bjp-823	306	38	http://dx.doi.org/10.1016/0002-9343(77)90874-9	http://dx.doi.org/10.1016/0002-9343(77)90874-9	ADJ
bjp-823	306	39	http://dx.doi.org/10.1161/01.cir.0000133317.49796.0e	http://dx.doi.org/10.1161/01.cir.0000133317.49796.0e	VERB
bjp-823	306	40	http://dx.doi.org/10.1161/01.cir.0000133317.49796.0e	http://dx.doi.org/10.1161/01.cir.0000133317.49796.0e	VERB
bjp-823	307	1	http://dx.doi.org/10.1016/s0002-9149(98)00448-2	http://dx.doi.org/10.1016/s0002-9149(98)00448-2	NOUN
bjp-823	307	2	http://dx.doi.org/10.1016/s0002-9149(98)00448-2	http://dx.doi.org/10.1016/s0002-9149(98)00448-2	NOUN
bjp-823	307	3	http://dx.doi.org/10.1185/03007990152005351	http://dx.doi.org/10.1185/03007990152005351	NOUN
bjp-823	307	4	http://dx.doi.org/10.1185/03007990152005351	http://dx.doi.org/10.1185/03007990152005351	NOUN
bjp-823	308	1	http://dx.doi.org/10.1016/j.jacc.2005.02.052	http://dx.doi.org/10.1016/j.jacc.2005.02.052	PROPN
bjp-823	308	2	http://dx.doi.org/10.1016/j.jacc.2005.02.052	http://dx.doi.org/10.1016/j.jacc.2005.02.052	PROPN
bjp-823	308	3	http://dx.doi.org/10.1016/0895-4356(89)90002-4	http://dx.doi.org/10.1016/0895-4356(89)90002-4	VERB
bjp-823	308	4	http://dx.doi.org/10.1038/sj.ijo.0802704	http://dx.doi.org/10.1038/sj.ijo.0802704	ADV
bjp-823	308	5	http://dx.doi.org/10.1038/sj.ijo.0802704	http://dx.doi.org/10.1038/sj.ijo.0802704	X
bjp-823	308	6	http://dx.doi.org/10.1016/j.bcp.2003.09.014	http://dx.doi.org/10.1016/j.bcp.2003.09.014	PROPN
bjp-823	308	7	http://dx.doi.org/10.1016/j.bcp.2003.09.014	http://dx.doi.org/10.1016/j.bcp.2003.09.014	PROPN
bjp-823	308	8	http://dx.doi.org/10.1016/s0021-9150(97)00313-4	http://dx.doi.org/10.1016/s0021-9150(97)00313-4	PROPN
bjp-823	308	9	http://dx.doi.org/10.1016/s0021-9150(97)00313-4	http://dx.doi.org/10.1016/s0021-9150(97)00313-4	PROPN
bjp-823	308	10	author	author	NOUN
bjp-823	308	11	info	info	PROPN
bjp-823	308	12	a.	a.	PROPN
bjp-823	308	13	k.	k.	PROPN
bjp-823	308	14	m.	m.	PROPN
bjp-823	308	15	mosharrof	mosharrof	PROPN
bjp-823	308	16	hossain	hossain	PROPN
bjp-823	308	17	(	(	PUNCT
bjp-823	308	18	principal	principal	ADJ
bjp-823	308	19	contact	contact	NOUN
bjp-823	308	20	)	)	PUNCT
bjp-823	309	1	e	e	NOUN
bjp-823	309	2	-	-	NOUN
bjp-823	309	3	mail	mail	NOUN
bjp-823	309	4	:	:	PUNCT
bjp-823	309	5	ahmosharrof@hotmail.com	ahmosharrof@hotmail.com	X
bjp-823	309	6	prospective	prospective	ADJ
bjp-823	309	7	trial	trial	NOUN
bjp-823	309	8	.	.	PUNCT
bjp-823	310	1	j	j	PROPN
bjp-823	310	2	cardiovasc	cardiovasc	PROPN
bjp-823	310	3	pharmacol	pharmacol	PROPN
bjp-823	310	4	.	.	PUNCT
bjp-823	310	5	1996	1996	NUM
bjp-823	310	6	;	;	PUNCT
bjp-823	310	7	1	1	NUM
bjp-823	310	8	:	:	SYM
bjp-823	310	9	107	107	NUM
bjp-823	310	10	-	-	SYM
bjp-823	310	11	16	16	NUM
bjp-823	310	12	.	.	PUNCT
bjp-823	311	1	sultana	sultana	PROPN
bjp-823	311	2	n	n	PROPN
bjp-823	311	3	,	,	PUNCT
bjp-823	311	4	haque	haque	PROPN
bjp-823	311	5	mn	mn	PROPN
bjp-823	311	6	,	,	PUNCT
bjp-823	311	7	ali	ali	PROPN
bjp-823	311	8	ms	ms	PROPN
bjp-823	311	9	,	,	PUNCT
bjp-823	311	10	begum	begum	PROPN
bjp-823	311	11	ba	ba	PROPN
bjp-823	311	12	,	,	PUNCT
bjp-823	311	13	jahan	jahan	PROPN
bjp-823	311	14	n	n	CCONJ
bjp-823	311	15	,	,	PUNCT
bjp-823	311	16	akter	akter	PROPN
bjp-823	311	17	s	s	PART
bjp-823	311	18	,	,	PUNCT
bjp-823	311	19	et	et	PROPN
bjp-823	311	20	al	al	PROPN
bjp-823	311	21	.	.	PUNCT
bjp-823	312	1	a	a	DET
bjp-823	312	2	comparative	comparative	ADJ
bjp-823	312	3	study	study	NOUN
bjp-823	312	4	of	of	ADP
bjp-823	312	5	body	body	NOUN
bjp-823	312	6	iron	iron	NOUN
bjp-823	312	7	status	status	NOUN
bjp-823	312	8	and	and	CCONJ
bjp-823	312	9	lipid	lipid	NOUN
bjp-823	312	10	profile	profile	NOUN
bjp-823	312	11	in	in	ADP
bjp-823	312	12	acute	acute	ADJ
bjp-823	312	13	myocardial	myocardial	ADJ
bjp-823	312	14	infarction	infarction	NOUN
bjp-823	312	15	patients	patient	NOUN
bjp-823	312	16	.	.	PUNCT
bjp-823	313	1	mymensingh	mymensingh	PROPN
bjp-823	313	2	med	med	PROPN
bjp-823	313	3	j.	j.	PROPN
bjp-823	313	4	2002	2002	NUM
bjp-823	313	5	;	;	PUNCT
bjp-823	313	6	11	11	NUM
bjp-823	313	7	:	:	SYM
bjp-823	313	8	87	87	NUM
bjp-823	313	9	-	-	SYM
bjp-823	313	10	90	90	NUM
bjp-823	313	11	.	.	PUNCT
bjp-823	314	1	taylor	taylor	PROPN
bjp-823	314	2	aj	aj	PROPN
bjp-823	314	3	.	.	PROPN
bjp-823	314	4	evidence	evidence	NOUN
bjp-823	314	5	to	to	PART
bjp-823	314	6	support	support	VERB
bjp-823	314	7	aggressive	aggressive	ADJ
bjp-823	314	8	management	management	NOUN
bjp-823	314	9	of	of	ADP
bjp-823	314	10	hdl	hdl	PROPN
bjp-823	314	11	-	-	PUNCT
bjp-823	314	12	cholesterol	cholesterol	NOUN
bjp-823	314	13	:	:	PUNCT
bjp-823	314	14	implications	implication	NOUN
bjp-823	314	15	of	of	ADP
bjp-823	314	16	recent	recent	ADJ
bjp-823	314	17	trials	trial	NOUN
bjp-823	314	18	.	.	PUNCT
bjp-823	315	1	eur	eur	PROPN
bjp-823	315	2	heart	heart	NOUN
bjp-823	315	3	j	j	PROPN
bjp-823	315	4	suppl	suppl	PROPN
bjp-823	315	5	.	.	PUNCT
bjp-823	316	1	2006	2006	NUM
bjp-823	316	2	,	,	PUNCT
bjp-823	316	3	8	8	NUM
bjp-823	316	4	f	f	NOUN
bjp-823	316	5	:	:	PUNCT
bjp-823	316	6	74	74	NUM
bjp-823	316	7	-	-	SYM
bjp-823	316	8	80	80	NUM
bjp-823	316	9	.	.	PUNCT
bjp-823	317	1	venkataraman	venkataraman	NOUN
bjp-823	317	2	r	r	PROPN
bjp-823	317	3	,	,	PUNCT
bjp-823	317	4	nanda	nanda	PROPN
bjp-823	317	5	nc	nc	PROPN
bjp-823	317	6	,	,	PUNCT
bjp-823	317	7	baweja	baweja	ADV
bjp-823	317	8	g	g	PROPN
bjp-823	317	9	,	,	PUNCT
bjp-823	317	10	parikh	parikh	PROPN
bjp-823	317	11	n	n	CCONJ
bjp-823	317	12	,	,	PUNCT
bjp-823	317	13	bhatia	bhatia	PROPN
bjp-823	317	14	v.	v.	CCONJ
bjp-823	317	15	prevalence	prevalence	NOUN
bjp-823	317	16	of	of	ADP
bjp-823	317	17	diabetes	diabetes	NOUN
bjp-823	317	18	mellitus	mellitus	NOUN
bjp-823	317	19	and	and	CCONJ
bjp-823	317	20	related	related	ADJ
bjp-823	317	21	conditions	condition	NOUN
bjp-823	317	22	in	in	ADP
bjp-823	317	23	asian	asian	ADJ
bjp-823	317	24	indians	indians	PROPN
bjp-823	317	25	living	live	VERB
bjp-823	317	26	in	in	ADP
bjp-823	317	27	the	the	DET
bjp-823	317	28	united	united	PROPN
bjp-823	317	29	states	states	PROPN
bjp-823	317	30	.	.	PUNCT
bjp-823	318	1	am	be	AUX
bjp-823	318	2	j	j	PROPN
bjp-823	318	3	cardiol	cardiol	NOUN
bjp-823	318	4	.	.	PUNCT
bjp-823	319	1	2004	2004	NUM
bjp-823	319	2	;	;	PUNCT
bjp-823	319	3	94	94	NUM
bjp-823	319	4	:	:	SYM
bjp-823	319	5	977	977	NUM
bjp-823	319	6	-	-	SYM
bjp-823	319	7	80	80	NUM
bjp-823	319	8	.	.	PUNCT
bjp-823	320	1	http://dx.doi.org/10.1016/j.amjcard.2004.06.048	http://dx.doi.org/10.1016/j.amjcard.2004.06.048	PROPN
bjp-823	320	2	watts	watts	PROPN
bjp-823	320	3	gf	gf	PROPN
bjp-823	320	4	,	,	PUNCT
bjp-823	320	5	dimmitt	dimmitt	PROPN
bjp-823	320	6	sb	sb	PROPN
bjp-823	320	7	.	.	PROPN
bjp-823	320	8	fibrate	fibrate	VERB
bjp-823	320	9	dyslipoproteinemia	dyslipoproteinemia	NOUN
bjp-823	320	10	and	and	CCONJ
bjp-823	320	11	cardiovascular	cardiovascular	ADJ
bjp-823	320	12	disease	disease	NOUN
bjp-823	320	13	.	.	PUNCT
bjp-823	321	1	curr	curr	PROPN
bjp-823	321	2	opin	opin	NOUN
bjp-823	321	3	lipid	lipid	NOUN
bjp-823	321	4	1999	1999	NUM
bjp-823	321	5	;	;	PUNCT
bjp-823	321	6	10	10	NUM
bjp-823	321	7	:	:	SYM
bjp-823	321	8	561	561	NUM
bjp-823	321	9	-	-	PUNCT
bjp-823	321	10	74.http://	74.http://	NOUN
bjp-823	321	11	dx.doi.org/10.1097/00041433-199912000-00011	dx.doi.org/10.1097/00041433-199912000-00011	PROPN
bjp-823	321	12	16	16	NUM
bjp-823	321	13	bangladesh	bangladesh	NOUN
bjp-823	321	14	j	j	PROPN
bjp-823	321	15	pharmacol	pharmacol	PROPN
bjp-823	321	16	2008	2008	NUM
bjp-823	321	17	;	;	PUNCT
bjp-823	321	18	3	3	NUM
bjp-823	321	19	:	:	SYM
bjp-823	321	20	8	8	NUM
bjp-823	321	21	-	-	SYM
bjp-823	321	22	16	16	NUM
bjp-823	321	23	http://dx.doi.org/10.1016/j.amjcard.2004.06.048	http://dx.doi.org/10.1016/j.amjcard.2004.06.048	PROPN
bjp-823	321	24	http://dx.doi.org/10.1097/00041433-199912000-00011	http://dx.doi.org/10.1097/00041433-199912000-00011	PROPN
bjp-823	321	25	http://dx.doi.org/10.1097/00041433-199912000-00011	http://dx.doi.org/10.1097/00041433-199912000-00011	PROPN
bjp-823	321	26	conclusion	conclusion	NOUN
bjp-823	321	27	:	:	PUNCT
bjp-823	321	28	references	reference	NOUN
bjp-823	321	29	:	:	PUNCT
bjp-823	321	30	dateprinted	dateprinte	VERB
bjp-823	321	31	:	:	PUNCT
bjp-823	321	32	this	this	DET
bjp-823	321	33	article	article	NOUN
bjp-823	321	34	was	be	AUX
bjp-823	321	35	downloaded	download	VERB
bjp-823	321	36	by	by	ADP
bjp-823	321	37	you	you	PRON
bjp-823	321	38	on	on	ADP
bjp-823	321	39	:	:	PUNCT
bjp-823	321	40	nov	nov	PROPN
bjp-823	321	41	14	14	NUM
bjp-823	321	42	,	,	PUNCT
bjp-823	321	43	2017	2017	NUM